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Summary 
 
This work is structured as follows: 
 
In Section 1 we discuss the clinical problem of heart failure. In particular, we 
present the phenomenon known as ventricular mechanical dyssynchrony: its 
impact on cardiac function, the therapy for its treatment and the methods for 
its quantification. Specifically, we describe the conductance catheter and its 
use for the measurement of dyssynchrony. At the end of the Section 1, we 
propose a new set of indexes to quantify the dyssynchrony that are studied 
and validated thereafter. 
In Section 2 we describe the studies carried out in this work: we report the 
experimental protocols, we present and discuss the results obtained. 
Finally, we report the overall conclusions drawn from this work and we try to 
envisage future works and possible clinical applications of our results. 
Ancillary studies that were carried out during this work mainly to investigate 
several aspects of cardiac resynchronization therapy (CRT) are mentioned in 
Appendix. 
 
-------- 
 
Ventricular mechanical dyssynchrony plays a regulating role already in normal 
physiology but is especially important in pathological conditions, such as 
hypertrophy, ischemia, infarction, or heart failure (Chapter 1,2.). 
Several prospective randomized controlled trials supported the clinical 
efficacy and safety of cardiac resynchronization therapy (CRT) in patients with 
moderate or severe heart failure and ventricular dyssynchrony. CRT 
resynchronizes ventricular contraction by simultaneous pacing of both left and 
right ventricle (biventricular pacing) (Chapter 1.). 
Currently, the conductance catheter method has been used extensively to 
assess global systolic and diastolic ventricular function and, more recently, 
the ability of this instrument to pick-up multiple segmental volume signals has 
been used to quantify mechanical ventricular dyssynchrony. Specifically, 
novel indexes based on volume signals acquired with the conductance 
catheter were introduced to quantify dyssynchrony (Chapter 3,4.). 
Present work was aimed to describe the characteristics of the conductance-
volume signals, to investigate the performance of the indexes of ventricular 
dyssynchrony described in literature and to introduce and validate improved 
dyssynchrony indexes. Morevoer, using the conductance catheter method 
and the new indexes, the clinical problem of the ventricular pacing site 
optimization was addressed and the measurement protocol to adopt for 
hemodynamic tests on cardiac pacing was investigated. 
 
In accordance to the aims of the work, in addition to the classical time-domain 
parameters, a new set of indexes has been extracted, based on coherent 
averaging procedure and on spectral and cross-spectral analysis (Chapter 4.). 
Our analyses were carried out on patients with indications for 
electrophysiologic study or device implantation (Chapter 5.). For the first time, 
besides patients with heart failure, indexes of mechanical dyssynchrony 
based on conductance catheter were extracted and studied in a population of 
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patients with preserved ventricular function, providing information on the 
normal range of such a kind of values. 
By performing a frequency domain analysis and by applying an optimized 
coherent averaging procedure (Chapter 6.a.), we were able to describe some 
characteristics of the conductance-volume signals (Chapter 6.b.). 
We unmasked the presence of considerable beat-to-beat variations in 
dyssynchrony that seemed more frequent in patients with ventricular 
dysfunction and to play a role in discriminating patients. These non-recurrent 
mechanical ventricular non-uniformities are probably the expression of the 
substantial beat-to-beat hemodynamic variations, often associated with heart 
failure and due to cardiopulmonary interaction and conduction disturbances. 
We investigated how the coherent averaging procedure may affect or refine 
the conductance based indexes; in addition, we proposed and tested a new 
set of indexes which quantify the non-periodic components of the volume 
signals. 
Using the new set of indexes we studied the acute effects of the CRT and the 
right ventricular pacing, in patients with heart failure and patients with 
preserved ventricular function. 
In the overall population we observed a correlation between the hemodynamic 
changes induced by the pacing and the indexes of dyssynchrony, and this 
may have practical implications for hemodynamic-guided device implantation. 
The optimal ventricular pacing site for patients with conventional indications 
for pacing remains controversial. The majority of them do not meet current 
clinical indications for CRT pacing. Thus, we carried out an analysis to 
compare the impact of several ventricular pacing sites on global and regional 
ventricular function and dyssynchrony (Chapter 6.c.). We observed that right 
ventricular pacing worsens cardiac function in patients with and without 
ventricular dysfunction unless the pacing site is optimized. CRT preserves left 
ventricular function in patients with normal ejection fraction and improves 
function in patients with poor ejection fraction despite no clinical indication for 
CRT. Moreover, the analysis of the results obtained using new indexes of 
regional dyssynchrony, suggests that pacing site may influence overall global 
ventricular function depending on its relative effects on regional function and 
synchrony. 
Another clinical problem that has been investigated in this work is the optimal 
right ventricular lead location for CRT (Chapter 6.d.). Similarly to the previous 
analysis, using novel parameters describing local synchrony and efficiency, 
we tested the hypothesis and we demonstrated that biventricular pacing with 
alternative right ventricular pacing sites produces acute improvement of 
ventricular systolic function and improves mechanical synchrony when 
compared to standard right ventricular pacing. Although no specific right 
ventricular location was shown to be superior during CRT, the right ventricular 
pacing site that produced the optimal acute hemodynamic response varied 
between patients. 
 
Acute hemodynamic effects of cardiac pacing are conventionally evaluated 
after stabilization episodes. The applied duration of stabilization periods in 
most cardiac pacing studies varied considerably. 
With an ad hoc protocol (Chapter 6.e.) and indexes of mechanical 
dyssynchrony derived by conductance catheter we demonstrated that the 
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usage of stabilization periods during evaluation of cardiac pacing may mask 
early changes in systolic and diastolic intra-ventricular dyssynchrony. In fact, 
at the onset of ventricular pacing, the main dyssynchrony and ventricular 
performance changes occur within a 10s time span, initiated by the changes 
in ventricular mechanical dyssynchrony induced by aberrant conduction and 
followed by a partial or even complete recovery. 
It was already demonstrated in normal animals that ventricular mechanical 
dyssynchrony may act as a physiologic modulator of cardiac performance 
together with heart rate, contractile state, preload and afterload. The present 
observation, which shows the compensatory mechanism of mechanical 
dyssynchrony, suggests that ventricular dyssynchrony may be regarded as an 
intrinsic cardiac property, with baseline dyssynchrony at increased level in 
heart failure patients. 
To make available an independent system for cardiac output estimation, in 
order to confirm the results obtained with conductance volume method, we 
developed and validated a novel technique to apply the Modelflow method (a 
method that derives an aortic flow waveform from arterial pressure by 
simulation of a non-linear three-element aortic input impedance model, 
Wesseling et al. 1993) to the left ventricular pressure signal, instead of the 
arterial pressure used in the classical approach (Chapter 7.). 
The results confirmed that in patients without valve abnormalities, undergoing 
conductance catheter evaluations, the continuous monitoring of cardiac output 
using the intra-ventricular pressure signal is reliable. Thus, cardiac output can 
be monitored quantitatively and continuously with a simple and low-cost 
method. 
During this work, additional studies were carried out to investigate several 
areas of uncertainty of CRT. The results of these studies are briefly presented 
in Appendix: the long-term survival in patients treated with CRT in clinical 
practice, the effects of CRT in patients with mild symptoms of heart failure and 
in very old patients, the limited thoracotomy as a second choice alternative to 
transvenous implant for CRT delivery, the evolution and prognostic 
significance of diastolic filling pattern in CRT, the selection of candidates to 
CRT with echocardiographic criteria and the prediction of response to the 
therapy. 
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Introduction 
 
Ventricular contraction normally occurs in a highly coordinated manner. 
Mechanical activation of the ventricles depends on the rapid spread of electric 
signals via specialized fibers (His-Purkinje system) that arborize throughout 
the right ventricular and left ventricular endocardia. In patients with slowed-
down or blocked His-Purkinje activation left ventricular activation and 
contraction become dyssynchronous.  
Ventricular mechanical dyssynchrony is most commonly identified clinically by 
a prolonged QRS duration with left bundle-branch block morphology on 
surface electrocardiogram but can also be detected by echocardiographic 
imaging of contraction timing. 
Ventricular mechanical dyssynchrony plays a regulating role already in normal 
physiology but is especially important in pathological conditions, such as 
hypertrophy, ischemia, infarction, or heart failure. Dyssynchrony exacerbates 
heart failure in a variety of ways, generating cardiac inefficiency as well as 
pathobiologic changes at the tissue, cellular, and molecular levels (Chapter 
1.b.). 
The abnormal activation sequence induced by spontaneous conduction 
defects or by right ventricular pacing generates changes in regional 
ventricular loading conditions, possibly redistributes myocardial blood flow, 
and creates a regional non-uniform myocardial metabolism. These effects of 
ventricular dyssynchrony might contribute to disease progression in left 
ventricle systolic dysfunction patients. Moreover, it is likely that these 
consequences of ventricular dyssynchrony lead to rearrangement of both 
contractile and non-contractile cellular elements and perhaps the extra-
cellular matrix in the heart, thus stimulating the process of ventricular 
remodeling. Therefore, it is conceivable that dyssynchrony represents a newly 
appreciated patho-physiological process that directly depresses ventricular 
function and ultimately leads to ventricular dilatation and heart failure (Chapter 
1.b.i.). 
An overwhelming amount of evidence from prospective randomized controlled 
trials supports the clinical efficacy and safety of cardiac resynchronization 
therapy (CRT) in patients with moderate or severe heart failure and ventricular 
dyssynchrony. 
In CRT, simultaneous pacing of both left and right ventricle (biventricular 
pacing) is delivered to resynchronize ventricular contraction. With biventricular 
pacing, separate pacing leads are placed to stimulate the ventricles. A third 
pacing lead is placed in the right atrium to permit the synchronization of the 
ventricular pacing to the atrial depolarization. CRT makes heart failure 
patients feel better, improves cardiac structure and function, and reduces all-
cause as well as heart failure morbidity and mortality. Thus, there may be a 
clinical mandate for use of CRT in many patients with chronic heart failure 
(Chapter 1.b.ii.). 
However, a number of key clinical research questions remain, perhaps most 
importantly the issue of why apparently suitable patients do not respond to 
CRT. Rates of non-response to CRT are quoted as 20–30%. These issues 
are also relevant to patients who do respond to CRT as potentially their 
response might be further increased. 
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The data indicates that the extent of mechanical dyssynchrony and left 
ventricular pacing site are likely to be important. In fact, as all patients with a 
ventricular conduction abnormality may not benefit from CRT and some 
patients with a normal QRS duration derive benefit from this therapy, it is 
logical to conclude that electrically measured ventricular dyssynchrony (by 
ECG) is a relatively crude reflection of mechanical ventricular dyssynchrony 
and it is reasonable to consider new techniques for quantifying the degree of 
mechanical dyssynchrony (Chapter 2.). 
In this context, echocardiography-guided measurements of ventricular 
dyssynchrony are as yet not standardized, and none of the reported variables 
have been prospectively tested. 
Acute hemodynamic studies have suggested that pacing site is crucial for 
improving ventricular mechanics. Thus, it can be postulated that non-
responder patients are paced at a suboptimal site. Recent echocardiographic 
studies have shown that in a substantial proportion of patients, the 
anatomically selected pacing site does not always coincide with ventricular 
regions having large mechanical delay. 
Whether MRI or echocardiography will help in identifying the most optimal 
pacing site is still under investigation. 
In conclusion, it will be useful if additional methods can be developed that 
identify dyssynchrony in the human heart in a more sensitive and specific 
way, and potentially helpful if they are utilized to help place CRT leads in the 
future. Ensuring that dyssynchrony has been eliminated by careful selection of 
the ventricular locations for CRT may reduce the number of non-responders 
to this form of therapy. 
Currently, the conductance catheter method has been used extensively to 
assess global systolic and diastolic ventricular function (Chapter 3.) and more 
recently the ability of this instrument to pick-up multiple segmental volume 
signals has been used to quantify mechanical ventricular dyssynchrony 
(Chapter 4.a.). 
 
The aims of this work were: 
- To describe the characteristics of the conductance-volume signals by 
means of the analysis in frequency domain and using coherent averaging, 
in order to investigate the performance and the potential limitations of the 
indexes of ventricular dyssynchrony introduced by Steendijk et al. (Am J 
Physiol 2004); 
- To introduce new improved indexes to quantify the dyssynchrony, and to 
assess their ability to discriminate patients with and without ventricular 
dysfunction as well as describe the effects of cardiac pacing; 
- To address the clinical problem of the ventricular pacing site optimization 
for CRT and for conventional right ventricular pacing, using the 
conductance catheter method and the new indexes that have been 
derived; 
- To investigate the measurement protocol to adopt for hemodynamic tests 
on cardiac pacing. 
 
The analyses included in this work were carried out on patients with 
indications for electrophysiologic study or device implantation. For the first 
time, besides patients with heart failure, indexes of mechanical dyssynchrony 
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based on conductance catheter were extracted and studied in a population of 
patients with preserved ventricular function, providing information on the 
normal range of such a kind of values. 
In addition to the classical time-domain parameters, a new set of indexes has 
been extracted, based on coherent averaging procedure and on spectral and 
cross-spectral analysis. We performed a frequency domain analysis and we 
applied an optimized coherent averaging procedure in order to describe some 
characteristics of the conductance-volume signals. 
We investigated how the coherent averaging procedure may affect or refine 
the conductance based indexes; in addition, we proposed and tested a new 
set of indexes which quantify the non-periodic components of the volume 
signals. 
Using the new set of indexes we studied the acute effects of the CRT and the 
right ventricular pacing, in patients with heart failure and patients with 
preserved ventricular function. 
Moreover, using conductance catheter technique and the new indexes of 
ventricular dyssynchrony we studied the impact of several ventricular pacing 
sites on global and regional ventricular function and dyssynchrony, and we 
investigated the optimal right ventricular lead location for CRT 
A further protocol was carried out to assess how the stabilization periods that 
are usually applied to study the acute hemodynamic effects of cardiac pacing 
and that in most studies varied considerably, may affect the results of the 
analysis. 
Finally, we developed and validated a novel technique to derive an aortic flow 
waveform from the left ventricular pressure signal to estimate the cardiac 
output, in order to confirm the results obtained with conductance volume 
method. 
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1. The Clinical Problem 
1.a. Heart Failure 
1.a.i. Definition of Heart Failure 
 
Heart failure (HF) is a complex clinical syndrome that can result from any 
structural or functional cardiac disorder that impairs the ability of the ventricle 
to fill with or eject blood (1). 
The cardinal manifestations of HF are dyspnea and fatigue, which may limit 
exercise tolerance, and fluid retention, which may lead to pulmonary 
congestion and peripheral edema. Both abnormalities can impair the 
functional capacity and quality of life of affected individuals, but they do not 
necessarily dominate the clinical picture at the same time. Some patients 
have exercise intolerance but little evidence of fluid retention, whereas others 
complain primarily of edema and report few symptoms of dyspnea or fatigue. 
The clinical syndrome of HF may result from disorders of the pericardium, 
myocardium, endocardium, or great vessels, but the majority of patients with 
HF has symptoms due to an impairment of left ventricle (LV) myocardial 
function. Heart failure may be associated with a wide spectrum of LV 
functional abnormalities, which may range from patients with normal LV size 
and preserved ejection fraction (EF) to those with severe dilatation and/or 
markedly reduced EF. In most patients, abnormalities of systolic and diastolic 
dysfunction coexist, regardless of EF. Patients with normal EF may have a 
different natural history and may require different treatment strategies than 
patients with reduced EF, although such differences remain controversial. 
Coronary artery disease, hypertension, and dilated cardiomyopathy are the 
causes of HF in a substantial proportion of patients in the Western world. As 
many as 30% of patients with dilated cardiomyopathy may have a genetic 
cause (2). Valvular heart disease is still a common cause of HF. In fact, nearly 
any form of heart disease may ultimately lead to the HF syndrome. 
 
1.a.ii. Heart Failure as a Symptomatic Disorder 
 
The approach that is most commonly used to quantify the degree of functional 
limitation imposed by HF is one first developed by the New York Heart 
Association (NYHA). This system assigns patients to 1 of 4 functional classes, 
depending on the degree of effort needed to elicit symptoms: patients may 
have symptoms of HF at rest (class IV), on less-than-ordinary exertion (class 
III), on ordinary exertion (class II), or only at levels of exertion that would limit 
normal individuals (class I). Although the functional class tends to deteriorate 
over periods of time, most patients with HF do not typically show an 
uninterrupted and inexorable worsening of symptoms. Instead, the severity of 
symptoms characteristically fluctuates even in the absence of changes in 
medications, and changes in medications and diet can have either favorable 
or adverse effects on functional capacity in the absence of measurable 
changes in ventricular function. Some patients may demonstrate remarkable 
recovery, sometimes associated with improvement in structural and functional 
abnormalities. Usually, sustained improvement is associated with drug 
therapy, and that therapy should be continued indefinitely. 
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The mechanisms responsible for the exercise intolerance of patients with 
chronic HF have not been defined clearly. Although HF is generally regarded 
as a hemodynamic disorder, many studies have indicated that there is a poor 
relation between measures of cardiac performance and the symptoms 
produced by the disease. Patients with a very low EF may be asymptomatic, 
whereas patients with preserved EF may have severe disability. The apparent 
discordance between EF and the degree of functional impairment is not well 
understood but may be explained in part by alterations in ventricular 
distensibility, valvular regurgitation, pericardial restraint, cardiac rhythm, 
conduction abnormalities, and right ventricular function (2). In addition, in 
ambulatory patients, many noncardiac factors may contribute substantially to 
exercise intolerance. These factors include but are not limited to changes in 
peripheral vascular function, skeletal muscle physiology, pulmonary 
dynamics, neurohormonal and reflex autonomic activity, and renal sodium 
handling. The existence of these noncardiac factors may explain why the 
hemodynamic improvement produced by therapeutic agents in patients with 
chronic HF may not be immediately or necessarily translated into clinical 
improvement. Although pharmacological interventions may produce rapid 
changes in hemodynamic variables, signs and symptoms may improve slowly 
over weeks or months or not at all. 
 
1.a.iii. Heart Failure as a Progressive Disorder 
 
Left ventricular dysfunction begins with some injury to, or stress on, the 
myocardium and is generally a progressive process, even in the absence of a 
new identifiable insult to the heart. The principal manifestation of such 
progression is a change in the geometry and structure of the LV, such that the 
chamber dilates and/or hypertrophies and becomes more spherical — a 
process referred to as cardiac remodeling. This change in chamber size and 
structure not only increases the hemodynamic stresses on the walls of the 
failing heart and depresses its mechanical performance but may also increase 
regurgitant flow through the mitral valve. These effects, in turn, serve to 
sustain and exacerbate the remodeling process. Cardiac remodeling generally 
precedes the development of symptoms (occasionally by months or even 
years), continues after the appearance of symptoms, and contributes 
substantially to worsening of symptoms despite treatment. 
Progression of coronary artery disease, diabetes mellitus, hypertension, or the 
onset of atrial fibrillation may also contribute to the progression of HF. The 
development of structural abnormalities can have 1 of 3 outcomes: patients 
die before developing symptoms, patients develop symptoms controlled by 
treatment, or patients die of progressive HF. Sudden death can interrupt this 
course at any time. 
Although several factors can accelerate the process of LV remodeling, there 
is substantial evidence that the activation of endogenous neurohormonal 
systems plays an important role in cardiac remodeling and thereby in the 
progression of HF. Patients with HF have elevated circulating or tissue levels 
of norepinephrine, angiotensin II, aldosterone, endothelin, vasopressin, and 
cytokines, which can act (alone or in concert) to adversely affect the structure 
and function of the heart. These neurohormonal factors not only increase the 
hemodynamic stresses on the ventricle by causing sodium retention and 
 13
peripheral vasoconstriction but may also exert direct toxic effects on cardiac 
cells and stimulate myocardial fibrosis, which can further alter the architecture 
and impair the performance of the failing heart. Neurohormonal activation also 
has direct deleterious effects on the myocytes and interstitium, altering the 
performance and phenotype of these cells. The development of HF can be 
appropriately characterized by considering 4 stages of the disease. This 
staging system recognizes that HF, like coronary artery disease, has 
established risk factors and structural prerequisites; that the development of 
HF has asymptomatic and symptomatic phases; and that specific treatments 
targeted at each stage can reduce the morbidity and mortality of HF (Figure 
1). 
 
 
 
 
 
Figure 1. Stages in the development of HF/recommended therapy by stage. FHx CM 
indicates family history of cardiomyopathy; ACEI, angiotensin converting enzyme inhibitors; 
and ARB, angiotensin receptor blocker. (From 1) 
 
 
1.a.iv. The Current Treatment 
 
Most patients with HF should be routinely managed with a combination of 3 
types of drugs: a diuretic, an Angiotensin Converting Enzyme Inhibitor (ACEI), 
and a beta-blocker (3). The value of these drugs has been established by the 
results of numerous large-scale clinical trials, and the evidence supporting a 
central role for their use is compelling and persuasive. Patients with evidence 
of fluid retention should take a diuretic until a euvolemic state is achieved, and 
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diuretic therapy should be continued to prevent the recurrence of fluid 
retention. Even if the patient has responded favorably to the diuretic, 
treatment with both an ACEI and a beta-blocker should be initiated and 
maintained in patients who can tolerate them because they have been shown 
to favorably influence the long-term prognosis of HF. 
Therapy with digoxin as a fourth agent may be initiated at any time to reduce 
symptoms, prevent hospitalization, control rhythm, and enhance exercise 
tolerance. 
 
Diuretics 
Controlled trials have demonstrated the ability of diuretic drugs to increase 
urinary sodium excretion and decrease physical signs of fluid retention in 
patients with HF. In these short-term studies, diuretic therapy has led to a 
reduction in jugular venous pressures, pulmonary congestion, peripheral 
edema, and body weight, all of which were observed within days of initiation 
of therapy. In intermediate-term studies, diuretics have been shown to 
improve cardiac function, symptoms, and exercise tolerance in patients with 
HF. There have been no long-term studies of diuretic therapy in HF, and thus, 
their effects on morbidity and mortality are not known. 
 
Angiotensin Converting Enzyme Inhibitors 
Angiotensin converting enzyme inhibitors have been evaluated in more than 
7000 patients with HF who participated in more than 30 placebo-controlled 
clinical trials. 
Analysis of this collective experience indicates that ACEIs can alleviate 
symptoms, improve clinical status, and enhance the overall sense of well-
being of patients with HF. In addition, ACEIs can reduce the risk of death and 
the combined risk of death or hospitalization. These benefits of ACE inhibition 
were seen in patients with mild, moderate, or severe symptoms and in 
patients with or without coronary artery disease. 
 
Beta-adrenergic receptor blockers. 
Beta-blockers act principally to inhibit the adverse effects of the sympathetic 
nervous system in patients with HF, and these effects far outweigh their well-
known negative inotropic overeffects. Whereas cardiac adrenergic drive 
initially supports the performance of the failing heart, long-term activation of 
the sympathetic nervous system exerts deleterious effects that can be 
antagonized by the use of beta-blockers. Sympathetic activation can increase 
ventricular volumes and pressure by causing peripheral vasoconstriction and 
by impairing sodium excretion by the kidneys. Norepinephrine can also induce 
cardiac hypertrophy but restrict the ability of the coronary arteries to supply 
blood to the thickened ventricular wall, leading to myocardial ischemia. 
Activation of the sympathetic nervous system can also provoke arrhythmias 
by increasing the automaticity of cardiac cells, increasing triggered activity in 
the heart, and promoting the development of hypokalemia. Norepinephrine 
can also increase heart rate and potentiate the activity and actions of other 
neurohormonal systems. Finally, by stimulating growth and oxidative stress in 
terminally differentiated cells, norepinephrine can trigger programmed cell 
death or apoptosis. These deleterious effects are mediated through actions on 
alpha-1–, beta-1–, and beta-2–adrenergic receptors. 
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Betablockers have now been evaluated in more than 20 000 patients with HF 
who participated in more than 20 published placebo-controlled clinical trials. 
This collective experience indicates that long-term treatment with beta-
blockers can lessen the symptoms of HF, improve the clinical status of 
patients, and enhance the patient’s overall sense of well-being. In addition, 
like ACEIs, beta-blockers can reduce the risk of death and the combined risk 
of death or hospitalization. 
 
Non pharmacological treatment of HF – Implantable Cardioverter Defibrillators 
Patients with LV dilation and reduced EF frequently manifest ventricular 
tachyarrhythmias, both nonsustained ventricular tachycardia (VT) and 
sustained VT. The cardiac mortality of patients with all types of ventricular 
tachyarrhythmias is high. 
Patients with previous cardiac arrest or documented sustained ventricular 
arrhythmias have a high risk of recurrent events. Implantation of an 
implantable cardioverter defibrillator (ICD) has been shown to reduce mortality 
in cardiac arrest survivors. An ICD is indicated for secondary prevention of 
death from ventricular tachyarrhythmias in patients with otherwise good 
clinical function and prognosis, for whom prolongation of survival is a goal. 
Patients with chronic HF and a low EF who experience syncope of unclear 
origin have a high rate of subsequent sudden death and should also be 
considered for placement of an ICD (4). 
Patients with low EF without prior history of cardiac arrest, spontaneous VT, 
or inducible VT (positive programmed electrical stimulation study) have a risk 
of sudden death that is lower than for those who have experienced previous 
events, but it remains significant. 
The role of ICDs in the primary prevention of sudden death in patients without 
prior history of symptomatic arrhythmias has been explored recently in a 
number of trials. If sustained ventricular tachyarrhythmias can be induced in 
the electrophysiology laboratory in patients with previous myocardial infarction 
or chronic ischemic heart disease, the risk of sudden death in these patients 
is in the range of 5% to 6% per year and can be improved by ICD implantation 
(5). The role of ICD implantation for the primary prevention of sudden death in 
patients with HF and low EF and no history of spontaneous or inducible VT 
has been addressed by several large trials. The first of these demonstrated 
that ICDs, compared with standard medical therapy, decreased the 
occurrence of total mortality for patients with EF less than or equal to 30% 
after remote myocardial infarction (6). Absolute mortality was decreased in the 
ICD arm by 5.6%, a relative decrease of 31% over 20 months. A second trial 
examining the benefit of ICD implantation for patients with EF less than 35% 
and NYHA class II to III symptoms of HF included both ischemic and 
nonischemic causes of HF; absolute mortality was decreased by 7.2% over a 
5-year period in the arm that received an ICD. This represented a relative 
mortality decrease of 23%, which was a survival increase of 11% (7).  
 
1.a.v. Epidemiology and Economic Impact of Chronic Heart Failure 
 
Heart failure is a major and growing public health problem.  
Heart failure is diagnosed in 1–2% of the general population in developed 
countries (8). Approximately 5 million patients in the United States have HF, 
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and over 550 000 patients are diagnosed with HF for the first time each year 
(9). The disorder is the primary reason for 12 to 15 million office visits and 6.5 
million hospital days each year (10). From 1990 to 1999, the annual number 
of hospitalizations has increased from approximately 810 000 to over 1 million 
for HF as a primary diagnosis and from 2.4 to 3.6 million for HF as a primary 
or secondary diagnosis (11). In 2001, nearly 53 000 patients died of HF as a 
primary cause. The number of HF deaths has increased steadily despite 
advances in treatment, in part because of increasing numbers of patients with 
HF due to better treatment and “salvage” of patients with acute myocardial 
infarctions earlier in life (9). 
Heart failure is primarily a condition of the elderly (12), and thus the widely 
recognized “aging of the population” also contributes to the increasing 
incidence of HF. The incidence of HF approaches 10 per 1000 population 
after age 65 (9), and approximately 80% of patients hospitalized with HF are 
more than 65 years old (13). 
Direct costs due to HF were (in one million per one million population) 26 in 
the UK, 37 in Germany, 39 in France and 70 in the US, respectively. In the US 
$ 38 billion have been spent for patients with chronic HF in 1991 and the 
expenditures for HF were higher than that for the treatment of cancer and 
myocardial infarction (10). 
Overall, chronic HF consumes 1–2% of the total healthcare resources in the 
developed countries. The economic burden of HF may become 
unmanageable in the setting of an ageing population indicating the need for 
cost-effective treatment options and preventive strategies. 
Repeated hospitalizations are not only a powerful marker of poor prognosis 
and of poor life quality but also for increased costs for the health care system. 
The direct costs are mainly attributed to hospitalizations (approximately 75%), 
with an average cost of approximately 10,000 per patient per hospitalization 
(10). In the EuroHeart Failure survey programme 24% of patients had been 
readmitted to hospital within 12 weeks of discharge (14). The three main 
causes of hospitalizations due to chronic heart failure are sodium retention 
(55% of cases), angina or myocardial infarction (25%) and arrhythmia (15%) 
(15). 
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1.b. Ventricular Dyssynchrony 
 
Recently, poorly synchronized activation of the LV itself has been shown to 
compromise global systolic function and has been linked to increased 
morbidity, arrhythmia susceptibility, and mortality in patients with HF (16-18). 
Ventricular contraction normally occurs in a highly coordinated manner. 
Mechanical activation of the ventricles depends on the rapid spread of electric 
signals via specialized fibers (His-Purkinje system) that arborize throughout 
the right ventricular (RV) and LV endocardia (19). Normal activation occurs 
from the endocardium to the epicardium (20) as well as from the apex to the 
base (21) and is nearly coincident in all regions of the LV. In patients with 
slowed-down or blocked His-Purkinje activation (a circumstance frequently 
compounded by sluggish intramyocardial conduction) (22), LV activation and 
contraction become dyssynchronous. 
Dyssynchrony plays a regulating role already in normal physiology (23) but is 
especially important in pathological conditions, such as hypertrophy (24), 
ischemia (25), infarction (26), or HF (27). 
This is most commonly identified clinically by a prolonged QRS duration with 
left bundle-branch block (LBBB) morphology on surface electrocardiogram but 
can also be detected by echocardiographic imaging of contraction timing. 
Dyssynchrony exacerbates HF in a variety of ways, generating cardiac 
inefficiency as well as pathobiologic changes at the tissue, cellular, and 
molecular levels. Established predictors of HF mortality include age, degree of 
LV systolic impairment, and NYHA functional class. Recently, intraventricular 
LV dyssynchrony (identified either indirectly through QRS prolongation on 
surface electrocardiogram or directly by tissue Doppler echocardiography) 
has been identified as an independent powerful predictor of mortality in 
patients with HF (16,17). 
Iuliano et al (16) investigated the prognostic significance of QRS duration in 
the CHF-STAT patient cohort, retrospectively analyzing mortality trends in 669 
patients with HF. Over a period of 45 months, 272 deaths occurred (41% 
mortality rate), with sudden death accounting for roughly half of those events. 
The mortality rate was significantly higher in patients with a QRS duration 
longer than 120 milliseconds (49.3%) as compared with patients with a QRS 
duration shorter than 120 milliseconds (34%). 
Independent predictors of mortality (after controlling for EF, age, NYHA class, 
etiology of dilated cardiomyopathy, LBBB, and medical therapy) included QRS 
duration, EF, and NYHA class. Although LBBB morphology on 
electrocardiogram was associated with increased mortality rates, right bundle-
branch block (RBBB) morphology was not. 
In a similar study, Baldasseroni et al (17) investigated 1-year mortality in 5517 
patients enrolled in the Italian Network on Congestive Heart Failure Registry. 
Complete LBBB (QRS duration >140ms) was present in 25%, complete RBBB 
was in 6%, and other intraventricular delays were in 6% of the patients. 
Overall mortality was 11.9%, with sudden death accounting for 46% of total 
deaths. Mortality in patients with LBBB was 16% (vs that of 11% in patients 
with RBBB and that of 8% in patients with other forms of bundle-branch 
block). After controlling for multiple covariates (age, etiology of disease, EF, 
NYHA class, medical therapy with beta-blockers and angiotensin-converting 
enzyme inhibitors, third heart sound, atrial fibrillation, ventricular tachycardia), 
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LBBB was found to be an independent predictor of both overall mortality and 
mortality from sudden cardiac death. 
Dyssynchrony can also be induced by an artificial pacemaker, and evidence 
suggests that this can itself lead to LV systolic failure (see Appendix.a.). 
 
1.b.i. Impact of Ventricular Dyssynchrony on Chamber Function 
 
Left ventricular dyssynchrony typically results from delay in the activation of 
the lateral LV free wall and is manifest frequently (but not necessarily) as 
LBBB on surface electrocardiogram. Contraction of the septum and anterior 
LV in early systole results in pre-stretch of the still-quiescent lateral wall, 
delaying intracavitary pressure rise and mitral valve closure. Late systolic 
activation of the LV lateral free wall leads to a corresponding stretch of the 
anteroseptal region, thereby competing with aortic ejection and reducing net 
cardiac output. The result is mechanical inefficiency, with transmission of the 
ventricular blood pool between 2 intracavitary sinks (the stretched lateral wall 
in early systole and the anteroseptal region in late systole). Functional mitral 
regurgitation, caused by delay in both the rise in LV intracavitary pressure and 
discoordinate papillary muscle contraction, can exacerbate this inefficiency 
further. 
The immediate effects of LV dyssynchrony on global systolic function have 
been demonstrated quantitatively through pacing studies on both ex vivo 
whole organ preparations and in vivo models. Compared with atrial pacing 
and activation of the LV through the His-Purkinje network, RV pacing causes 
reductions in net generated LV pressure (28, 29), dP/dtmax (30), stroke 
volume (29), and the slope of the end-systolic pressure-volume relationship 
(ESPVR) (28). Right ventricular pacing–induced dyssynchrony also shifts the 
ESPVR to the right (29), demonstrating a load-independent compromise of LV 
mechanical function. Many of the deleterious effects of pacing-induced 
dyssynchrony are best appreciated in ventricular pressure-volume loop 
tracings (Figure 2B). 
In addition to a rightward shift in the ESPVR, stroke volume in paced 
dyssynchronous ventricles is decreased (29), leading to increased LV end-
systolic volume and, in turn, increased LV end-systolic wall stress. Recent 
investigations of regional myocardial work by tagged magnetic resonance 
imaging of dyssynchronous hearts have further defined the mechanical 
inefficiency generated by LV discoordination. 
Prinzen et al (31) paced the hearts of anesthetized dogs from the right atrium, 
right ventricle, or left ventricle. Regional myocardial work, represented by the 
stress-strain loop area for a given region, was markedly heterogeneous 
between early-activated and late-activated myocardial segments (Figure 2A). 
In early-activated territories, myocardial work was essentially zero. In contrast, 
late-activated zones underwent increased fiber strain (distension) as well as 
stress and consequently performed a disproportionate amount of net 
myocardial work. 
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Figure 2. A, Stress-
strain loops from early-
activated and late-
activated myocardial 
regions in 
dyssynchronous hearts. 
In early-activated 
regions, contraction 
initially occurs at low 
stress levels (a) as 
quiescent late-activated 
regions undergo 
passive stretch. 
Subsequently in systole, 
early-activated regions 
undergo reciprocal 
deformation as the late-
activated territories 
contract (c). The small 
net area of the stress-
strain loop in early-
activated regions 
reflects reduced 
regional work 
performed. In late-
activated territories, 
passive stretch in early 
systole generates 
increased stress before 
contraction (b). The increased stress-strain loop area reflects increased work performed by 
late-activated territories. B, Pressure-volume loops showing the effect of LV dyssynchrony 
induced by RV pacing. Stroke volume is reduced, the LV ESPVR is shifted to the right, and 
end-systolic volume and stress are increased. (From 29 and 31) 
 
 
In both regions, work is wasted: anteroseptal contraction results primarily in 
distension of the lateral free wall and may occur early enough relative to mitral 
valve closure to result in functional mitral regurgitation; lateral LV contraction 
in late systole ejects blood into the systemic vasculature but also generates 
distension of the anteroseptal LV. The net impact of mechanical dyssynchrony 
on myocardial energetics has been reported. Although external work by the 
heart on the body declines with acute dyssynchrony, the oxygen consumption 
required remains similar, thus confirming mechanical inefficiency (32,33). 
In the context of established LV dysfunction, mechanical dyssynchrony has 
clear additive deleterious effects. However, chronic dyssynchrony can itself 
result in abnormal chamber function. This was recently reported by Vernooy 
et al (34), who assessed cardiac structure and function for 16 weeks after 
ablation of the LBBB. They observed a gradual decline in the ejection fraction 
of 23% and an increase in chamber dimensions of 25%. The mechanisms 
underlying dyssynchrony-induced changes in LV systolic function and 
architecture are as yet unknown. 
 
1.b.ii. Cardiac Resynchronization Therapy 
 
Approximately one third of patients with low EF and class III to IV symptoms 
of HF manifest a QRS duration greater than 120 ms (35-37). 
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It has been hypothesized that simultaneous pacing of both the LV and RV 
(biventricular pacing) to resynchronize ventricular contraction (cardiac-
resynchronization therapy, or CRT) might be beneficial in patients with HF 
and ventricular dyssynchrony. With biventricular pacing, separate pacing 
leads are placed to stimulate the RV and LV, with pacing through each lead 
timed to coordinate electrical activation (Figure 3). A third pacing lead is 
placed in the right atrium to permit the synchronization of the ventricular 
pacing to the atrial depolarization. 
Although biventricular pacing does not restore the physiologic conduction 
pattern, it eliminates the delay in electrical activation of the left ventricular free 
wall (38). 
 
1.b.ii.1. Cardiac Mechanoenergetics of Resynchronization Therapy 
 
The mechanical and energetic consequences of intraventricular dyssynchrony 
can be mitigated by biventricular (BiV) pacing. Early stimulation of the lateral 
LV free wall results in recoordination of ventricular contraction (39). The 
effects of ventricular resynchronization on LV mechanical work are 
instantaneous, with appreciable increases in dP/dtmax, aortic systolic 
pressure, and cardiac output occurring within one beat of LV pacing onset. 
Stroke volume increases immediately and with a decline in end-systolic 
stress. Underlying these laudatory effects on global LV systolic function is the 
elimination of early systolic stretch and late systolic stretch in the lateral and 
anteroseptal LV walls, respectively; instead, both territories contract 
throughout systole. 
The beneficial effects of mechanical LV resynchronization appear 
independent of whether electric synchrony is concomitantly achieved. 
Long-term ventricular resynchronization with BiV pacing results in further 
improvement of LV function and induces reverse remodeling in patients with 
dilated cardiomyopathy. In a study on 25 patients with class III or IV HF and 
QRS widths longer than 140ms, Yu et al. (40) demonstrated reductions in 
both end-systolic and end-diastolic volumes after 3 months of long-term BiV 
pacing.  
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Figure 3. The cardiac 
conduction system is 
designed to initiate 
depolarization of the 
cardiac ventricles widely 
and synchronously. 
Panel A shows the 
anatomy of the system, 
with the locations of the 
atrioventricular (AV) 
node, the bundle of His, 
and the right and left 
bundle branches. With 
normal conduction, the 
LV and RV are 
depolarized 
simultaneously, with 
consequent simultaneous 
contraction (Panel B). In 
Panel B, yellow areas are 
the sites of earliest 
depolarization (at the 
terminal ramifications of 
the conduction system), 
with successive regions 
of depolarization shown 
in orange, red, and pink. 
In the setting of LBBB, 
the RV free wall and the 
interventricular septum 
are depolarized rapidly 
(Panel C). There is a 
clinically significant delay in the depolarization of the LV free wall. As a result, LV contraction 
is dyssynchronous. In Panel C, the sites of earliest depolarization are yellow and are all in the 
RV; successive regions of depolarization are shown in orange, red, pink, purple, and blue. 
With CRT, pacemaker leads are situated to stimulate both ventricles, thus bypassing the 
conduction block in the left bundle branch (Panel D). Simultaneous depolarization and 
simultaneous contraction of the ventricles is restored. In Panel D, the sites of early 
depolarizations are yellow and are near the tip of both pacemaker leads as well as in the 
branches of the normally conducting right bundle-branch system. Successive regions of 
depolarization are shown in orange, red, pink, and purple. 
 
 
Importantly, at this time point, they stopped pacing and found that although 
dP/dtmax immediately declined (immediate CRT effect), chamber volumes 
were not immediately altered. This supports a remodeling effect rather than 
an active effect of CRT itself on long-term chamber volumes. Subsequent 
studies such as the MIRACLE trial (41) and Vigor-CHF (42) have reported 
approximately 10% reductions of both end-systolic and end-diastolic volumes 
with 6-month CRT. 
In contrast to therapy with positive inotropes, the increase in systolic function 
obtained from CRT in dyssynchronous failing hearts does not increase (and 
may actually reduce) myocardial oxygen consumption. Nelson et al. (43) first 
reported on the energetics of a traditional inotropic treatment (dobutamine) vs 
CRT in dyssynchronous LV failure. They found that equivalent increases in 
dP/dtmax triggered marked differences in oxygen consumption, with 
consumption (per beat) rising nearly 20% with dobutamine but falling by 10% 
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with CRT. It remains unknown whether CRT reverses the electrophysiologic 
changes reported to occur with chronic dyssynchrony, and it is equally unclear 
what the net effects of CRT are on arrhythmia susceptibility in patients with 
HF. In theory, CRT could have antiarrhythmic effects caused by salutary 
changes in LV systolic function and geometry or by reversal of dyssynchrony-
coupled pathologic changes in electrophysiology and molecular expression. 
Conversely, some have expressed concern that the use of an epicardial 
pacemaker (LV lead in the CRT system) is arrhythmogenic because of 
differences in transmural conduction and repolarization (44). Studies on the 
effect of CRT on the incidence of ventricular arrhythmias have provided mixed 
results. Cardiac resynchronization therapy neither reduced nor increased the 
incidence of ventricular tachycardia (polymorphic or monomorphic) in patients 
from the Contak-CD and InSync-ICD studies, (45) whereas some smaller 
studies found lower rates of appropriate ICD firings in patients with ICD-CRT 
systems (46-48). In the recent and larger CARE-HF trial, mortality from both 
pump failure and sudden death declined with CRT only, arguing against a 
proarrhythmic CRT effect and perhaps favoring an antiarrhythmic effect (49). 
Very little is still known about the molecular changes induced by chronic 
dyssynchrony or on what can be reversed by CRT, but this is presently under 
study. In a recent study on tumor necrosis factor a expression, apoptotic 
index, and myocardial fibrosis in patients with cardiomyopathy before CRT 
and after CRT, resynchronization therapy appeared to reduce interstitial 
myocardial collagen volume, tumor necrosis factor a levels, and apoptosis 
(50). Clearly, more human and animal studies are needed to address the 
effects of CRT at the molecular level. 
 
1.b.ii.2. Clinical Evidence 
 
The initial randomized trials of CRT involved no more than 500 patients and 
lasted less than one year (51-55). These trials enrolled patients with NYHA 
class III or IV HF, with other requirements typically including sinus rhythm, an 
EF of 35 percent or less, and a QRS interval of at least 120ms. These trials 
confirmed that the physiological effects of CRT were associated with 
increases in functional capacity and improvements in the quality of life. Such 
changes could be demonstrated as early as one month after the device was 
implanted (54). Two subsequent trials, Comparison of Medical Therapy, 
Pacing, and Defibrillation in Heart Failure (COMPANION) and Cardiac 
Resynchronization–Heart Failure (CARE-HF), evaluated the effect of CRT on 
survival (49, 56). As in most of the earlier trials, enrollment criteria included 
sinus rhythm, an NYHA class of III or IV, an EF of 35 percent or less, and a 
QRS interval of at least 120ms. In both trials, the risk of death from any cause 
was reduced by CRT as compared with no pacing; this difference was not 
significant in the COMPANION trial (hazard ratio, 0.76; P=0.06), but it was 
significant in the CARE-HF study (hazard ratio, 0.64; P<0.002). 
 
1.b.ii.3. Clinical Use 
 
Current indications for CRT include dilated cardiomyopathy (ischemic or 
nonischemic), an LVEF of 35 percent or less, a QRS interval of at least 
120ms, and NYHA class III or IV HF despite optimal medical therapy (49,56). 
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Increased risks of bleeding or infection are relative contraindications, as is the 
presence of any other major life-limiting medical condition, such as advanced 
cancer. It has been suggested that patients whose HF is severe enough to 
require parenteral inotropic therapy should not receive a biventricular 
pacemaker (57). Candidates for CRT may need a device with both cardiac-
resynchronization and cardioverter–defibrillator functions; most candidates for 
BiV pacing are also candidates for an ICD (7). 
 
1.b.ii.4. Implant 
 
The implantation of a BiV pacemaker requires a method for pacing the LV. In 
the standard approach, a specifically designed pacing lead is inserted into the 
mouth of the coronary sinus (in the right atrium) and advanced posteriorly 
around the atrioventricular-valve ring. 
The lead is then passed into a venous branch running along the free wall of 
the LV (58). In some patients, the LV electrode cannot be properly positioned 
through the coronary sinus; minimally invasive thoracic surgical techniques 
have been used for lead placement in such patients (59). 
No specific preparation is required before the implantation of a biventricular 
pacemaker. Implantation is performed by a cardiologist or cardiac surgeon 
with the patient under local anesthesia. After the pacemaker has been 
implanted, some patients report symptomatic improvement almost 
immediately, although it is unclear how much of this effect is psychological. As 
noted above, in clinical trials, objective evidence of functional improvement 
has been documented as early as one month after implantation (54). An 
electrocardiogram is obtained to document the new baseline appearance with 
pacing. Care of the incision site used for the implant is similar to that for other 
pacemakers. Patients who receive a BiV pacemaker must undergo periodic 
clinical evaluation as well as have the device evaluated. Lead impedance, 
device programming, and battery life are all checked on a regular basis.  
 
1.b.ii.5. Areas of Uncertainty 
 
Several areas of uncertainty remain. 
 
Long-term survival in patients treated with CRT in clinical practice. The 
characteristics of patients enrolled in randomized controlled trials are strictly 
defined and frequently different from those of “real world” patients. Currently, 
apart from single-center observations, studies reporting the long-term survival 
of patients treated with CRT outside the realm of randomized controlled trials 
are still lacking, and so are analyses concerning the persistence of CRT 
benefit following the first year of treatment (see Appendix.b.). 
 
Effects of CRT in patients with mild symptoms of HF. It has not been 
established whether CRT is beneficial in patients with mild HF (NYHA class 
II), since only two small trials have included such patients (53, 60). In these 
analyses, CRT did not significantly improve functional status or the quality of 
life, although it did increase LV volumes and, in one trial, EF. The Multicenter 
Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy 
(MADIT-CRT) and the Resynchronization Reverses Remodeling in Systolic 
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Left Ventricular Dysfunction (REVERSE) trial will evaluate the role of ICD with 
or without CRT in large cohorts of patients with NYHA class I or II HF (see 
Appendix.c.). 
 
Efficacy of CRT in very old patients. Generally, resynchronization trials have 
excluded very old patients (>80 years old), and little data exists on the 
outcomes after CRT in the elderly. This represents an important limitation, 
since almost half of the patients evaluated in community studies are over 80 
years old (see Appendix.d.). 
 
The site of left ventricle stimulation. Butter et al. (61) studied 30 patients 
undergoing CRT. Benefit from CRT was significantly greater when the lateral 
wall was paced as compared to the anterior wall. 
Gold et al. (62) showed that pacing from different sites within a given vein 
could have a substantial impact on acute hemodynamic benefits and that 
there was a major inter-individual variation in optimal pacing site. Dekker et al. 
(63) produced similar data in 11 patients using an epicardial approach. 
Rosillo et al. (64) evaluated 233 CRT patients and compared two groups 
based on anatomic lead position. After implant, EF improved significantly only 
in subjects with leads in the lateral and postero-lateral branches. 
However, in a similar retrospective analysis of 158 patients Gasparini et al. 
(65) did not find a difference in EF benefit between septal and lateral pacing 
sites. 
Ansalone et al. (66) investigated 31 patients by tissue Doppler imaging (TDI) 
to identify the most delayed site of LV contraction before CRT. They found 
that the lack of concordance between the site of delay and the site of pacing 
is likely to reduce the improvement in LV performance due to BIV. 
The sum of these data suggests that pacing at late activated LV free wall sites 
produces the best results and that there is considerable and important inter-
patient variation in the location of these sites. 
However, in patients receiving BIV, the LV lead positioning varies randomly 
for several anatomical and technical reasons so that LV pacing cannot be 
applied at the optimal site in all patients. 
 
LV lead implantation technique. The LV lead is implanted with a transvenous 
approach in the majority of the cases. Unfortunately, LV pacing via 
transvenous procedure has an overall success rate ranging from 88% to 92% 
according to different experiences. Moreover, limited availability of suitable 
coronary sinus tributary veins often increases difficulties in achieving the 
optimal hemodynamic response. Alternative approaches to CRT were not 
consistently studied, although some experiences have been recently reported 
(see Appendix.e.). 
 
The effects of CRT on diastolic function. Advanced stage of HF is 
characterized by a heterogeneous picture, where signs and symptoms of 
diastolic and systolic dysfunction coexist. In dilated cardiomyopathy the 
abnormalities of diastolic function occur early, often preceding dysfunction of 
contraction phase, and have a major role in producing symptoms. Several 
trials showed the mechanisms of action and the effects of CRT on systolic 
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function, while the effects on diastolic function are controversial and 
conflicting data have been published so far (see Appendix.f.). 
 
Ventricular dyssynchrony and the selection of candidates for CRT. CRT does 
not result in significant clinical improvement in 20 to 30 percent of patients 
(54). Although there may be various explanations for this observation, it has 
been suggested that an increased QRS interval may not be the best criterion 
for benefit from CRT and that guidelines for the selection of candidates for 
CRT should suggest the use of echocardiography to identify dyssynchrony 
(67). 
However, none of the major clinical trials of CRT used echocardiographic 
measures of dyssynchrony as the principal criteria for enrollment. 
Furthermore, it is not clear which echocardiographic variables should be used 
to select candidates for CRT (see Appendix.g. and h.). 
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2. Non-Invasive Evaluation and Quantification of Ventricular 
Dyssynchrony 
 
Quantification of non-uniform mechanical function and dyssynchrony may 
lead to a more complete diagnosis of ventricular dysfunction. Moreover, it may 
guide therapy, because patients with extensive dyssynchrony are likely to 
benefit from resynchronization therapy. 
 
2.a. QRS Duration to Assess Dyssynchrony and to Predict Response to 
CRT 
 
The response to CRT was initially considered to result in part from 
resynchronization of interventricular dyssynchrony (dyssynchrony between 
the left and right ventricle). Thus, patients with interventricular dyssynchrony 
were selected for CRT. This selection was based on the QRS duration, 
because this parameter is considered to reflect interventricular dyssynchrony. 
Indeed, Rouleau et al. (68) demonstrated a good relation between 
interventricular dyssynchrony (assessed by tissue Doppler imaging [TDI]) and 
QRS duration. Accordingly, patients with wide QRS were considered 
candidates for CRT. In general, studies used QRS duration >120 to 130 ms 
as a selection criterion. The initial studies required the presence of a left 
bundle branch block pattern on the electrocardiogram, whereas more recent 
studies also included patients with non-specific interventricular conduction 
delay (a poorly defined entity) or even right bundle branch block pattern. The 
beneficial effect of CRT on symptoms, exercise capacity, systolic LV function, 
and hospitalization rate was demonstrated in these patients with wide QRS 
complex. In addition, data from the Pacing Therapies in Congestive Heart 
Failure (PATH-CHF) II trial demonstrated that the benefit of CRT was most 
pronounced in patients with QRS duration >150 ms (as compared to patients 
with QRS duration 120 to 150 ms) (69). These observations tend to support 
the use of the QRS duration for patient selection. However, careful analysis of 
the individual patients in many CRT studies demonstrated that 20% to 30% of 
the patients failed to respond to CRT, despite prolonged QRS duration. These 
observations prompted Molhoek et al. (70) to analyze the precise value of the 
QRS duration to predict response to CRT. Their study included 61 patients, 
and 45 (74%) responded to CRT. The QRS duration at baseline before pacing 
was similar between the responders and non-responders (179 ± 30 ms vs. 
171 ± 32 ms; p = NS). However, a significant shortening in QRS duration after 
six months of CRT was observed only in responders. Receiver operating 
characteristic curve analysis showed that a reduction in QRS duration >10 ms 
had a high sensitivity (73%) with low specificity (44%) in prediction of 
responders. Conversely, a reduction in QRS duration >50 ms was highly 
specific (88%) but not sensitive (18%) to predict response to CRT. It has 
subsequently been suggested that intraventricular dyssynchrony may predict 
response to CRT more accurately (67). In this respect, studies using TDI 
demonstrated that patients with intraventricular dyssynchrony had a high 
likelihood of a positive response to CRT (67). Bleeker et al. (71) evaluated the 
relation between QRS duration and LV dyssynchrony (assessed by TDI) in 90 
patients with severe HF; EF <35%; and narrow (<120 ms), intermediate (120 
to 150 ms), or wide (>150 ms) QRS complexes. Substantial LV dyssynchrony 
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on TDI was present in 27%, 60%, and 70% of patients, respectively. When 
QRS duration was considered as a continuous variable, no relation between 
QRS duration and LV dyssynchrony could be demonstrated. Ghio et al. (72) 
confirmed the absence of LV dyssynchrony in 48% of patients with an 
intermediate (120 to 150 ms) QRS complex and in 28% of patients with a 
wide (>150 ms) QRS complex. These observations indicate that patients with 
a wider QRS complex have a higher likelihood of LV dyssynchrony, although 
30% of patients with wide (>150 ms) QRS complex lack LV dyssynchrony. 
This 30% may partially explain a similar percentage of non-responders in the 
large trials. These observations have resulted in many echocardiographic 
studies evaluating different echocardiographic parameters to detect LV 
dyssynchrony and predict response to CRT. 
 
2.b. Echocardiographic Quantification of Ventricular Dyssynchrony and 
Selection of Responders to CRT 
 
A variety of echocardiographic techniques have been suggested for the 
assessment of LV dyssynchrony and prediction of response to CRT. These 
techniques include M-mode assessment, two-dimensional echocardiography 
using phase imaging or intravenous contrast, TDI, and potentially three-
dimensional echocardiography (67). Tissue Doppler imaging is the most 
extensively tested technique, and different methods have been proposed, 
including pulsed-wave TDI, color-coded TDI, tissue tracking, displacement 
mapping, strain and strain rate imaging, and, most recently, tissue 
synchronization imaging (TSI). A comprehensive summary of the merits of the 
different techniques to predict response to CRT is provided in Table 1. 
 
M-Mode Echocardiography 
Using an M-mode recording from the parasternal short-axis view (at the level 
of the papillary muscles), the septal-to-posterior wall motion delay can be 
obtained, and a cutoff value of 130 ms or more was proposed as a marker of 
intraventricular dyssynchrony. Pitzalis et al. (73) evaluated 20 patients and 
reported a sensitivity and specificity of 100% and 63%, respectively, to predict 
response to CRT. In addition, the authors recently demonstrated the 
prognostic value of the septal-to-posterior wall motion delay (74). However, 
this parameter is often difficult to obtain. Marcus et al. (75) evaluated the 
feasibility of obtaining this parameter in the patients of the CONTAK-CD 
database. A clear definition of the systolic deflection of both the septal and 
posterior wall was possible in only 45% of 79 patients. Moreover, the septal-
to-posterior wall motion delay did not correlate with LV reverse remodeling. 
Most importantly, the sensitivity and specificity to predict response (both 
clinical and echocardiographic) were 24% and 66%. These findings were 
similar in patients with ischemic and dilated cardiomyopathy. 
 
Two-Dimensional Echocardiography 
The first use of two-dimensional echocardiography was that of a 
semiautomatic method for endocardial border delineation (76). The degree of 
LV dyssynchrony was quantified in two-dimensional echocardiographic 
sequences from the apical four-chamber view, focusing on the septal-lateral 
relationships. Computer-generated regional wall movement curves were 
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compared by a mathematical phase analysis, based on Fourier 
transformation. The resulting septal-lateral phase angle difference is a 
quantitative measure for intraventricular (dys)synchrony. Using this approach, 
patients with extensive LV dyssynchrony between the septum and lateral wall 
exhibited an immediate improvement in hemodynamics after CRT. The 
second approach utilized echo contrast (Optison, Mallinckrodt, Hazelwood, 
Missouri) to optimize LV border detection (77). With the improved LV border 
detection, regional fractional area changes were determined and plotted 
versus time, yielding displacement maps. From these maps, the LV 
dyssynchrony between the septum and lateral wall was determined. The 
authors observed an acute reduction in LV dyssynchrony after biventricular 
pacing, which correlated with an acute increase in EF. No studies on the two-
dimensional techniques for prediction of long-term outcome have been 
published. 
 
TDI, Strain, and Strain Rate Imaging 
Tissue Doppler imaging measures the velocity of longitudinal cardiac motion 
and allows comparison of timing of motion in relation to electrical activity 
(QRS complex). Different parameters can be derived, and the most frequently 
used include the peak systolic velocity, the time to onset of systolic velocity, 
and the time to peak systolic velocity. The TDI measurements can be 
obtained directly using pulsed-wave TDI and using color-coded TDI, which 
needs post-processing. With pulsed-wave TDI, only one region can be 
interrogated at a time making the procedure time-consuming and precludes 
comparison of segments simultaneously. Because measurements are 
influenced by differences in heart rate, loading conditions and respiration 
measurements that are not simultaneous may be less meaningful. In addition, 
the timing of peak systolic velocity is often difficult to identify, resulting in 
imprecise information on LV dyssynchrony. There is limited evidence of 
pulsed-wave TDI to predict response to CRT. Two studies have demonstrated 
a relation between LV dyssynchrony on pulsed-wave TDI and improvement in 
symptoms and/or EF after CRT (78, 79), but prediction of response was not 
addressed. 
Several studies have used color-coded TDI to assess LV dyssynchrony and 
predict outcome (Table 1) (80-85). From these color-coded images, TDI 
tracings can be obtained by post-processing, and the majority of studies have 
used time to peak systolic velocity to assess LV dyssynchrony. Initially, 
investigators focused on the four-chamber view to identify LV dyssynchrony 
by color-coded TDI. Velocity tracings were derived from the basal septal and 
lateral segments, and the septal-to-lateral delay was measured. It was shown 
that a delay >60 ms was predictive of acute response to CRT (81). 
Subsequently, a four-segment model was applied, which included four basal 
segments (septal, lateral, inferior, and anterior) (86). It was shown that a delay 
>65 ms allowed prediction of response to CRT. Using this cutoff value, 
sensitivity/specificity for prediction of clinical improvement (defined by an 
improvement in NYHA functional class and 6-min walking distance) were both 
80% whereas sensitivity/specificity for LV reverse remodeling (defined as a 
>15% reduction in LV end-systolic volume) were both 92%. In addition, 
patients with LV dyssynchrony >65 ms had a favorable prognosis after CRT. 
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The extensive studies by Yu et al. (87, 80, 81) have used a 12-segment 
model. Tracings were derived from 12 segments, and an LV dyssynchrony 
index was derived from the standard deviation of all 12 time intervals 
demonstrating that a dyssynchrony index >31 ms yielded a sensitivity and 
specificity of 96% and 78% to predict LV reverse remodeling (87). In general, 
prediction of response to CRT based on time to peak systolic velocity (using a 
varying number of segments) yields a high sensitivity (ranging from 76% to 
97%) and specificity (ranging from 55% to 92%) (Table 1). Seven studies 
have used tissue tracking, strain, and/or strain rate imaging (84, 85,87-91). 
Tissue tracking (GE Vingmed, Horten, Norway) provides a color-coded 
display of myocardial displacement, allowing for easy visualization LV 
dyssynchrony and the region of latest activation. Sogaard et al. (85) 
pioneered this approach and demonstrated that the number of segments with 
delayed longitudinal contraction was related to the improvement in EF during 
CRT. Strain and strain rate analysis is performed by off-line analysis of the 
color-coded tissue Doppler images. Strain analysis allows direct assessment 
of the extent and timing of myocardial deformation during systole and is 
expressed as the percentage of segmental shortening or lengthening in 
relation to its original length (67). The main advantage over TDI is that strain 
analysis allows differentiation between active systolic contraction and passive 
motion. This is important in patients with ischemic cardiomyopathy with the 
presence of scar tissue. Breithardt et al. (88) showed that CRT reversed the 
pathologic septal-lateral strain relationships and reduced the incidence of 
early systolic pre-stretch in the late activated wall and of post-systolic 
shortening. However, no study with strain or strain rate imaging has so far 
reported on the actual prediction of response to CRT (Table 1), except for Yu 
et al. (87), who demonstrated that strain rate imaging could not predict LV 
reverse remodeling. Despite the technical advantages of the strain imaging, 
the technique has not become routine practice in the evaluation of patients 
considered for CRT. The main limitations are the time-consuming aspect of 
the technique, the high operator dependency, and the moderate 
reproducibility. Only one direct comparison between TDI and strain rate 
imaging has been reported in 54 patients undergoing CRT (87). Left 
ventricular dyssynchrony on TDI was predictive of LV reverse remodeling, but 
strain rate imaging failed to predict response to CRT (87). 
 
TSI to Assess LV Dyssynchrony 
A recent addition to the tissue Doppler approach to quantify LV dyssynchrony 
has been the automated color-coding of time to peak longitudinal velocities. 
This color-coding of temporal velocity data is superimposed on the routine 
two-dimensional echocardiographic images to provide visual mechanical 
information on the anatomical regions. Tissue synchronization imaging (GE 
Vingmed) (90-93) is a signal-processing algorithm of the tissue Doppler data 
to automatically detect peak positive velocity and then color-code the time to 
peak velocities in green for normal timing, yellow-orange for moderate delay, 
and red for severe delays in peak longitudinal velocity. 
 
Three-Dimensional Echocardiography to Assess LV Dyssynchrony 
Three-dimensional echocardiography has evolved from a technique based on 
reconstruction of multiple two-dimensional scan planes to an almost real-time 
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methodology. Left ventricular volumes and EF can be assessed with high 
accuracy (94). In the context of LV dyssynchrony, analysis of regional function 
in the time-domain is important (67), and a series of plots is obtained 
representing the change in volume for each segment (usually 16 or 17 
segments) throughout the cycle. With synchronous contraction of all 
segments, each segment would be expected to achieve the minimum volume 
at almost the same point in the cardiac cycle. In LV dyssynchrony, dispersion 
exists in the timing of the point of minimum volume for each of the segments. 
The degree of dispersion reflects the severity of LV dyssynchrony (95). 
Parametric “polar-map” displays (of the three-dimensional data) of the timing 
of LV contraction have been developed to facilitate interpretation of data. This 
methodology examines regional LV contraction at approximately 3,000 points 
over the endocardial surface rather than in 16 or 17 segments. Color-coding is 
used to identify the region/site of latest activation, and this is potentially useful 
for electrophysiologists to select the optimal LV lead position. Zhang et al. 
(96) used three-dimensional echocardiography in 13 patients who had 
previously received CRT; when CRT was withheld, significant LV 
dyssynchrony occurred, associated with a decrease in EF. Currently, no 
extensive data are available on the prediction of response to CRT using three-
dimensional echocardiography. 
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Table 1. Echocardiographic Studies on LV Dyssynchrony to Predict Response to CRT. 
 
 
Authors Patients (n) 
Follow-Up 
Period 
(month) 
Echo Technique Methodology for LV Dyssynchrony Main Findings Sensitivity (%) 
Specificity 
(%) 
Pitzalis et al. 2002 20 1 M-mode Septal-to-posterior wall motion delay Septal-to-posterior delay ≥130 ms predicted LV reverse remodeling 100 63 
Pitzalis et al.2005 60 14 M-mode Septal-to-posterior wall motion delay Septal-to-posterior delay ≥130 ms predicted event-free survival NA NA 
Marcus et al. 2005 79 6 M-mode Septal-to-posterior wall motion delay 
Septal-to-posterior delay ≥130 ms 
insufficient to predict LV reverse 
remodeling 
24 66 
Breithardt et al. 
2002 34 Acute 
2D phase 
imaging 
Difference between the lateral and 
septal wall motion phase angles 
Delayed lateral wall motion predicted 
acute hemodynamic improvement NA NA 
Kawaguchi et al. 
2002 10 9 Contrast echo 
Septal and lateral fractional area 
changes 
↑ Septal inward motion, ↓ spatial and 
temporal LV dyssynchrony by 40%, and 
correlated with ↑ LVEF 
NA NA 
Penicka et al. 2004 49 6 Pulsed-wave TDI Ts(onset) of 3 basal LV and 1 basal RV segments 
Summation of inter- and intra(LV)-
ventricular delay >102 ms predicted ↑ 
LVEF 
96 71 
Ansalone et al. 
2001 21 1 Pulsed-wave TDI 
Systolic dyssynchrony among 5 basal 
segments 
Extensive LV dyssynchrony resulted in ↑ 
in symptoms, and ↑ LVEF NA NA 
Garrigue et al. 
2001 12 12 Pulsed-wave TDI 
Ts(onset) between septum and lateral 
wall 
Post-CRT reduction in LV dyssynchrony 
and improvement in symptoms NA NA 
Bordachar et al. 
2004 41 3 
Pulsed-wave 
TDI, M-mode, 
Pulsed-wave 
Doppler 
Maximal difference in 12 LV segments 
for Ts, Ts(onset), Ts-SD, and DLC 
Maximal difference in 12 LV segments for 
Ts, T(onset), Ts-SD closely correlated with 
improvement of MR and CO, but not 
interventricular delay by pulsed-wave 
Doppler echo 
NA NA 
Yu et al. 2002 25 3 Color-coded TDI Ts of 12 LV segments in ejection phase 
Improve LV dyssynchrony by delaying Ts 
in 12 LV segments globally resulting in 
homogenous Ts 
NA NA 
Bax et al. 2003 25 Acute Color-coded TDI Septal-to-lateral delay of Ts in ejection phase 
Septal-to-lateral delay of Ts ≥60 ms 
predicted ↑ LVEF 76 88 
Yu et al. 2003 30 3 Color-coded TDI Ts-SD of 12 LV segments in ejection phase 
Ts-SD of 12 LV segments >33 ms 
predicted LV reverse remodeling NA NA 
Bax et al. 2004 85 12 Color-coded TDI Septal-to-lateral delay of Ts in ejection Phase 
Septal-to-lateral delay of Ts ≥65 ms 
predicted LV reverse remodeling; and 
associated with lower event rate 
92 92 
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Authors Patients (n) 
Follow-Up 
Period 
(month) 
Echo Technique Methodology for LV Dyssynchrony Main Findings Sensitivity (%) 
Specificity 
(%) 
Notabartolo et al. 
2004 49 3 Color-coded TDI 
Maximal difference in Ts in 6 basal 
segments (both ejection phase and 
post-systolic shortening) 
Maximal difference in Ts in 6 basal 
segments >110 ms predicted reverse 
remodeling 
97 55 
Yu et al. 2004 54 3 Color-coded TDI, SRI 
Ts-SD of 12 LV segments in ejection 
phase (and 17 other parameters) 
Ts-SD of 12 LV segments >31 ms 
predicted LV reverse remodeling 96 78 
Sogaard et al. 
2002 20 12 
Color-coded TDI, 
SRI DLC 
Number of basal segments with DLC 
predicted ↑ LVEF NA NA 
Sogaard et al. 
2002 20 Acute 
Color-coded TDI, 
TT, SRI TT and DLC 
Optimization of V-V timing by TT resulted 
in ↓ DLC and ↑ LVEF NA NA 
Breithardt et al. 
2003 18 Acute Strain, SRI 
Strain and SRI at septal and lateral 
walls 
Baseline: lateral wall strain and strain rate 
higher than septal; CRT: septal wall strain 
and strain rate higher than lateral 
NA NA 
Sun et al. 2004 34 Acute Displacement, strain, and SRI 
Strain, SRI, and displacement at septal 
and lateral walls 
↑ LVEF and ↑ peak strain rate at lateral 
wall by CRT; ↑ Septal and inferior wall 
displacement by LV pacing 
NA NA 
Popovic et al. 2002 22 1-12 Displacement and strain Strain at septal and lateral walls 
↑ Global LV peak strain, ↓ coefficient of 
change in LV strain, no change in septal 
or lateral wall displacement 
NA NA 
Dohi et al. 2005 38 Acute TSI and strain Peak radial strain septum versus posterior wall 
Delay in septal-posterior strain ≥130 ms, 
predicted ↑ stroke volume 95 88 
Gorcsan III et al. 
2004 29 Acute TSI 
Septal-posterior delay (both ejection 
phase and post-systolic shortening) 
Septal-posterior delay ≥65 ms predicted 1 
stroke volume 87 100 
Yu et al. 2005 56 3 TSI 
Ts-SD of 12 LV segments in ejection 
phase (inclusion of post-systolic 
shortening) 
Ts-SD of 12 LV segments in ejection 
phase >34 ms predicted reverse LV 
remodeling 
87 81 
Zhang et al. 2005 13 3 3D echo Time to minimal systolic volume (Tmsv) in 6, 12, and 16 LV segments 
Improvement of Tmsv parameters during 
CRT Tmsv of 16 LV segments by 3D echo 
correlated closely with Ts-SD of 12 LV 
segments by TDI 
NA NA 
 
CO = cardiac output; DLC = delayed longitudinal contraction; MR = mitral regurgitation; SRI = strain rate imaging; TMSV = time to minimal systolic volume; Ts 
= time to peak myocardial systolic velocity; TSI = tissue synchronization imaging; Ts(onset) = time to onset of myocardial systolic velocity; Ts-SD = standard 
deviation of time to peak myocardial systolic velocity; TT = tissue tracking; V-V interventricular. 
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2.c. MRI Quantification of Ventricular Dyssynchrony and Selection of 
Responders to CRT 
 
Most mechanical dyssynchrony analysis is based on echo-Doppler methods, 
which in turn are largely derived from only two-dimensional longitudinal 
motion data. This choice of orientation is mainly based on practical grounds 
given available windows for transducer placement. However, cardiac 
contraction is principally circumferential, and thus echo-based Doppler 
methods may not provide the most accurate and comprehensive assessment 
of global dyssynchrony in HF. Further, the variance of repeated 
echocardiographic measures is fairly high owing to dependence on operator 
experience, machine settings, available acoustic windows, and angle of 
incidence effects. This can introduce noise when applying such approaches to 
the routine clinical setting. Quantitative magnetic resonance imaging (MRI)-
based strain analysis provides highly reproducible, high-resolution three-
dimensional circumferential and longitudinal myocardial activation data that 
are largely operator- and patient-independent and thus may be better suited 
to characterize dyssynchronous HF and identify appropriate candidates for 
CRT. 
Cine mode MRI is an excellent imaging modality for the assessment of global 
and regional myocardial function in patients with contractile dysfunction (97). 
This method captures multiple slices and phases of the heart to generate 
what appears to be a real-time representation of cardiac contraction. Global 
function is measured by simple volumetric analysis of the LV, whereas 
regional myocardial function is most commonly derived from qualitative wall 
motion assessment and/or quantitative methods that track myocardial 
deformation over the cardiac cycle. 
The evolution of advanced MRI quantitative strain pulse sequence algorithms 
designed to work with traditional cine-MRI, as well as new methods to analyze 
their output, have opened new avenues for assessment of cardiac 
dysfunction.  
 
Cine Myocardial Tagging 
Magnetic resonance imaging myocardial tagging is a technique that places 
non-physical markers (stripes or grids) inside the myocardium by manipulating 
the magnetization of the tissue using special encoding pulses (98,99). These 
markers, called tags, appear in the acquired images as dark lines and serve 
as fiducial myocardial markers that move and bend with the myocardium to 
which they are linked. In addition to simplifying the visual/qualitative 
assessment of cardiac wall motion abnormalities, analysis of the relative 
movement of these tags over the cardiac cycle is used to calculate local 
myocardial motion or strain (relative shortening). There are three primary 
strains for three-dimensional deformation— circumferential, radial, and 
longitudinal —and each can be computed. Techniques for such analysis were 
developed by O’Dell et al. (100) to generate detailed four-dimensional 
mechano-anatomic activation maps from MRI tagged data sets. The analytic 
algorithm (FINTAGS) has been used to characterize mechanical 
dyssynchrony in animal models (101,102) and in humans with HF and 
intraventricular conduction delay (103,104). Although the information 
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generated by this approach is comprehensive, processing and analysis time is 
extensive, limiting its clinical utility. 
 
Harmonic Phase Analysis of Tagged MRI 
To enhance the clinical utility of myocardial tagging data acquisitions, a rapid 
analysis method called harmonic phase (HARP) has recently been developed 
(105) and commercialized (Diagnosoft, Inc., Palo Alto, California). This 
approach shortens the analysis time to generate regional dynamic color stain 
maps/data from 1 week to under 2 min for three to four myocardial slices. The 
HARP method measures the motion from tagged magnetic resonance images 
by filtering harmonic peaks in the frequency domain of the images (106,107). 
The resulting image is then decomposed into a harmonic magnitude and 
harmonic phase, which are related to the underlying anatomy of the heart and 
tag deformation, respectively. The HARP method measures the local strain of 
tissue by measuring the frequency of the tag lines. If the tissue contracts, the 
tag lines become closer to each other and the tag frequency increases in 
proportion to that contraction, and vice versa. Circumferential strain in a given 
angular sector of each slice is then plotted during the cardiac cycle. 
 
Strain-Encoded MRI 
Although faster, HARP analysis still requires some post-processing. A more 
automatic alternative is strain-encoded (SENC) MRI, a new method for direct 
imaging of regional strain that does not require complex image processing 
(108-110). The SENC imaging is derived from a standard myocardial tagging 
sequence that tags the tissue at end-diastole with a sinusoidal tag pattern 
designed to modulate the longitudinal magnetization orthogonal to the 
imaging plane. Deformations of tissue during systole will change the local 
frequency of the pattern in proportion to the through-plane strain component. 
The distribution of regional contraction (circumferential shortening in long-axis 
views or longitudinal compression in short-axis views) is then displayed as 
contrast in the images. The SENC technique has several features that make it 
especially well suited for assessing dyssynchronous HF and CRT, in that it 
provides: 1) instantaneous real-time quantitative strain measurements without 
the need for user intervention; 2) higher spatial resolution over standard 
tagging as a result of reduced tag spacing; 3) allows acquisition of both 
circumferential and longitudinal myocardial stain information; and 4) 
application to assessment of regional function of the right as well as the LV. 
 
CRT and MRI Device Compatibility 
Although new methods have substantially improved the practicality of MRI 
CRT assessment, there remain a number of concerns, including cost, longer 
examination times, need for complex imaging/data processing infrastructure, 
and, perhaps most importantly, inability to image patients with implanted 
devices.  
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3. An Invasive Method of Evaluation of Left Ventricle Mechanics: the 
Conductance Catheter 
 
Assessment of cardiac function is of vital importance in clinical cardiology for 
diagnosis, monitoring, and treatment. A prerequisite for quantification of 
cardiac function is a reliable estimation of pressure–volume relationships of 
the LV. 
Besides pressure, that can only be obtained invasively using a transducer 
mounted on a catheter, absolute ventricular volume should be determined 
continuously. However, it must be considered that the volume of the LV is not 
easy to define, due to the displacement of the atrio-ventricular plane and, if 
defined, that volume is not easy to measure. 
As for spatial resolution, volume is best measured using for example MRI or 
computed tomography, but the temporal resolution of these techniques is still 
limited. Thus, they do not meet the requirements for on-line registration or 
high temporal resolution. Ultrasound can be used for estimation of LV volume, 
but it is not suitable for obtaining absolute volumes, unless temporal 
resolution is decreased. 
There are alternatives, e.g. metallic radiopaque markers and sonomicrometry, 
but they are not used in clinical practice because of their invasiveness (111, 
112). 
In 1981, Baan and co-workers presented a new volume measurement 
technique, which was based on conductance measurement (113, 114). 
The principle used to obtain intraventricular volume, i.e. the time-varying 
volume of blood contained within the cavity, was by measuring electrical 
conductance of the blood employing a multi-pole catheter (Figure 4). The 
catheter was placed within the ventricle along its long axis in such a way that 
the electrode at the tip was situated within the apex and the proximal one just 
above the aortic valve. 
A weak alternating current (0.4 mA peak-to-peak, 20 kHz) was induced 
between these electrodes in order to set up an electrical field within the 
ventricular cavity. The induced voltage was then measured with six electrodes 
in between, yielding 5 segmental voltages. 
Since the conductance of the blood itself is constant (neglecting long term 
changes in haematocrite) the measured voltage will be proportional to blood 
resistivity, and thus inversely proportional to the conductance or amount of 
blood between the measuring (voltage) electrodes. 
 
[ ]segmentpsegment
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Vsegment(t) = Time-varying (intraventricular) segmental volume 
α =  Slope factor 
L =  Inter-electrode distance 
σb =   Specific conductivity of blood 
Gsegment(t) =  Time-varying segmental conductance 
Gp,segment = Parallel conductance; conductance of structures surrounding the 
intraventricular blood 
The segmental volumes are then summed to form total volume. 
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This method has several advantages over other methods which determine 
intra- ventricular volumes. The results are obtained immediately, i.e. on-line, 
and precise geometric assumptions regarding the ventricle or labor-intensive 
analyses are not required. 
 
 
 
Figure 4. The catheter has 12 electrodes and should be positioned along the long axis of the 
LV. The two most distal and two most proximal electrodes are employed to generate the 
electrical field. This dual pair of current electrodes enables the use of a dual excitation mode. 
Other 6 electrodes are used pairwise to measure segmental conductance signals. Two 
electrodes are used to record the intracardial ECG. A micromanometer measures real-time 
LV pressure. 
 
Dual Field Catheters 
Implicit in the volume calculation from conductance data, an assumption is 
made that the electrical field is homogenous. Since this is not the case, 
especially in larger LV, a dual-field catheter was introduced (115, 116). 
Proximal and distal to the existing pair of current electrodes, another pair was 
positioned. This pair of electrodes also generates current with the same 
frequency, but with opposite polarity. This was suggested to give a more 
homogenous field, and thus a more linear relation between true volume and 
volume estimate from the conductance method (115). This was also reported 
to be true although results were not perfect, especially, as mentioned, for 
larger ventricles (116, 117). 
 
3.a. Calibration 
 
The conductivity of blood (σb) is determined in practice by taking a small 
arterial sample and transferring it to a measuring cell. 
The slope factor (α) is a correction factor accounting for the fact that the 
ventricle is not a regular cylinder. Alpha is determined through an independent 
cardiac output measurement, such as thermo-dilution: the dynamic range of 
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the conductance signal has to be multiplied with a calibration factor (α) to 
reflect the amount of blood ejected into aorta during a minute. 
The conductive tissues and fluids surrounding the ventricle contribute to the 
measured electrical conductance of the blood inside the ventricle, causing an 
offset in the relation between measured conductance and true intra-ventricular 
volume (114). This offset is called parallel conductance. When parallel 
conductance is not quantified, only changes in conductance as a measure of 
changes in volume can be presented (113, 118-120). 
To extend the conductance method to absolute volume measurements, a 
method to determine tissue conductance has been introduced by Baan et al. 
(114). They determined conductance of the tissues surrounding the blood in 
the ventricular cavity, by changing the specific conductivity (σb) of blood by 
injecting hypertonic saline into the pulmonary artery (Figure 5). The 
conductance signal was recorded and the successive conductance values at 
end-diastole (Gdias) were plotted versus the corresponding values at end-
systole (Gsys). 
 
 
 
Figure 5. The method to determine the correction volume Gp is a dilution technique, which 
relies on the analysis of the conductance signal during an induced transient change in blood 
conductivity. In order for this method to work properly, the heart must be in a relatively steady 
state, with no beat-to-beat changes in end-diastolic and end-systolic volume. A small bolus of 
hypertonic saline is injected into the pulmonary artery, allowing good mixing with the blood 
before it enters the LV. As the mixture enters the LV, a temporary, gradual change in the 
conductance signal will occur over several beats. The increase in the conductance signal is 
then analyzed to extrapolate the effects of decreasing conductivity. 
 
A linear regression line was fitted through Gsys – Gdias points and extrapolated 
to the identity line. The intersection point between the lines corresponds to a 
zero value of conductivity of blood (σb), and therefore, yields parallel 
conductance (Gp). A disadvantage of this extrapolation method is that a small 
variation in the determined Gdias and Gsys values will result in a large error in 
the extrapolated value of parallel conductance.  
Since introduction in the early 1980s, other calibration techniques have been 
described. Three different techniques are presented: 1) the dual frequency 
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method, 2) development of the dilution technique, and 3) the volume reduction 
technique. 
The dual frequency technique was first described by Gawne et al., indicating 
that surrounding structures have different frequency characteristics compared 
to blood: a dual frequency catheter system could then separate the two (blood 
from tissue), and thus calculate Gp (121). This concept has later been 
contradicted by another study (122). Theoretically, this technique is very 
elegant, since Gp can be estimated without any further manipulation that 
might be harmful to the patient. 
The dilution technique still uses a bolus of hypertonic saline, but instead of 
extrapolating to the point where blood conductivity is zero, the area below the 
dilution curve is analysed (123). A better reproducibility is achieved, and fewer 
injections are needed. 
The third technique described is a development of the suction technique, 
where the left ventricle is emptied – the conductance thus measured is equal 
to Gp (114, 124). 
This method is for understandable reasons not applicable in clinical use. 
Instead the inflow of blood from vena cava inferior or superior is reduced, and 
the volume curve is extrapolated to zero (125). Thus, Gp can be calculated.  
 
Calibration Discussion 
The parallel conductance Gp has been under severe investigation, probably 
due to the fact that it is difficult to measure accurately. For example, the saline 
bolus itself is reported to effect the measured variable, as well as bolus 
temperature (126). Other investigated variables possibly affecting parallel 
conductance are lung insufflation, and LV ventricular volume (127-130). 
Further, different studies propose that parallel conductance does or does not 
vary during the cardiac cycle, and slope factor alpha is reported to vary during 
a heart beat (131,132). The most recent study, though, implies that Gp does 
vary during the cardiac cycle, and that it must be corrected for (133). 
There is definitely a need for more studies in this matter, at least to confirm 
the latest results (see Chapter 7). 
 
3.b. Clinical Application 
 
This method has gained a wide interest, with literary hundreds of articles 
published since the introduction.  
Only one year after introducing the conductance technique in 1981, Baan et 
al. reported of use of this catheter in humans, for obtaining relative volumes 
(i.e. without calibration) (134). Two years later, they introduced all of the 
technique to measure true volume, including calibration methods to determine 
the gain factor (α) and the parallel conductance (Gp) (114). 
Kass et al. were the first to report the use of the same technique in humans 
(135).  
Currently, the conductance catheter is used mainly to assess global systolic 
and diastolic function to investigate pathologies, the outcome of drug 
treatment and surgical procedures, and the effects of ventricular pacing 
therapies (136-144). 
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Recently, new methods were introduced to estimate mechanical 
dyssynchrony, using the segmental volume signals obtained with the 
conductance catheter. 
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4. Quantification of Left Ventricular Dyssynchrony by Conductance 
Catheter 
 
Conductance method has been used extensively to assess global systolic and 
diastolic ventricular function and more recently the ability of this instrument to 
pick-up multiple segmental volume signals has been used to quantify 
mechanical ventricular dyssynchrony (145, 146). 
The use of conductance method may offer several technical advantages. After 
catheter placement, the signals are obtained continuously without operator 
interaction. Real-time display of dyssynchrony indexes is technically feasible 
and should enable immediate quantification of the effects of interventions, 
and, e.g., the effects of changes in pacemaker settings. The method is 
invasive, but positioning of the catheter in the LV largely eliminates problems 
with through-plane motion inherent in most imaging methods. Heart failure is 
often associated with substantial beat-to-beat hemodynamic variations due to 
changes in cycle length, cardiopulmonary interaction and conduction 
disturbances. Thus techniques (like magnetic resonance imaging) that require 
hemodynamic steady-state and beat averaging to increase signal-to-noise 
may filter out important components of dyssynchrony. Furthermore, the 
temporal resolution of the conductance signals (4 ms) is relatively high. 
 
To quantify dyssynchrony, novel indexes based on volume signals acquired 
with the conductance catheter were introduced. The conductance catheter 
was validated previously (114), and the segmental signals reflect 
instantaneous volume slices perpendicular to the LV long axis as obtained by 
cine-computerized tomography (147). 
Nonuniform LV performance was determined from the segmental LV 
conductance signals and characterized by the following indexes. 
 
4.a. Classical Parameters in the Time-Domain 
 
Mechanical dyssynchrony. At each time point, a segmental signal is defined 
as dyssynchronous if its change (i.e., dSV/dt) is opposite to the simultaneous 
change in the total LV volume (dTV/dt). Segmental dyssynchrony is quantified 
by calculating the percentage of time within the cardiac cycle that a segment 
is dyssynchronous. 
Overall LV dyssynchrony (DYS) is calculated as the mean of the segmental 
dyssynchronies (140). DYS may be calculated within each specified time 
interval, i.e. during systole and diastole, with systole defined as the period 
between the moments of dP/dtmax and dP/dtmin (Figure 6). 
 
Internal flow. Nonuniform contraction and filling is associated with ineffective 
shifting of blood volume within the LV. This internal flow (IF) is quantified by 
calculating the sum of the absolute volume changes of all segments and 
subtracting the absolute total volume change: [ ] 2//)(/)()( ∑ −= dttdTVdttdSVitIF  
Note that dTV(t)/dt represents the effective flow into or out of the LV. Thus IF 
measures the segment-to-segment blood volume shifts, which do not result in 
effective filling or ejection. Division by two takes into account that any non-
effective segmental volume change is balanced by an equal but opposite 
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volume change in the remaining segments. IF fraction (IFF) is calculated by 
integrating IF(t) over the full cardiac cycle and dividing by the integrated 
absolute effective flow (145) (Figure 6). 
 
Figure 6. Panel a: Example of patient with low values of DYS and IFF both in systolic and 
diastolic phase. Panel b: Marked DYS and IFF are evident in all segmental signals: changes 
of segmental volumes (dVseg/dt) are opposite to the simultaneous change in the total LV 
volume (dVLV/dt). 
 
Mechanical dispersion. In the HF patients, a substantial dispersion is present 
in the onset of contraction between the segments. 
This dispersion is assessed by segmental lag times which are determined by 
calculating the cross correlations between TV(t) and SV(t) for all systolic time 
points (i.e., between dP/dtmax and dP/dtmin). For each segment the lag 
which produces the highest linear correlation is determined. Mechanical 
dispersion (DISP) is defined as 2 × standard deviation of the segmental lag 
times (145) (Figure 7). 
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Figure 7. DISP is assessed by segmental lag times between Vlv(t) and Vi(t) for all systolic 
time points. DISP is defined as 2 × standard deviation of the segmental lag times. 
 
In HF patients, the conductance-derived dyssynchrony indexes were 
compared with the delay in timing of peak systolic velocity between the septal 
and lateral wall as obtained by tissue-Doppler echocardiography. Septal-to-
lateral delay has recently been introduced as an index of mechanical 
dyssynchrony (81). A significant correlation was found for both DYS and IFF, 
but DISP did not reach a statistically significant correlation. Apparently, 
patients with a larger septal-to-lateral delay also show more segmental 
dyssynchrony, as reflected by DISP and IFF. The lack of correlation with DISP 
was unclear.  
 
Discussion and Limitations 
Determination of absolute LV volume from the conductance catheter requires 
careful calibration, however the dyssynchrony indexes can be calculated from 
the raw segmental conductance signals and do not require calibration. 
Correction for parallel conductance is not required because the calculations 
are based on volume changes, and correction for slope factor is not required 
because segmental volume changes are judged relative to the global LV 
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volume changes. The latter, however, implicitly assumes that the segmental 
slope factors are all the same (and thus equal to the slope factor for global 
volume). This assumption may be a concern because theoretical studies 
indicate that volume in the segments closest to the current electrodes may be 
relatively underestimated due to electric field inhomogeneity, especially in 
enlarged hearts (148-150). 
However, recent analysis showed that the influence of a potential 
underestimation of the outer segments on the dyssynchrony indexes is 
relatively small (145). 
Optimally, the conductance catheter is placed in a straight position from the 
aortic valve to the LV apex. The distance from the pigtail to the first 
measurement electrode is about 2 cm. Thus volume changes in the most 
apical part of the LV are not measured. If this region is highly 
dyssynchronous, as might be the case in patients with apical infarcts, 
underestimation of dyssynchrony may be expected. 
Furthermore, the segmental conductance catheter signals do not provide an 
anatomic view but represent the total volume of slices perpendicular to the LV 
long axis. Thus, e.g., in CAD patients, abnormal regional wall motion might be 
obscured by compensatory wall motions within the same circumferential 
segment. The proposed dyssynchrony indexes therefore reflect 
intersegmental differences in contraction and filling and may underestimate 
phase changes obtained by comparing regional lateral and septal wall 
motions, e.g., using tissue Doppler imaging. 
Finally, up to now normal subjects were not studied and thus normal ranges 
for the dyssynchrony indexes are not established yet. 
Similarly the prognostic value of the dyssynchrony indexes was not 
investigated. 
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4.b. New Parameters in the Time-Domain Derived from 
Echocardiography 
 
Recently, new parameters have been introduced to quantify LV dyssynchrony 
with echocardiographic techniques. These indices can be directly applied to 
conductance method: 
 
Cycle Efficiency. Calculated as previously described (151) by the formula: 
CE=SW/[ΔLVP*ΔLV volume], with SW = stroke work, ΔLVP = end-systolic – 
end-diastolic LV pressure. This index quantifies distortions in the shape of the 
pressure-volume diagram. The calculation assumes that the optimal 
contraction would have CE value near 1.0, corresponding to a rectangular 
pressure volume diagram. Decreases in cycle efficiency may be caused by 
multiple factors including isovolumic volume shifts as well as changes in 
afterload and ventricular stiffness (Figure 8). Similarly, regional cycle 
efficiency can be calculated from the most basal to the most apical segmental 
volume signal plotted against LV pressure. Differences in regional cycle 
efficiency during isovolumic filling or emptying may indicate inefficient patterns 
contraction or relaxation due to dyssynchrony. 
 
Figure 8. Four pressure-volume loops. In the upper panels mild incoordination is shown. In 
the lower panels incoordination is greater — note the increase in cavity size while the 
ventricular pressure generated is still relatively high, and the reduction of volume when the 
ventricular pressure is low. 
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Time exceeding aortic closure.  In order to measure diastolic dyssynchrony 
and specifically to quantify LV contraction in diastolic phase, a new index was 
proposed, quantitatively reflecting the whole temporal amount spent by 12 LV 
segments in contracting after aortic valve closure (152). 
Using strain imaging that reflects myocardial deformation, the time of strain 
tracing exceeding aortic valve closure (ExcT) was measured in each segment 
as the interval between the marker of aortic closure and the nadir of the strain 
tracing. ExcT was considered 0 when the nadir of strain curve did not exceed 
aortic valve closure. The overall time of strain exceeding aortic valve closure 
(oExcT) was computed as the sum of the 12 segmental ExcTs. 
The index may be implemented in conductance method by considering each 
segment presenting a systolic phase (negative dSVi/dt) persisting during the 
phase of global diastole (positive dTV/dt). oExcT is estimated as the sum of 
these delays for all segments (Figure 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. The segments 1, 2 and 3 present a systolic phase (negative dSVi/dt) persisting 
during the phase of global diastole. oExcT is estimated as the sum of the lags for these 
segments. 
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4.c. The Coherent Averaging 
 
Following the original approach, each dyssynchrony index is extracted for 
each cardiac cycle and then averaged over consecutive beats. 
 
Coherent averaging is used to recover the response to repetitively applied 
stimuli when that response is embedded in random noise (153,154). The 
coherent averaging method is based on the principle that each segment of the 
signal contains an invariant component x(t), plus a noise component n(t). 
In coherent averaging, all x(t) are systematically added, whereas the random 
noise components are summed and tend toward zero, in the following 
hypotheses: n(t) is additive, uncorrelated with x(t), stationary and normally 
distributed with zero mean. 
 
The presence of a noise component may influence the estimation of 
mechanical dyssynchrony performed over single cardiac cycles. In particular, 
noise components may alter the measure of repetitive mechanical 
inhomogenities. The impact of signal processing procedures such as coherent 
averaging on mechanical LV dyssynchrony estimation has never been 
evaluated. 
 
The use of coherent averaging permits to investigate the characteristics of the 
volume signals and to introduce new improved indexes of ventricular 
dyssynchrony. 
 
4.d. Parameters in the Time-Domain by Coherent Averaging 
 
Instead of calculating the indexes from the original signals, the coherent 
averaging is performed to extract a template of cardiac cycle for each 
segmental volume signal (Figure 10), and for the total volume. In this work, 
three new indexes have been derived from the templates with the standard 
method: 
 
- Mechanical dyssynchrony of averaged signal (DYSCoh), 
- Internal flow fraction of averaged signal (IFFCoh), 
- Mechanical dispersion of averaged signal (DISPCoh). 
 
These indexes of dyssynchrony permit to quantify the repetitive component of 
the mechanical inhomogenities. 
 
The procedure of coherent averaging permits to derive the residual signal, 
that is the difference between the segmental volume signal SVi and its 
estimated template. This signal represents the sum of all non-repetitive 
components of ventricular mechanics. The percentage power of this signal 
with respect to the total power of SVi (Resi, i.e. segmental residual powers), 
permits to quantify the amount of non-repetitive components in the volume 
signal. 
 
- Segmental residual power (Res1, Res2, Res3, Res4, Res5), 
- Total residual power (ResTotAvg): the average of segmental values. 
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In addition, the total residual power has been estimated in 4 frequency bands 
(the bandwidth of the volume signals is 125Hz), thus deriving 4 new indexes:  
 
- from 0 to 1 Hz (ResTotAvg0-1), 
- from 1 to 5 Hz (ResTotAvg1-5), 
- from 5 to 20 Hz (ResTotAvg5-20), 
- from 20 to 125 Hz (ResTotAvg>20). 
 
 
Figure 10. Segmental volume signal [Panel a] and total volume [Panel b]. The graphs on the 
right show the signal templates (red curves) obtained from several cardiac cycles using the 
coherent averaging. 
 
4.e. Parameters in the Frequency Domain 
 
The continually changing temporal or phase relationship between two time 
series may be quantified in the frequency domain by magnitude-squared 
coherence (155). Magnitude-squared coherence (C(f)) between two 
recordings is defined as 
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Where x(t) and y(t) are two simultaneous recordings, Sxy is the cross power 
spectrum between signals x and y, and Sxx and Syy are the individual power 
spectra for signals x and y, respectively. C(f) is a measure of the linear 
relation between signals as a function of frequency, f, and is a real quantity 
with value between zero and one. In other terms, C(f) measures the 
constancy of the time delay (phase) at a specific frequency between signals x 
and y. Two linearly related signals (in the absence of noise) will have an C(f) 
function equal to one at all frequencies present in both signals, while two 
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random, uncorrelated signals will have an C(f) equal to zero at all frequencies. 
Any linear operation (multiplication by a constant or addition of a constant) on 
one or both of the signals will not alter the C(f) between x and y. However, 
additive, uncorrelated noise and system nonlinearities will reduce C(f) for two 
similar signals. 
C(f) may be estimated for sampled data using a method of overlapped and 
averaged FFT spectral estimates (156). Basically, estimates of Sxx, Syy and 
Sxy are determined using a periodogram technique, and their estimates are 
then used in the definition of C(f). 
 
The C(f) functions between each segmental volume SVi and the TV have 
been estimated over the band 0-125 Hz. A Total Coherence function has 
been defined over the band 0-125 Hz  by averaging the 5 C(f) functions. From 
the Total Coherence function, 5 new frequency domain indexes have been 
extracted:  
 
- mean value of the Total Coherence over the band 0-125 Hz (CohTot) 
- mean value of the Total Coherence from 0 to 1 Hz (Coh0-1), 
- mean value of the Total Coherence from 1 to 5 Hz (Coh1-5), 
- mean value of the Total Coherence from 5 to 20 Hz (Coh5-20), 
- mean value of the Total Coherence from 20 to 125 Hz (Coh>20). 
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5. Experimental Protocols 
 
The Institutional Review Boards at the Careggi Hospital (Florence), the Detroit 
Medical Center (Detroit) and the Istituto Auxologico Ospedale S. Luca (Milan) 
approved the experimental design and all subjects provided written informed 
consent. 
Patients with indications for electrophysiologic study or device implantation 
were included. Patients with a previously implanted device, valvular 
insufficiency or stenosis were excluded from participation. 
 
5.a. Ventricular Pressure and Volume Measurements 
 
LV pressure and volume were measured using a 7F, 12-electrode 
combination high fidelity micromanometer-conductance catheter (CD Leycom, 
Zoetermeer, The Netherlands) inserted through a femoral artery and 
advanced into the LV apex over an 0.025 flexible guide wire using 
fluoroscopic guidance. The catheter was connected to a cardiac function 
analyzer (CFL 512, CD Leycom) that automatically recorded (sample rate: 
250 Hz, accuracy: 12 bit) and displayed pressure and up to 7 segmental 
volumes delineated by the electrodes. 
The signal analysis was performed off-line with a custom-made software. 
The pigtail of the conductance catheter was accurately positioned in the apex, 
and the interelectrode spacing was adjusted to the long heart axis. Segmental 
volumes originating from the proximal ascending aorta were discarded. 
 
5.b. Pacing Protocol 
 
Temporary pacing electrodes were positioned in the right ventricular apex, 
right ventricular outflow tract free wall and septum, and LV free wall. 
Experimental interventions were performed after electrophysiologic study and 
before device implant. Constant atrial overdrive pacing (AAI) was maintained 
throughout the protocol at a rate of 10 bpm greater than the sinus rate. 
Baseline data were recorded during AAI pacing. Each patient was randomly 
assigned to receive dual chamber pacing from the sites to test using a Latin 
square design. AV delay was programmed to the measured p to His interval 
minus 10 ms in order to limit the potential effects of atrial contraction and 
partial intrinsic conduction through the AV node. Data were collected under 
steady-state hemodynamic conditions after a minimum of 2 minutes of 
stabilization at each pacing configuration. The transitions from atrial pacing to 
dual chamber pacing and back to atrial pacing were recorded continuously. 
 
5.c. Data Analysis 
 
When required by the specific experimental protocol, hemodynamic status 
was evaluated using multiple parameters. Indices of LV pressure, volume, 
and function were calculated and averaged over 8 to 10 beats at end 
expiration from the raw LV pressure and conductance volume data including 
LV systolic (LVSP) and end-diastolic (LVEDP) pressure, +dP/dtMAX and –
dP/dtMIN, LV end-systolic (LVESV) and end-diastolic volume (LVEDV), LV 
stroke volume (SV) defined as the difference between conductance volumes 
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at the times of +dP/dtMAX and –dP/dtMIN, stroke work (SW) calculated as the 
area of the pressure-volume diagram, cardiac output (CO), ejection fraction 
(EF), and the time constant of isovolumic relaxation (τ). End-diastole was 
identified immediately before the isovolumic increase in LV dP/dt and end-
systole was defined as the maximum ratio of LV pressure to volume. 
 
7.d. Off-Line Signal Analysis System 
 
The system for off-line data analysis was developed in LabVIEW 5.1 (National 
Instrument, Houston, TX, USA). (Figure 11) 
The acquired signals are shown and the user is allowed to select the cardiac 
cycles to analyze and the segmental volume signals to consider in the 
estimation of the total volume curve. Specific cardiac cycles can be indicated 
and removed from the analysis to exclude ectopic beats. 
 
 
 
Figure 11. Panel of the analysis system. It includes the indicators representing the acquired 
signals, the controls to select the cardiac cycles to analyze and the signals to include in the 
total volume estimation. 
 
Moreover, the system permits to show the signal on the pressure-volume 
plane and to extract all relevant hemodynamic indexes. 
The dP/dt signal is calculated from the ventricular pressure signal. The noise 
in the original signal is amplified when the derivative is taken: digital low-pass 
filtering was used to remove the noise. A digital low-pass filter model was 
implemented using the cascaded form of infinite impulse response (IIR) 
filtering technique (Butterworth filter of order four and a cut-off frequency of 10 
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Hz). The Butterworth filter model was used because of its smooth response at 
passband frequencies. 
The time shift caused by the digital filtering was cancelled out by the following 
equalization technique. The discrete filtered signal (dP/dt) is first reversed 
before being filtered again using the same filter. The resultant signal is 
reversed to give a filtered dP/dt which is free of time lag. (Figure 12 Panel i – 
filtered segnal: red curve) 
Similarly, the dVol/dt signal is obtained from the ventricular volume signal. 
(Figure 12 Panel g – filtered signal: red curve) 
 
Timing points 
The system estimates the end diastolic point from the intra-cardiac 
electrogram (maximum of R-wave, identified with parabolic interpolation of the 
signal in order to minimize the jitter error). (Figure 12 Panel a – red markers) 
The maximum and minimum of dP/dt signal are identified to define the start 
and the end systole. (Figure 12 Panel i – white markers) 
The minimum of volume signal during systolic phase is extracted. (Figure 12 
Panel f – white markers). 
The point of peak filling rate is identified by the maximum of dVol/dt signal and 
distinguishes the early and late-diastolic phases. (Figure 12 Panel g – red 
markers) 
 
Indexes of dyssynchrony 
According to the methods described before, the system permits the estimation 
of following dyssynchrony indexes: 
 
- Mechanical dyssynchrony (DYS), 
- Internal flow fraction (IFF), 
- Mechanical dispersion (DISP), 
- Cycle Efficiency (CE), 
- Time exceeding aortic closure (oExcT), 
- Mechanical dyssynchrony of averaged signal (DYSCoh), 
- Internal flow fraction of averaged signal (IFFCoh), 
- Mechanical dispersion of averaged signal (DISPCoh), 
- Segmental residual power (Res1, Res2, Res3, Res4, Res5), 
- Total residual power (ResTotAvg), 
- from 0 to 1 Hz (ResTotAvg0-1), 
- from 1 to 5 Hz (ResTotAvg1-5), 
- from 5 to 20 Hz (ResTotAvg5-20), 
- from 20 to 125 Hz (ResTotAvg>20), 
- Total Coherence (CohTot), 
- from 0 to 1 Hz (Coh0-1), 
- from 1 to 5 Hz (Coh1-5), 
- from 5 to 20 Hz (Coh5-20), 
- from 20 to 125 Hz (Coh>20). 
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Figure 12. Acquired and estimated signals with the calculated timing points. 
 
 
Coherent averaging and alignment algorithms 
In order to implement the coherent averaging, the system permits to apply 3 
algorithms for alignment of the cardiac cycles: 
Use of single fiducial point: 
1. Maximum of ECG R-wave, 
2. Zero of first derivative of LV pressure signal (157), 
Maximization of cross correlation function of: 
3. Consecutive beats signals, 
4. Systolic phase of consecutive beats signals (from the point of max dP/dt to 
min dP/dt). 
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6. Experimental Results 
 
6.a. Optimal Algorithm to Implement Coherent Averaging of the 
Ventricular Volume Signals 
 
This chapter is published in: 
S Valsecchi, L Padeletti, GB Perego, F Censi, P Bartolini, JJ Schreuder. Estimation of 
Ventricular Mechanical Dyssynchrony by Conductance Catheter: Methodological 
Considerations and Experimental Results. Computers in Cardiology 2006. Poster Session 
PA8 (Abs.225). 
 
Introduction 
 
Four alignment algorithms have been considered to perform coherent 
averaging for total and segmental volume template extraction. 
Aim of this analysis was to identify the optimal algorithm of cardiac cycle 
alignment. 
 
Methods 
 
Patients with indications for electrophysiologic study or device implantation 
were studied. Subjects with a previously implanted device, valvular 
insufficiency or stenosis were excluded from analysis. For a detailed 
description of methods see Chapter 5. For this analysis we considered the 
conductance catheter recordings collected with the patient in sinus rhythm in 
the absence of ventricular pacing. 
 
Data Analysis 
Sequences of 20 consecutive cardiac cycles were considered, all ectopic 
beats were excluded from the analysis. The analysis was performed on the 
total volume signal, estimated as the sum of 4 segmental volumes. 
We identified the method resulting in the minimum mean square error (MSE) 
between the original signal and the resulting template. 
Statistical analysis was performed with paired Student’s t-test for comparisons 
between MSE values. Statistical significance was assumed at p<0.05. Results 
are presented as mean±SD. 
 
Results 
 
A total of 12 patients were studied (7 males, 67±14 years, 71±11Kg, 
171±8cm). 
The MSE associated to the alignment algorithms under test (All.1: Max R-
wave; All.2: dP/dt=0; All.3: Max correlation function; All.4: Max correlation 
function of systolic phase signals) is reported in Table 2 for each subject. 
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Table 2.  MSE associated to the four alignment algorithms. 
Patient 
MSE All.1 
[ml^2] 
MSE All.2 
[ml^2] 
MSE All.3 
[ml^2] 
MSE All.4 
[ml^2] 
1 2.003 10.576 2.099 2.055 
2 2.496 4.660 2.785 2.617 
3 0.554 5.453 1.293 0.586 
4 2.221 1.931 3.086 2.375 
5 0.978 4.460 1.167 1.012 
6 2.198 4.560 7.519 2.364 
7 0.716 0.766 0.874 0.767 
8 0.932 0.984 1.248 1.082 
9 3.214 9.552 8.083 3.22 
10 1.409 10.331 1.925 1.501 
11 0.839 0.818 0.98 0.918 
12 0.587 0.632 1.093 0.642 
      
mean 1.512 4.560 2.679 1.595 
stddev 0.883 3.799 2.498 0.893 
p-value Vs.All.1 0.01 0.05 0.00 
 
Conclusions 
 
In our population, the alignment method using R-wave identification resulted 
in the best performance. 
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6.b. Indexes for the Quantification of Left Ventricular Mechanical 
Dyssynchrony by Conductance Catheter 
 
This chapter is published in: 
S Valsecchi, L Padeletti, GB Perego, F Censi, P Bartolini, JJ Schreuder. Estimation of 
Ventricular Mechanical Dyssynchrony by Conductance Catheter: Methodological 
Considerations and Experimental Results. Computers in Cardiology 2006. Poster Session 
PA8 (Abs.225). 
 
Introduction 
 
Analysis 1 
Background noise could affect the estimation of mechanical dyssynchrony 
when performed on each cardiac cycle. Random noise components could 
alter the estimation of dyssynchrony due only to recurrent mechanical LV 
nonuniformities. The impact of signal processing procedures such as coherent 
averaging and signal alignment on mechanical LV dyssynchrony estimation 
has never been evaluated.  
We characterized conductance-volume singals with an analysis in frequency 
domain and using coherent averaging. 
We evaluated new methods for LV dyssynchrony estimation, using coherent 
averaging with alignment algorithm before averaging. Moreover, new 
improved indexes were introduced to quantify non-recurrent components of 
volume signals. 
To test our approach we compared data from congestive heart failure (HF) 
patients with left bundle branch block (LBBB) with those from patients with 
preserved LV function. 
 
Analysis 2 
CRT was demonstrated to mitigate the mechanical and energetic 
consequences of intraventricular dyssynchrony in HF patients with LBBB. 
Moreover, in patients with preserved LV function dyssynchrony can be 
induced by right ventricular apical pacing and evidence suggests that this can 
itself lead to LV systolic failure. 
We studied the acute effects of CRT in patients with HF and the effects of 
right ventricular apical pacing in healthy subjects. Moreover, we assessed the 
ability of the indexes of mechanical dyssynchrony to describe the changes in 
LV activation induced by different pacing modalities. 
 
Methods 
 
Sequences of 30 s, i.e. 40-50 consecutive non-arrhythmic cardiac cycles at 
fixed heart rate induced by atrial pacing (at 10 bpm above the sinus rate) and 
steady-state conditions were selected for off-line analysis using custom-
designed software. 
The system for coherent averaging estimation uses an algorithm for cadiac 
cycles alignment based on single fiducial point, i.e. maximum of R-wave, that 
demonstrated to minimize the mean square error with respect other methods. 
For the spectral analysis, the periodogram of the signals was estimated. 
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To reduce spectral leakage a Hamming window was applied after removal of 
the mean value. The length of segments was 1000 samples and a segment-
overlap of 30% was used. 
As reported in Chapter 4.e., the spectral coherence was estimated as the 
mean value of the coherence function between each segmental volume and 
the total volume over the band considered. The values obtained for all 
segments were averaged to obtain the total value. 
 
Analysis 1 
For this analysis, we used the recordings obtained during atrial pacing and 
spontaneous ventricular activation. The spectral characteristics were 
extracted and compared between the two groups of patients. The classical 
indexes in the time-domain were compared with the ones obtained with 
coherent averaging. Finally, a head-to-head comparison of all indexes was 
performed to estimate the ability to discriminate the patient groups. 
 
Analysis 2 
In this analysis the recordings obtained during atrial pacing and during 
ventricular pacing (CRT and right ventricular apical pacing) were considered. 
Intra-patient comparisons were performed between pacing modes.  
The data analysis is described in Chapter 5.. In particular, the hemodynamic 
variables analyzed were: LV systolic and end-diastolic pressure, positive 
(dP/dt) and negative (n dP/dt) maximum of first derivative pressure, LV end-
systolic and end-diastolic volume, stroke volume (SV), stroke work (SW), 
cardiac output (CO), and the time constant of isovolumic relaxation (Tau). 
Classical and new indexes of dyssynchrony were estimated and compared 
between pacing modes. 
Regression analysis was performed to identify variables associated to the 
changes of LV function. 
 
Statistical Analysis 
All data are presented as means±SD.  
Differences between distributions were compared by a t-test for Gaussian 
variables, and by Mann-Whitney nonparametric test for nongaussian 
variables. Statistical correlations between variables were tested by least-
squares linear regression. A P value < 0.01 was considered significant. We 
performed receiver-operating characteristic (ROC) curve analysis to test the 
diagnostic performance of the indexes to discriminate the patient groups. 
Sensitivities and specificities at the optimal cut-off point were determined. 
 
Results 
 
The study population consisted of 27 consecutive patients. 
• 15 HF patients with left bundle branch block  (HF Group): 
11 males, 68±6 years, 7 with ischemic etiology, NYHA class 3.1±0.5, ejection 
fraction 26±6%, QRS duration 167±24 ms. 
• 12 patients with preserved LV function (no-HF Group): 
7 males, 67±14 years, ejection fraction 57±9%, QRS duration 88±21 ms. 
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Analysis 1 
 
Characterization of conductance-volume signals 
The frequency analysis, performed to extract dyssynchrony indexes, 
permitted to characterize conductance-volume SVi and TV singals. 
Some characteristics of the power spectrum of TV signal are reported in Table 
3 (similar results were obtained for SVi signals, but were not reported): power 
and frequency peaks in different bands. 
The majority of the signal power is in the band from 1 to 5 Hz (programmed 
heart rate during acquisition from 70 to 100 bpm). The components above 
20Hz are associated to less than 1% of the total signal power. The frequency 
peak in the 0 – 1 Hz band matches with the respiratory rate and the power in 
this band seems higher in HF group. 
 
Table 3. Characteristics of the power spectrum of TV signal. 
 
 no-HF HF p-values 
Power 0-1Hz, % 4.34±6.26 9.12±12.00 0.071 
       Peak 0-1Hz, Hz 0.41±0.17 0.45±0.12  
Power 1-5Hz, % 93.24±6.45 88.44±11.85 0.194 
       Peak 1-5Hz, Hz 1.52±0.20 1.44±0.13  
Power 5-20Hz, % 2.16±1.84 2.21±1.34 0.946 
       Peak 5-20Hz, Hz 8.37±0.88 7.63±0.80  
Power >20Hz, % 0.25±0.25 0.23±0.15 0.814 
       Peak >20Hz, Hz 37.59±5.12 44.14±7.59  
 
Parameters in the time domain and the coherent averaging 
DYSCoh resulted significantly lower than DYS in HF patients (25.8±4.8% Vs. 
32.6±3.9%, p=0.000) and in no-HF patients (19.6±9.3% Vs. 26.0±7.2%, 
p=0.000). Both indexes were significantly higher in HF group (even if non-
significantly for DYSCoh). 
Similar results were obtained for IFF: IFF was higher than  IFFCoh (estimated 
on the template) (25.8±18.8% Vs. 17.3±18.7% in no-HF group and 
40.8±13.6% Vs. 20.8±11.1% in HF group, both p=0.000). Also in this case, 
IFF and IFFCoh were higher for HF group (significance level reached only for 
IFF). 
No differences resulted between DISP and DISPCoh in no.HF patients 
(23.4±16.4ms Vs. 23.2±16.9ms, p=0.870).While, DISPCoh was significantly 
higher than DISP in HF patients (48.3±19.8ms vs. 35.6±13.2ms, p=0.006). 
Differences were not observed in DISP values between no-HF and HF. 
However, DISPCoh was higher for HF patients. 
 
Performance of parameters under test 
Table 4 summarizes the results of the comparison between groups for all 
indexes considered in the analysis, represented as mean ± standard 
deviation.  
Overall, 7 parameters permitted to discriminate the two groups (p<0.01): 
DISPCoh, Coh1-5, Coh5-20, ResTotAvg, Res2, ResTotAvg1-5, CE. 
 59
Table 5 shows the results of the ROC curve analysis. Optimal cut-off with 
sensitivity and specificity values are reported for the 7 variables obtained from 
previous comparison. In Figure 13 the ROC curves are shown. 
 
 
Table 4. Indexes of mechanical dyssynchrony in no-HF and HF groups. 
 
 no-HF HF p-values Test 
     
DYS, % 26.0±7.2 32.6±3.9 0.012 t-test 
DYSCoh, % 19.6±9.3 25.8±4.8 0.054 t-test 
IFF, % 25.8±18.8 40.8±13.6 0.033 t-test 
IFFCoh, % 17.3±18.7 20.8±11.1 0.139 Mann-Whitney 
DISP, ms 23.4±16.4 35.6±13.2 0.068 t-test 
DISPCoh, ms 23.2±16.9 48.3±19.8 0.003* t-test 
CohTot 0.44±0.07 0.37±0.10 0.016 Mann-Whitney 
Coh0-1 0.63±0.19 0.51±0.18 0.099 t-test 
Coh1-5 0.69±0.10 0.57±0.10 0.004* t-test 
Coh5-20 0.47±0.07 0.32±0.04 0.000* t-test 
Coh>20 0.43±0.08 0.37±0.12 0.041 Mann-Whitney 
ResTotAvg, % 11.1±9.9 25.7±13.1 0.006* Mann-Whitney 
Res1, % 17.5±19.1 34.1±21.7 0.028 Mann-Whitney 
Res2, % 9.8±8.5 28.9±19.9 0.004* t-test 
Res3, % 7.2±6.6 20.7±20.2 0.019 Mann-Whitney 
Res4, % 10.1±10.7 23.3±12.7 0.021 Mann-Whitney 
Res5, % 17.3±17.2 21.5±12.6 0.213 Mann-Whitney 
ResTotAvg0-1, % 80.1±39.0 64.9±36.0 0.323 Mann-Whitney 
ResTotAvg1-5, % 6.4±8.4 16.6±9.3 0.005* Mann-Whitney 
ResTotAvg5-20, % 45.2±17.8 59.5±21.4 0.070 t-test 
ResTotAvg>20, % 78.0±26.0 89.9±18.3 0.252 Mann-Whitney 
CE 0.78±0.12 0.58±0.16 0.000* Mann-Whitney 
oExcT, ms 6.9±8.8 15.7±10.5 0.016 Mann-Whitney 
* p<0.01 
 
 
 
Table 5. ROC curve analysis of the tested variables. 
 
 
Area Under Curve 
(95% CI) p-value Cut-off Sensitivity Specificity
DISPCoh, ms 0.83 (0.66-1.00) 0.007 41.71 0.64 0.90 
Coh1-5 0.81 (0.65-0.98) 0.006 0.57 0.67 0.92 
Coh5-20 0.98 (0.94-1.02) 0.000 0.40 1.00 0.92 
Res2, % 0.82 (0.65-0.99) 0.006 24.26 0.64 1.00 
ResTotAvg, % 0.81 (0.64-0.98) 0.007 19.69 0.71 0.83 
ResTotAvg1-5, % 0.81 (0.63-0.99) 0.006 10.25 0.80 0.83 
CE 0.88 (0.75-1.00) 0.001 0.70 0.80 0.83 
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Figure 13. The ROC curve analysis demonstrated a sensitivity of 100% and a specificity of 
92% for Coh5-20, with a cut-off = 0.40. 
 
Analysis 2 
 
The results of the analysis are reported in Table 6. Among subjects of HF 
group, the biventricular pacing resulted in a marked improvement of cardiac 
function (significant increase of maximum dP/dt and a trend toward an 
increase of cardiac output, stroke volume and stroke work as well as a 
reduction in end-systolic volume) associated to a significant reduction of 
dyssynchrony, as evidenced by IFF, CE, CohTot, Coh>20, and a trend for 
DISPCoh, oExcT, Coh5-20, ResTotAvg, ResTotAvg1-5, ResTotAvg>20. 
Among subjects of the no-HF group, the right ventricular pacing impaired 
cardiac function, as shown by an increase of Tau and a trend to a reduction of 
maximum dP/dt, demonstrating a compromised diastolic and systolic function. 
In this case, indexes of dyssynchrony did not present significant differences. 
In the overall population, we observed a significant correlation between 
changes in stroke volume and following indexes: IFF (r=-0.68, p=0.000), CE 
(r=0.85, p=0.000), CohTot (r=0.51, p=0.017), Coh>20 (r=0.53, p=0.004). 
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Table 6. Acute effects of CRT in the HF group and right ventricular pacing in no-HF group. 
 
 HF no-HF 
 Baseline CRT Baseline 
Right V. 
Pacing 
CO, l/min 2.4±1.1 4.2±3.6* 4.2±1.4 3.9±1.7 
EDVolume, ml 246.6±69.3 232.0±63.0 137.9±39.1 135.2±38.8 
ESVolume, ml 215.8±65.6 198.9±81.3* 102.9±38.6 104.1±39.1 
EDPressure, mmHg 16.1±8.6 14.6±8.0 10.0±5.4 11.2±2.2 
ESPressure, mmHg 102.9±19.7 103.8±17.5 128.3±16.7 123.3±22.9 
dP/dt, mmHg/s 750.0±169.6 813.3±153.0** 1659.1±319.1 1559.7±283.6* 
n dP/dt, mmHg/s -765.0±134.3 -788.9±113.9 -1782.3±437.6 -1628.8±489.7 
Tau, ms 43.8±9.6 42.7±9.0 33.7±5.6 37.5±6.7** 
SV, ml 22.5±16.6 35.9±38.0* 38.3±28.7 33.5±26.0 
SW, l*mmHg 2.0±1.6 3.3±3.5* 4.4±3.2 3.7±2.6 
DYS, % 28.4±5.5 27.5±4.6 24.5±9.4 25.1±8.2 
IFF, % 38.4±15.1 31.1±12.9** 29.8±19.1 29.7±17.8 
DISPCoh, ms 55.7±25.4 44.5±28.3* 39.4±28.8 40.4±27.2 
CE 0.5±0.2 0.7±0.2** 0.8±0.1 0.8±0.2 
oExcT, ms 14.4±11.8 9.0±9.0* 6.9±8.8 5.4±6.3 
CohTot 0.40±0.12 0.52±0.12** 0.41±0.05 0.45±0.10 
Coh0-1 0.53±0.17 0.50±0.17 0.60±0.14 2.77±6.13 
Coh1-5 0.58±0.11 0.57±0.11 0.65±0.10 0.65±0.06 
Coh5-20 0.36±0.12 0.38±0.12* 0.45±0.06 0.44±0.07 
Coh>20 0.40±0.13 0.53±0.13** 0.40±0.06 0.44±0.11 
ResTotAvg, % 30.9±18.8 28.9±16.7* 14.9±10.3 20.1±15.9 
Res1, % 40.0±24.7 40.1±22.3 23.9±20.8 28.1±16.8 
Res2, % 30.7±21.0 27.2±17.4 13.5±8.1 16.1±13.3 
Res3, % 27.6±25.8 24.2±19.5 9.0±7.6 12.7±15.0 
Res4, % 29.6±20.3 25.2±17.1 10.7±11.3 20.1±23.9 
Res5, % 25.0±16.7 26.6±19.2 17.3±17.2 23.4±23.0 
ResTotAvg0-1, % 81.6±57.0 106.1±62.7 90.9±35.5 125.8±36.4 
ResTotAvg1-5, % 21.3±15.9 18.0±13.1* 9.0±9.3 10.0±8.0 
ResTotAvg5-20, % 62.9±20.1 58.6±21.0 45.3±20.1 36.2±16.6 
ResTotAvg>20, % 95.7±19.4 79.7±26.9* 75.4±28.6 191.1±427.4 
p-values: * < 0.05; ** <0.01 
 
 
Discussion and Conclusions 
 
Dyssynchrony plays a regulating role already in normal physiology (23) but is 
especially important in pathological conditions, such as hypertrophy (24), 
ischemia (25), infarction (26), or heart failure (27). Quantification of 
nonuniform mechanical function and dyssynchrony may lead to a more 
complete diagnosis of ventricular dysfunction (140,142). Moreover, it may 
guide therapy, because patients with extensive dyssynchrony are likely to 
benefit from resynchronization therapy (158). 
Currently, cardiac resynchronization by biventricular pacing is emerging as an 
important therapy for heart failure (158,159). Recently, magnetic resonance 
imaging (27,109) and echocardiography (66,76,77,80,85) have been used to 
visualize mechanical dyssynchrony, further emphasizing the important role of 
mechanical dyssynchrony in cardiac dysfunction. However, these methods 
are laborious and require substantial operator interaction and expertise. 
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Recently, novel indexes were introduce to quantify dyssynchrony based on 
volume signals acquired with the conductance catheter during cardiac 
catheterization. 
Quantification of nonuniform mechanical function and dyssynchrony may lead 
to a more complete diagnosis of ventricular dysfunction (140,142). Moreover, 
it may guide therapy, because patients with extensive dyssynchrony are likely 
to benefit from resynchronization therapy (158). 
 
Analysis 1 
 
To test the performance of the indexes we compared data obtained in the 
same conditions, from HF patients with left bundle branch block undergoing 
CRT implantation and from patients with preserved LV function. To the best of 
our knowledge, this is the first time that indexes of mechanical dyssynchrony 
based on volume signals acquired with the conductance catheter are studied 
in a population of normal patients. In fact, previous work used as control 
group a population with coronary artery disease and relatively preserved LV 
function before undergoing coronary artery bypass grafting (145). However, in 
such a kind of population the presence of dyssynchrony can not be excluded, 
due to akinetic ischemic areas. Moreover, in that study the two groups were 
studied in different conditions: the HF group in the catheterization laboratory, 
while the control group in the operating room during anesthesia and after 
sternotomy. 
Similarly, for the first time coherent averaging technique is applied either to 
extract new indexes to quantify ventricular dyssynchrony and to characterize 
the signals obtained with conductance catheter, differentiating repetitive and 
non-recurrent components. In fact, volumetry by conductance catheter 
permits to acquire, with high temporal resolution, real-time signals. This may 
allow to overcome the limitations of techniques like MRI or echocardiography 
that require beat averaging to derive indexes of dyssynchrony, masking all 
possible components associated with beat-to-beat hemodynamic variations.  
Present analysis permitted to describe some characteristics of the 
conductance-volume signals. The frequency analysis evidenced the absence 
of relevant components above 20 Hz: this result corroborate the validation of 
segmental signals acquisition obtained by comparison with cine-computerized 
tomography (147), whose sampling rate has approximately the same value. 
The amplitude of the components in the range 0-1 Hz, attributable to the 
respiratory artifact, resulted markedly higher in HF patients, this may be due 
to the higher (mechanical) cardio-pulmonary interaction or to an altered 
vasovagal activity. 
When extracting indexes to quantify synchronism between signals, random, 
spurious or non-synchronous components of the signals may play an 
important role. We hereby investigated how the coherent averaging procedure 
may affect or refine the conductance based indexes proposed by Steendijk et 
al. (145); in addition, we proposed a new set of indexes which quantify the 
non-periodic components of the volume signals different from the white 
acquisition noise. 
The implementation of coherent averaging unmasked the presence of 
considerable beat-to-beat variations in dyssynchrony that seem more frequent 
in patients with LV dysfunction and seem to play a role in discriminating 
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patients. These non-recurrent mechanical LV non-uniformities are probably 
the expression of the substantial beat-to-beat hemodynamic variations, often 
associated with HF and due to cardiopulmonary interaction and conduction 
disturbances 
This result is confirmed by the findings obtained by the new indexes based on 
residual percentage power that quantify the contribution of non-periodic 
components of the volume signals. In fact, ResTotAvg, Res2 and 
ResTotAvg1-5 resulted higher in HF group. 
When estimated on SV and TV templates, DYSCoh and IFFCoh resulted to 
be significantly lower than their counterparts estimated on each cardiac cycle; 
also, sensitivity and specificity associated to these new indexes were lower. 
These results suggest that the non-periodic components of the volume signals 
determine the random left ventricle activations reflecting cardiac 
dyssynchrony. 
The estimation of the mechanical dispersion (DISP) is instead improved by 
the coherent averaging: when estimated on SV and TV templates DISPCoh 
resulted significantly higher than when estimated for each cardiac cycle in HF 
patients. Coherent averaging optimizes the estimation of time delays when it 
is corrupted by spurious components. 
In the no-HF patients no significant differences have been found between 
DISP and DISPCoh because when the volume signals are less corrupted by 
non-periodic components, time lag estimations by cross-correlation are less 
affected by coherent averaging. 
This result may contribute to explain the lack of correlation noticed between 
DISP and the delay in timing of peak systolic velocity between the septal and 
lateral wall as obtained by tissue-Doppler echocardiography (16). Indeed, the 
extraction of that index from tissue-Doppler images requires the estimation of 
the average peak systolic velocity time over consecutive beats, a procedure 
equivalent to the coherent averaging method. 
Among new indexes in the frequency domain, Coh1-5 and especially Coh5-20 
demonstrated high values of sensitivity and specificity in discriminating 
groups. 
Among the indexes in the time-domain derived from echocardiography, CE 
demonstrated best performance in discriminating groups. In fact, this 
parameter is mainly affected by volume shifts during isovolumic phases that, 
as known from echo-TDI studies, characterize patients with heart failure and 
intra-ventricular conduction disorders. Moreover, this index offers the 
advantage to quantify regional efficiency, when estimated from segmental 
signals. However, the oExcT index, even if different between groups, did not 
emerge among the best parameters, probably because it quantifies only the 
diastolic component of the mechanical dyssynchrony. 
 
Analysis 2 
 
For the first time a complete set of conductance catheter based indexes of 
dyssynchrony were used to describe the acute effects of of the CRT and the 
right ventricular pacing. 
The results of this analysis are in agreement with the literature, describing a 
marked improvement of the cardiac function following CRT, in patients with 
ventricular dysfunction. 
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Among the indexes considered in this analysis, the ones that demonstrated 
higher sensitivity to the effects of CRT were IFF, CE, CohTot, Coh>20. This 
demonstrates that they are able to detect the reduction of internal ineffective 
flows, the inhomogeneity during isovolumic contraction and relaxation as well 
as the recovered coherence among segments that, as shown by previous 
analysis, is more accurately described by cross-spectral parameters. 
Moreover, the analysis confirms the impairment induced by right ventricular 
pacing in patients with preserved ventricular function, specifically on the 
diastolic function. 
In this group, the indexes of dyssynchrony did not demonstrate a significant 
increase following ventricular pacing. This result may be explained by the 
presence of the compensation mechanisms that, especially in healthy 
subjects, take place early after the onset of pacing and lead to a partial 
recovery of the cardiac function and the normalization of dyssynchrony 
indexes (see Chapter 6.e.). 
Moreover, as clearly shown in Chapter 6.c., in healthy subjects regional 
dysfunction may not be revealed by the assessment of the global ventricular 
function. 
In the overall population we observed a correlation between the changes in 
stroke volume induced by the pacing and the indexes of dyssynchrony. This 
result may have practical implications for pacing therapy delivery. 
In fact, some authors advocated the need to perform a patient tailoring of LV 
pacing site, due to the considerable inter-patient variation in the hemodynamic 
response to pacing (63,160). The identification of parameters associated to 
the hemodynamic improvement may help in guiding the implant optimization.  
Whether these acute results are associated to an improved long-term 
prognosis has to be defined. 
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6.c. Ventricular Pacing Lead Location: an Acute Evaluation of Global and 
Regional Left Ventricular Function and Dyssynchrony Using 
Conductance Catheter Indexes 
 
This chapter is published in: 
Lieberman R, Padeletti L, Schreuder J, K Jackson, A Michelucci, A Colella, W Eastman, S 
Valsecchi, DA Hettrick. Ventricular pacing lead location alters systemic hemodynamics and 
left ventricular function in patients with and without reduced ejection fraction. J Am Coll 
Cardiol 48:1634-1641, 2006. 
 
Introduction 
 
The optimal right ventricular (RV) pacing lead location for patients with a 
standard indication for ventricular pacing remains controversial. Clinical 
studies comparing atrial and ventricular-based pacing have demonstrated that 
atrial pacing modes delay the development of atrial tachyarrhythmias and 
reduce hospitalization for congestive heart failure compared to ventricular 
pacing modes (161-163). These results suggested that right ventricular apex 
(RVA) pacing might be detrimental to left ventricular (LV) function, presumably 
because bypass of the His-Purkinje system produces dysynchronous LV 
contraction. Indeed, several clinical and experimental studies examining the 
consequences of RVA pacing observed that this technique caused prolonged 
QRS duration, LV asymmetrical hypertrophy, dilatation, remodeling, mitral 
valve regurgitation, altered myocyte histology, reduced exercise capacity and 
coronary perfusion abnormalities (164-167). The DAVID clinical trial also 
suggested that RVA pacing was associated with an increased risk of death 
and hospitalization for heart failure in patients with an implantable defibrillator 
(168). The RV outflow tract (RVOT) was initially suggested as a potentially 
favorable alternative to RVA pacing. However, most investigations that 
compared RVOT to RVA pacing yielded equivocal results. This may be due to 
the heterogeneous populations and methodology of the trials as well as the 
short follow-up durations (169-172). Other recent clinical trials examined the 
utility of LV or biventricular (BiV) pacing to avoid the adverse hemodynamic 
consequences associated with RVA pacing (38,173,174). The results of these 
studies were encouraging, and emphasized an important relationship between 
ventricular pacing site(s), hemodynamics and LV dyssynchrony. However, 
many patients indicated for right ventricular pacing do not meet clinical 
requirements for BiV pacing. Thus, proper ventricular lead positioning may 
have important clinical ramifications on this broad device population. We 
compared systemic hemodynamics and LV systolic and diastolic function 
during acute RV, LV and BiV pacing in patients with and without preexisting 
LV dysfunction who did not meet current clinical indications for cardiac 
resynchronization therapy. 
 
Methods 
 
Patients with indications for electrophysiologic study or device implantation 
were prospectively stratified into two groups based on LV ejection fraction 
(EF) ≥40% or <40%. EF was determined before electrophysiologic study 
using standard echocardiographic techniques. Patients with QRS duration > 
120 ms were excluded from participation. 
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For LV pressure and volume measurements see Chapter 5.a.. 
A fluid-filled Swan-Ganz catheter was placed via a femoral vein and advanced 
into the proximal pulmonary artery for the determination of pulmonary artery 
pressure and stroke volume (thermodilution) and parallel conductance for 
conductance volume calibration. Parallel conductance was assessed by 
injection of 10ml hypertonic saline (6%) into the pulmonary artery (114). 
Absolute LV volumes were calculated by matching effective conductance 
stroke volume (SV) with simultaneously measured thermodilution SV and by 
subtracting parallel conductance from total volume. 
Temporary pacing electrodes were positioned in the right atrial appendage 
(RAA), RVA, RVOT free wall (RVF), RVOT septum (RVS) and LV free wall 
(LVF). 
Lead location was confirmed using standard criteria (175). High septal 
position was determined using right anterior oblique fluoroscopic view. RVS 
position was confirmed by negative QRS morphology in lead I. RVF was 
confirmed by positive morphology in lead I. 
For more details on the applied pacing protocol see Chapter 5.b.. 
 
Data Analysis 
The data analysis is described in Chapter 5.c.. In particular, the hemodynamic 
variables analyzed were: LV systolic (LVSP) and end-diastolic (LVEDP) 
pressure, +dP/dtMAX and –dP/dtMIN, LV end-systolic (LVESV) and end-
diastolic volume (LVEDV), SV, stroke work (SW), cardiac output (CO), EF, 
and the time constant of isovolumic relaxation (τ). Effective arterial elastance 
(EA), an index of LV afterload, was calculated by: (LVESP)/SV (176). 
In this analysis, following parameters were considered to quantify mechanical 
dyssynchrony. 
Mechanical dyssynchrony (DYS), estimated on each cardiac cycle according 
to the classical approach. In fact, it demonstrated a better performance in 
detecting dyssynchrony with respect to its counterpart estimated with 
coherent averaging (see Chapter 6.b.). This parameter was preferred 
because it permits to quantify ventricular dyssynchrony for specific segments 
of the cardiac cycle: systolic (DYSS) and diastolic (DYSD) dyssynchrony 
(145). 
Global cycle efficiency (CE), calculated as previously described (Chapter 4.b. 
and (151)). This parameter was demonstrated to detect ventricular 
dyssynchrony with high sensitivity and specificity (Chapter 6.b.), moreover it 
permits to quantify the dyssynchrony associated to each volume segment by 
means of its regional value: regional cycle efficiency (RCE). 
In order to evaluate whether the optimal RV pacing site varied between 
patients, the RV pacing sites resulting in the maximum or minimum SW and 
dP/dtMAX were compared to AAI. QRS duration was determined from the 12 
lead ECG. 
 
Statistical Analysis 
Hemodynamic data collected during dual-chamber pacing were compared 
based on ventricular pacing site and normal and depressed EF groups using 
2-way ANOVA for repeated measures. A Student-Neuman-Keuls test was 
used for post hoc comparisons. Dual chamber pacing interventions were 
compared to AAI pacing using one-way repeated measure ANOVA with 
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Dunnet’s test. Demographic data between groups were compared using t-test 
or Fischer’s exact test. A probability (p) value less than 0.05 was considered 
significant. All data are reported as mean±SD unless indicated. 
 
Results 
 
A total of 31 patients were enrolled (n=17 EF≥40%; n=14 EF<40%). Age, sex 
and QRS duration were similar between groups (Table 7). Patients with 
reduced EF had a greater incidence of cardiomyopathy, congestive heart 
failure, coronary artery disease, myocardial infarction, and previous coronary 
bypass surgery than patients with normal EF. No differences in the incidence 
of bradycardia and atrial and ventricular tachyarrhythmias were observed 
between groups. 
 
Table 7. Patient Demographics. 
 
 
Representative pressure-volume diagrams for one patient from each group 
are shown in Figure 14. Patients with preexisting LV dysfunction 
demonstrated reduced EF and LV +dP/dtMAX, -dP/dtMIN, decreased basal 
cycle efficiency, elevated LVEDV, and impaired diastolic relaxation compared 
to patients with EF≥40%. Pacing rate for experimental interventions was 
higher in patients with normal as compared to reduced EF. Programmed AV 
delay was similar during dual chamber pacing (103±31 vs. 110±23 ms) 
between groups. All pacing locations resulted in increased QRS duration 
relative to control. However, QRS duration was typically shorter during BiV 
pacing, compared to the other pacing sites (Tables 8&9). 
In patients with EF≥40%, one or more RV pacing sites, but not LVF or BiV 
pacing, reduced stroke work, cardiac output, stroke volume, EF, and impaired 
diastolic relaxation (Table 8, Figures 15&16). RV pacing sites also resulted in 
reduced LV systolic pressure, stroke volume and +dP/dtMAX, -dP/dtMIN and 
pulse pressure in patients with EF<40%. 
 68
Figure 14. Representative steady-state pressure-volume diagrams from one patient with 
EF≥40% (A) and EF<40%. (B) during atrial overdrive pacing (AAI) and during dual chamber 
pacing and dual chamber bi-ventricular (BiV) pacing. (C) Comparison of basal AAI data from 
A and B. Rectangle in part A illustrates calculation of global cycle efficiency. CE is equal to 
the percentage of area occupied by the actual pressure volume loop within a rectangle 
determined by LV pulse pressure and LV pulse volume. LVF = left ventricular free wall; RAA = 
right atrial; RVA = right ventricular apex; RVF = right ventricular outflow tract free wall; RVS = 
right ventricular outflow tract septum. 
 
 
EF≥40% 
EF<40% 
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Table 8. Hemodynamics in Patients with EF≥40%. 
 
Table 9. Hemodynamics in Patients with EF<40%. 
 
LV and BiV pacing increased stroke work, cardiac output, stroke volume, EF 
and +dP/dtMAX in patients with EF<40% compared to RV pacing (Table 9). 
Furthermore, LVF and BiV pacing also enhanced CE compared to RV pacing 
and AAI pacing in patients with depressed EF (Figure 16). Diastolic 
dyssynchrony index (DYSD) also decreased with RV pacing (Table 9). 
Preload (LVEDV), afterload (EA) and mean pulmonary wedge pressure were 
unchanged in both groups. Figure 17 shows an example of the six segmental 
pressure-volume diagrams ranging from apex (segment 1) to base (segment 
6) during atrial overdrive and dual chamber pacing from different ventricular 
sites in one patient with LV dysfunction. These data are summarized over the 
population in Figure 18 (A&B) using regional cycle efficiency (RCE) of the 
most apical and basal volume segment. RCE depended on pacing site and 
varied between the apex and base within pacing site in patients with EF<40%, 
but not the group with EF≥40%. In general, RVA pacing attenuated the apical 
RCE, and RVF and RVS pacing attenuated the basal RCE in the EF<40% 
group. RV minimum stroke work and dP/dtMAX were significantly lower 
compared to AAI, while the RV maximum values were similar to AAI (Figure 
19). 
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Figure 15. Alterations in LV stroke work (SW, panel A), stroke volume (SV, panel B), and 
+dP/dtMAX (panel C) during atrial overdrive (AAI) and alternate site ventricular pacing. a 
p<0.05 vs. EF≥40%, b p<0.05 vs. AAI (RM ANOVA, Dunnet’s comparison), c p<0.05 vs. RVA, 
d p<0.05 vs. RVS, e p<0.05 vs. RVF (2-way RM ANOVA, Student-Neuman-Keuls 
comparison). 
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Figure 16. Alterations in LV end systolic pressure (LVESP, panel A), LV end diastolic volume 
(LVEDV; panel B), and cycle efficiency (CE), an index of LV synchrony (panel C) during atrial 
overdrive (AAI) and alternate site ventricular pacing. a p<0.05 vs. EF≥40%, b p<0.05 vs. AAI, 
c p<0.05 vs. RVA (RM ANOVA, Dunnet’s comparison), d p<0.05 vs. RVS, e p<0.05 vs. RVF 
(2-way RM ANOVA, Student-Neuman-Keuls comparison). 
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Figure 17. Regional and global LV pressure volume loops during atrial overdrive and dual 
chamber pacing from different ventricular sites in a representative patient with EF<40%. 
Regions are numbered from apex (1) to base (6) corresponding to the sequential volume 
channels along the axis of the conductance catheter. These individual signals form the global 
pressure-volume loop when summed. Note that RV pacing from different sites changes the 
regional contributions to the global pressure volume loop. RVA pacing has a greater impact 
on the apical segments. Conversely, RVS and RVF pacing primarily distort the basal 
segment. LV and BiV pacing result in more homogenous distribution of regional work. 
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Figure 18. Distribution of regional cycle efficiency within the LV: Regional cycle efficiency was 
higher for the most apical and basal volume segment at each pacing site in patients with 
EF<40% (A) and EF≥40% (B). Regional cycle efficiency depended on pacing site and varied 
by region within pacing site in the group with EF<40% (A), but not the group with EF≥40%. In 
general, RVA pacing attenuated the apical segmental synchrony, and RVFW and RVS pacing 
attenuated the basal segmental synchrony in the with EF≥40% group. Data are mean±SE; (2-
way RM ANOVA Student-Neuman-Keuls comparison). 
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Figure 19. Stroke work (SW; top) and dP/dtMAX (Bottom) at the RV pacing site (RVA, RVS, 
or RVF) resulting in maximum (MAX RV) and minimum (MIN RV) stroke work or dP/dtMAX 
compared with stroke work measured during control (AAI): The site of maximal stroke work or 
dP/dtMAX was not different from AAI. Thus, RV pacing does not necessitate attenuated 
hemodynamics. However, the optimal RV site varied between patients. *p<0.05 vs. AAI, (RM 
ANOVA with Student-Neuman-Keuls post hoc comparison). 
 
 
Discussion 
 
General 
The majority of patients indicated for ventricular pacing do not meet current 
clinical indications for cardiac resynchronization therapy pacing. Furthermore, 
the optimal ventricular pacing site for patients with conventional indications for 
ventricular pacing remains controversial. The present results comparing the 
impact of several ventricular pacing sites on indices of LV systolic and 
diastolic function using pressure-volume analysis demonstrate that ventricular 
pacing lead location has a significant impact on LV function. In particular, 
acute RV pacing caused potentially deleterious reductions in cardiac output 
and stroke work concomitant with impaired diastolic relaxation and increased 
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LV end-diastolic pressure in patients with and without impaired LV function. 
The results further indicate that LV and BiV pacing significantly improved 
hemodynamics and function compared to RV pacing at 3 different sites in 
patients with preexisting LV dysfunction. 
 
Patient Population 
Few previously conducted clinical investigations have compared ventricular 
pacing sites in patients that do not meet current clinical requirements for 
resynchronization therapy. Simantirakis and colleagues recently observed 
improved LV function using both echocardiographic (173) and pressure-
volume analyses (174) during acute LV and BiV pacing as compared to RVA 
pacing in patients with permanent atrial fibrillation and narrow-QRS duration 
that required rate control. Turner and colleagues demonstrated improved 
contractile synchrony during LV pacing in patients with congestive heart 
failure in the presence of either a narrow or prolonged QRS duration (38). The 
current results confirm and extend these previous observations by quantifying 
the direct cardiovascular consequences of alternate site RV vs. LV vs. BiV 
pacing in normal and dysfunctional myocardium and by suggesting that the 
benefit of alternate site ventricular pacing may vary between populations as 
well as between patients within those populations. 
 
Role and Indexes of Dyssynchrony 
The present results support previous studies indicating that reduced EF is 
associated with basal LV contractile dyssynchrony, despite narrow QRS 
duration (71,177,178). For example, we observed lower basal global and 
regional cycle efficiency as well as generally increased dyssynchrony (DYSS, 
DYSD table 8,9) in patients with EF<40%.  
This finding completes the results of previous analysis, performed on patients 
with cardiac dysfunction and long QRS duration, and confirms that indexes of 
mechanical dyssynchrony (in this case CE and DYS) allow a more accurate 
identification of ventricular impairment than the QRS duration. 
In particular, the DYS index played an important role. In fact, it permitted to 
distinguish the phases of the cardiac cycle and to describe the diastolic 
dysfunction. It should be considered that the majority of parameters 
describing the ventricular dyssynchrony with echocardiographic techniques 
permits to detect only the inhomogenities of the systolic phase. 
Furthermore, QRS duration was greater during LV compared to BiV pacing, 
even though LV performance was similar during pacing with these 
configurations. These data confirm previous reports that QRS duration alone 
is a reliable indicator of neither mechanical synchrony nor LV function 
(71,177,178). RV pacing also produced increased LVEDP with no change in 
LVEDV in patients with EF > 40%, perhaps indicating the influence of 
ventricular interaction (179). 
The shape of the LV pressure diagram, as quantified by global cycle 
efficiency, improved during LV and BiV pacing in patients with EF<40%. In 
contrast, RV pacing had minimal impact on global cycle efficiency. However, 
the similarities in global cycle efficiency observed during RV pacing may have 
resulted from dissimilar changes in regional cycle efficiency and synchrony 
that depended on pacing site. This caveat is illustrated in Figures 17 and 18 in 
which segmental pressure-volume loops are plotted during atrial overdrive 
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and dual chamber pacing from different ventricular sites in one patient with LV 
dysfunction. Note that RV pacing from different sites produced important 
alterations in the regional contributions to the global pressure-volume loop. 
RVA pacing had a greater impact on apical segment loop morphology, 
whereas RVS and RVF pacing distorted the shape of the LV regional 
pressure-volume diagram in the basal segments. In contrast, LV and BiV 
pacing caused a more homogenous distribution of segmental work in the 
EF<40% group. These observations suggest that pacing site may influence 
overall global LV function depending on its relative effects on regional function 
and synchrony. The observations further suggest that avoiding the imposition 
of regional contractile dysfunction may be as important as the restoration of 
synchrony in order to improve long-term outcome. 
Moreover, it is essential to emphasize the importance of using indexes that 
allow the description of regional dyssynchrony, such as CE, for the study and 
the optimization of the pacing therapy. 
In conclusion, the conductance catheter demonstrated to be an essential tool 
for the assessment of the cardiac function and the dyssynchrony, allowing the 
automatic and operator-independent estimation of indexes that characterize 
the temporal and spatial distribution of ventricular inhomogenities. 
 
RVA vs. RVOT 
Several clinical trials have previously compared RVOT and RVA pacing (169-
172,180), but many of these studies were limited by small sample size or brief 
trial duration. The current results suggest that LV systolic and diastolic 
function may vary acutely with RV pacing sites in patients with normal and 
depressed EF, respectively. No RV pacing site was superior and RV pacing 
did not compromise stroke work or dP/dtMAX when the optimal RV pacing 
site was compared to AAI (Figure 19). Thus, acute hemodynamic optimization 
during lead placement may be desired to attenuate the detrimental effects of 
long term remodeling associated with RV pacing (167). Interestingly, 
hemodynamic optimization of ventricular pacing lead location has been 
demonstrated to improve cardiac performance during placement of temporary 
ventricular pacing leads during cardiac surgery (181). Such optimization may 
also be possible in patients in the catheterization laboratory using minimally or 
non-invasive techniques such as arterial pulse pressure, pulse oximetry or 
trans thoracic echocardiography. 
 
RV vs. LV and BiV 
Previous animal (182) and clinical (180,25,28) trials have shown that both BiV 
and LV pacing resulted in superior LV systolic function than RV pacing. The 
current findings confirm and extend these previous results in patients without 
preexisting LV dysfunction and with a narrow QRS duration. Hay (180) as well 
as Bordachar et al. (183) demonstrated that BiV pacing appeared to improve 
LV isovolumic relaxation in comparison to LV pacing in patients with 
congestive heart failure and a prolonged QRS duration. In contrast, our 
results indicated that -dP/dt MAX and τ were similar between BiV and LVF 
pacing sites in both patient groups (Table 8). The explanation for the 
difference in our results compared to the previous studies is not clear, but 
may have been related to differences in the baseline characteristics of the 
study populations. However, when considered together, the current and 
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previous results suggest that single site LV pacing may represent a useful 
alternative to BiV pacing in some patients, despite potential subtle effects on 
diastolic function. 
 
Limitations 
The role of LV lead location in patients indicated for cardiac resynchronization 
therapy has been studied recently using dP/dtMAX (62) or conductance 
catheter (63). Both trials reported that the optimal LV pacing lead location 
varied substantially between patients. 
We did not attempt to identify the best LV free wall lead location in the current 
investigation (63). Nevertheless, our results support the general hypothesis 
that the ideal site for RV or LV pacing should be tailored to the individual 
hemodynamic response of each patient. We quantified LV dyssynchrony 
using regional cycle efficiency (CE). This index is sensitive to volume shifts 
during isovolumic contraction and relaxation (151). The index may also be 
sensitive to afterload changes that can alter the trajectory of the PV loop 
during ejection. However, we observed no changes in EA, an index of LV 
afterload with pacing sites (Figures 15-16). Recent studies have emphasized 
the potential influence of heart rate on optimal lead position (180). Heart rate 
was held constant in the present trial by atrial pacing. Thus, paired analyses 
within patients should not have been affected by heart rate. Finally, BiV 
pacing interventions were performed with LVF and RVS. It is unknown if other 
RV sites would have produced similar results during BiV pacing. 
 
Conclusions 
Ventricular pacing lead location has an important impact on LV function in 
patients with narrow QRS duration in the presence or absence of preexisting 
LV dysfunction. LVF and BiV pacing preserved and improved systemic 
hemodynamics, LV function and LV cycle efficiency compared to RV sites in 
patients with normal and depressed EF, respectively. The data emphasize 
that optimizing hemodynamics during pacemaker implantation may be 
important in the selection of alternate ventricular pacing sites in patients with 
normal and depressed LV function. 
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6.d. Pressure-Volume Analysis of Right Ventricular Pacing Lead 
Location for Bi-Ventricular Pacing: Global and Regional Left Ventricular 
Function and Dyssynchrony 
 
This chapter is submitted to: 
L Padeletti, DA Hettrick, JJ Schreuder, A Michelucci, A Colella, W Eastman, S Valsecchi, P 
Cardano, R Lieberman. Pressure-Volume Analysis of Optimal Right Ventricular Pacing Lead 
Location for Bi-Ventricular Pacing in Patients with Narrow QRS Duration. Pacing Clin 
Electrophysiol. 
 
Introduction 
 
Cardiac resynchronization therapy (CRT) has been shown to improve ejection 
fraction and quality of life in patients with congestive heart failure (CHF) and 
prolonged QRS complex duration (51,54,60). Based on these encouraging 
results, other investigators have examined the clinical benefits of bi-ventricular 
pacing in populations with normal QRS duration (38,178,184,185). Most 
studies conducted to date were performed with the right ventricular lead 
positioned in the apical location (RVA). However, standard single site RVA 
pacing may be associated with atrial fibrillation or exacerbation of CHF (161-
163,168). Furthermore, the optimal right ventricular lead location for bi-
ventricular pacing has not been extensively examined (180). Many patients 
with clinical indications for RV pacing, including pacemakers and implantable 
defibrillators also do not present indications for CRT. Thus, alternate site or bi-
ventricular pacing may represent an important alternative in these patients 
when pacing is required.  We tested the hypothesis that patients with narrow 
QRS may benefit from bi-ventricular pacing compared to RV apical pacing 
and that left ventricular (LV) function may be further improved by optimizing 
the position of the RV pacing lead. 
 
Methods 
 
We studied patients with indications for electrophysiologic study or device 
implantation. Subjects with a previously implanted device, valvular 
insufficiency or stenosis, or measured QRS duration > 125 ms were excluded 
from analysis. 
For LV pressure and volume measurements see Chapter 5.a. and (114). 
Temporary pacing electrodes were positioned in the right atrial appendage 
(RAA), RVA, RV outflow tract free wall (RVF), RV outflow tract septum (RVS) 
and LV free wall (LVF) (160).  Lead location was confirmed from fluoroscopic 
inspection and ECG morphometry (175). 
For more details on the applied pacing protocol see Chapter 5.b.. In particular, 
constant atrial overdrive pacing (AAI) was maintained from the RAA 
throughout the protocol at a rate of 10 bpm greater than the sinus rate.   AV 
delay was programmed to the measured p-wave to His interval duration minus 
10 ms in order to avoid fusion pacing.  Each patient received dual chamber bi-
ventricular pacing from the LVF and each randomly assigned RV site.   
 
Data Analysis 
The data analysis is described in Chapter 5.c.. In particular, the hemodynamic 
variables analyzed were: LV systolic (LVSP) and end-diastolic (LVEDP) 
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pressure, +dP/dtMAX and –dP/dtMIN, LV stroke volume (SV), stroke work 
(SW), cardiac output (CO), EF, and the time constant of isovolumic relaxation 
(τ). 
Similarly to the previous analysis, following parameters were considered to 
quantify mechanical dyssynchrony: global (CE) and regional cycle efficiency 
(RCE) (Chapter 4.b. and (151)).  
 
Statistical Analysis 
All hemodynamic data obtained during dual chamber bi-ventricular pacing 
with different RV ventricular pacing sites and were compared using 1-way 
ANOVA for repeated measures. Regional cycle efficiency was compared 
between the LV apex and base during pacing interventions was compared 
using 2-way repeated measure ANOVA.  A Student-Neuman-Keuls test was 
used for post hoc comparisons.  A probability (p) value less than 0.05 was 
considered significant.  Data are presented a mean ± SD. 
 
Results 
 
Demographic data for the 13 patients included in the analysis are summarized 
in Table 10. 
The average overdrive-pacing rate was 73±13 bpm. The average 
programmed AV delay was 103±13 ms. Representative LV pressure-volume 
data from a patient during AAI pacing, dual chamber pacing from the RVA and 
bi-ventricular pacing from the LV and the RVS, RVF or RVA, respectively are 
depicted in Figure 20. Bi-ventricular pacing from the LV lead and any RV site 
significantly (p<0.05) increased stroke volume, cardiac output and LV 
+dP/dtMAX (Figure 21, Table 11 compared to RVA pacing. 
 
 
 
Table 10. Patient Demographics (n=13). 
Age (yrs) 61  ± 10 
Sex (M) 7 (54%) 
EF (%) 40 ± 17 
Cardiovascular History [n(%)]  
 Cardiomyopathy 6(46) 
 CHF 7(54) 
 CAD 7(54) 
 Hypertension 11(85) 
 MI 6(46) 
 CABG 6(46) 
 Atrial Tachyarrhythmias 2(15) 
 Ventricular Tachyarrhythmias 5(38) 
 Bradycardia 2(15) 
 Syncope 3(23) 
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Table 11.  Changes in LV Function during Bi-Ventricular and Right Ventricular Pacing. 
 AAI  LV-RVA LV-RVF LV-RVS RVA 
QRS Duration (ms) 96 ± 17 146 ± 18*† 156 ± 23* 141 ± 18*† 167 ±28* 
τ (ms) 37± 10 39 ± 10 39 ± 11 39 ± 11 42 ± 12 
-dP/dtMAX (mmHg/s) -1065 ± 360 -965 ± 293* -952 ± 300* -963 ± 268* -929 ± 350* 
LVESP (mmHg) 95 ± 27 91 ± 22 89 ± 26 91 ± 23 88 ± 24 
LVEDP (mmHg) 11 ± 7 11 ± 8 9 ± 8 9± 9 11 ± 7 
CO (l/min) 4.4 ± 1.4 4.6 ±2.0 4.8 ± 1.7† 4.7 ± 2.1† 4.0 ± 1.6 
EF (%) 38 ± 18 36 ± 17 38 ± 17 36 ± 17 34 ± 17 
n=13; data are mean±SD; * p<0.05 vs. AAI; † p<0.05 vs. RVA 
 
Global LV cycle efficiency was also enhanced during bi-ventricular pacing as 
compared to RVA pacing alone. No significant differences with bi-ventricular 
pacing between different RV pacing sites were observed.  However, choosing 
the optimal RV pacing site for bi-ventricular pacing for each patient increased 
stroke work, stroke volume, LV +dP/dtMAX and global CE (Figure 22). The 
RV site that produced optimal LV function varied among patients. 
 
 
 
Figure 20. Representative pressure-volume diagrams for one patient during atrial overdrive 
pacing (AAI) from the right atrial appendage (RAA), and during biventricular pacing from the 
LV free wall (LV) and right ventricular apex (RVA), right ventricular free wall (RVF) or right 
ventricular septal outflow tract (RVS).   
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Figure 21. Histograms illustrating alterations in stroke volume (SV, panel A), LV +dP/dtMAX 
(panel B), and global cycle efficiency (CE, panel C) during bi-ventricular pacing from various 
RV sites. *p<0.05 vs. RVA. 
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Figure 22.  Histogram depicting the impact of RV pacing site optimization during bi-ventricular 
pacing on hemodynamics and indices of LV function: Choosing the optimal RV pacing site 
during bi-ventricular pacing resulted in significant improvements over both RVA and sub-
optimal alternate RV sites. *p<0.05 vs. RVA; †p<0.05 vs. Best. 
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Figure 23.  Representative LV pressure-regional volume diagrams obtained for different 
pacing sites in a patient.  LV pressure is plotted as a function of each individual volume 
segment along the axis of the catheter ranging from the LV apex (segment 1) to the LV base 
(segment 7).  In this illustration, regional differences in the phase of volume shift are 
apparent.  Note that decreased global function during RVA pacing appeared to result from 
compromised regional function primarily near the apex.  Regional LV function also varies 
during BIV pacing with different RV pacing sites (abbreviations as Figure 20). 
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Figure 24.  Changes in regional cycle efficiency during ventricular pacing:  Apical segmental 
cycle efficiency was lower than basal segmental cycle efficiency during RVA pacing alone.  
Apical, but not basal segmental cycle efficiency was significantly (*p<0.05) greater during bi-
ventricular pacing from any RV site than during RVA pacing. 
 
Figure 23 shows regional pressure-volume loops constructed with individual 
segmental volume signals for one patient during atrial, dual chamber and bi-
ventricular pacing. The changes in regional cycle efficiency between the basal 
and apical volume segments are shown in figure 24. Regional cycle efficiency 
was lower in the apex as compared to the base during dual chamber RVA 
pacing. Regional cycle efficiency in the LV apex was greater during bi-
ventricular pacing from any RV site, but basal RCE was unaffected by pacing 
site.  
 
Discussion 
 
The results demonstrate that bi-ventricular pacing with alternate RV pacing 
sites produces acute improvement of LV systolic function and improves 
mechanical synchrony when compared to standard RVA pacing in the 
absence of a direct clinical indication for bi-ventricular pacing. Although no 
specific RV location was shown to be superior during bi-ventricular pacing, the 
RV pacing site that produced the optimal acute hemodynamic response 
varied between patients. Furthermore, optimization of RV lead location 
substantially enhanced acute LV performance during bi-ventricular pacing. 
We have previously shown that acute LV function was partially determined by 
right ventricular pacing site and that the RV outflow tract pacing did not 
always result in superior LV function compared to RVA (160). In our previous 
study, LV and bi-ventricular pacing preserved LV performance in patients with 
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normal LV function and improved LV function in patients with preexisting LV 
dysfunction. The current findings confirm and extend these previous results 
and suggest that the acute hemodynamic effects of bi-ventricular pacing are 
dependent on the specific RV lead location and that the optimal location may 
need to be determined at the time of implant. 
 
Hay and colleagues (180) recently reported that LV systolic and diastolic 
function were similar during bi-ventricular pacing from RVA as compared to 
the RV outflow tract in patients with congestive heart failure, prolonged QRS 
duration and chronic atrial fibrillation using pressure-volume analysis. The 
current results confirm these observations in patients without a clinical 
indication for CRT. The current findings further suggest that LV function may 
be acutely improved by carefully selecting the RV lead location during bi-
ventricular pacing. Other recent investigations also reported that the optimal 
LV pacing lead location varied substantially between patients (62,63). We did 
not attempt to identify the best LV free wall lead location in the current 
investigation, but our results support the hypothesis that the ideal site for RV 
pacing should be tailored to the individual hemodynamic response of each 
patient. 
 
The current results challenge established guidelines for ventricular lead 
placement in patients indicated for pacing but without indications for CRT.  
Several previous studies suggest that alternate site RV pacing, LV pacing and 
bi-ventricular pacing exert benefits in some patients beyond current clinical 
indications (38,178,184,185). For example, the recently published PAVE trial 
evaluated bi-ventricular pacing after AV nodal ablation in patients with 
permanent AF (186).  The results showed that bi-ventricular pacing improved 
functional capacity as compared to RV pacing alone. Other clinical studies 
have suggested that QRS duration is neither a sensitive nor specific indicator 
of LV mechanical dyssynchrony (38,178,184,185). Achilli and colleagues 
observed benefits for CRT therapy in patients with heart failure and narrow 
QRS duration and echocardiographically-validated mechanical dyssynchrony. 
In contrast, bi-ventricular pacing consistently improved acute LV function, 
even in patients that did not demonstrate basal dyssynchrony (as indicated by 
global cycle efficiency in the current study). Our data suggest that selective 
site biventricular pacing may represent a therapeutic option, but further 
prospective randomized clinical studies are required to confirm this 
hypothesis. 
 
Part of the difficulty in quantifying the relative benefit of alternate site RV 
pacing as compared to RVA pacing has been the precise validation of lead 
placement.  Previous attempts to identify specific RV septal or outflow tract 
sites using fluoroscopic or ECG data have been described (175), but these 
methods are often not consistently reproducible. Indeed, even the terminology 
used to describe specific RV septal or outflow sites has not been rigorously 
applied (172). 
 
Indexes of Dyssynchrony 
As an alternative to anatomic localization, some investigators have instead 
used QRS width as a surrogate for contractile synchrony (170,187). However, 
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QRS duration during RV pacing may not always be related to the synchrony 
of LV contraction or reflect the influence of pacing on hemodynamics. In the 
current investigation we based the choice of the optimal RV pacing on acute 
improvement of LV systolic function and CE (Figure 22). We believe that this 
strategy provides a useful early indication of LV functional response to pacing 
and therefore provides an advantage over previously described methods. 
In fact, CE demonstrated to identify the ventricular dyssynchrony with high 
sensitivity and specificity, allowing the estimation of regional efficiency, when 
estimated from segmental signals. 
To our knowledge, the current results are the first to suggest that global 
changes in cycle efficiency and LV performance may result primarily from 
alterations in LV apical function during pacing (Figures 23 and 24). Thus, 
global similarities in LV function during bi-ventricular pacing may result from 
dissimilar regional function depending on RV pacing site. 
These data also suggest a potential mechanism for the observed variability 
between patients in response to RV pacing site. The data are consistent with 
the hypothesis that an individual patient response to RV pacing site depends 
on the complex interaction between precise lead location, ventricular anatomy 
and conduction status and the presence of pre-existing myocardial 
dysfunction.  Prospective identification of the optimal RV pacing site for 
conventional or bi-ventricular pacing may be difficult unless a simultaneous 
hemodynamic assessment is performed. 
In this analysis, the conductance catheter was demonstrated to permit the 
automatic and operator-independent assessment of the cardiac function and 
the dyssynchrony, using indexes that characterize the temporal and spatial 
distribution of ventricular inhomogenities. 
The results should be interpreted within the constraints of several potential 
limitations. The current investigation included patients with and without 
symptomatic CHF. Alternative site RV pacing had similar effects in patients 
with heart failure as compared to those that did not (data not shown). A single 
programmed AV delay may have allowed varying degrees of intrinsic 
conduction and fusion to occur during alternate site RV pacing. However, we 
attempted to control intrinsic AV conduction by programming very short AV 
delays. Furthermore, the potential effects of alternate inter-ventricular timing 
delays were not investigated. Heart rate was held constant in the present trial 
by atrial pacing.  Thus, paired analyses within patients should not have been 
affected by heart rate. 
 
In summary, bi-ventricular pacing improves acute LV function compared to 
RVA pacing in patients with normal QRS duration. Global LV function did not 
vary significantly during bi-ventricular pacing from different RV sites but 
optimized RV lead position resulted in improved LV function in individual 
patients. These results may have important implications for tools and 
techniques for patients requiring ventricular pacing. 
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Introduction  
 
Animal and clinical studies comparing atrial and ventricular pacing indicate 
that right ventricular apex (RVA) pacing may be detrimental to left ventricular 
(LV) function since bypass of the His-Purkinje system produces LV 
dyssynchronous contraction (161-163). Brutsaert postulated that LV 
mechanical dyssynchrony may be regarded as modulator of cardiac 
performance together with heart rate, contractile state, preload and afterload 
(23). Recently it has been demonstrated that pacing site influences global LV 
function depending on its relative effects on regional function and synchrony 
(160). RV animal pacing studies showed decreased contractile function in 
early activated ventricular regions and hyper-functioning in late activated 
zones as well as decreased LV contractile state (28,101).  An inverse 
relationship between changes in contractile state and intra-ventricular 
dyssynchrony was demonstrated in patients undergoing LV restoration surgery 
(143). 
Although LV mechanical dyssynchrony has been demonstrated as key 
predictor for cardiac resynchronization therapy (CRT) efficacy, direct beat-to-
beat relationship between LV mechanical dyssynchrony and cardiac 
performance during cardiac pacing remains unknown (27,40,82,188). 
Accordingly the aim of the present study was to evaluate beat-to-beat effects 
of RV pacing on LV dyssynchrony and performance from the pressure-volume 
plane in patients with normal ejection fraction (EF) using the pressure-volume-
dyssynchrony catheter technique (27,114,140-142,145,147,188,189). 
 
Methods 
 
Patients 
Inclusion criteria were patients with normal EF with indications to undergo 
electrophysiological testing. Patients with a previously implanted device, 
valvular insufficiency or stenosis or QRS duration > 120 ms were excluded 
from participation. 
For LV pressure and volume measurements see Chapter 5.a.. 
Temporary pacing catheters were positioned in the RV apex (RVA), RV 
outflow tract free wall (RVF), and RV outflow tract septum (RVS).  Tip location 
was confirmed using standard criteria. 
For more details on the applied pacing protocol see Chapter 5.b.. Specifically, 
constant atrial overdrive pacing (AAI) was maintained throughout the protocol 
at a rate of 10 bpm greater than the sinus rate to avoid rhythm fluctuations. 
Baseline data were recorded during atrial pacing, followed by dual chamber 
pacing for 60 seconds from RVA, RVS, and RVF applied in random order 
 88
alternated by AAI pacing. The transitions from atrial pacing to dual chamber 
pacing and back to atrial pacing were recorded continuously. 
 
Mechanical Ventricular Dyssynchrony 
In order to quantify ventricular dyssynchrony for specific time-frames of the 
cardiac cycle and to track beat-to-beat changes of the parameters, following 
indexes were considered to quantify mechanical dyssynchrony: late systolic 
dyssynchrony (SysDysB) calculated from +dP/dtmax to end-systolic volume 
(ESV), early diastolic dyssynchrony from -dP/dtmax to peak filling rate (PFR) 
(DiaDysA) and total diastolic dyssynchrony (DiaDysT) from -dP/dtmax to R-
wave (see Chapter 4.a.). 
End-systolic elastance (Ees) was estimated by ESP divided by ESV. Effective 
arterial elastance (Ea) was calculated as ESP divided by SV. Ventricular 
arterial coupling was quantified as Ees/Ea (188). 
 
Data Analysis 
Multiple indices of LV systolic and diastolic function such as ESP, end-diastolic 
pressure (EDP) pressure, +dP/dtmax, -dP/dtmax, the time constant of isovolumic 
relaxation (Tau), ESV, end-diastolic volume (EDV), SV, PFR, EF and 
dyssynchrony values were extracted with off-line analysis. Values obtained 
during at least 3 heart cycles are expressed as mean±SD.  
Statistical analysis was performed with paired Student’s t-test for comparisons 
between no pacing and different pacing modes, and also by repeated-
measures analysis of variance (ANOVA). Statistical correlations between 
variables were tested by least-squares linear regression. Multiple variate 
regression analysis was used to detect best predictor of SV change. Statistical 
significance was assumed at p<0.05. Results are presented as mean±SD. 
 
Results 
 
Nine patients (5 males) were enrolled, mean age 66±14 years, mean EF 57±9 
% and mean QRS duration 88±21 ms. Table 12 shows hemodynamic 
characteristics obtained during sinus rhythm (SR), AAI pacing, and the 3 
different RV pacing sites. Values of SR and atrial pacing were based on 12 
beats after a stabilization of 5 min. RV pacing values were measured within 
10s after RV pacing onset, excluding the first 3 paced beats. Atrial pacing at 
10 beats above sinus rhythm increased cardiac output by 8% (p<.002), 
+dP/dtmax by 7% (p<.002) and –dP/dtmax by 3% (p<.03) at lower EDV (p<.02) 
and lower EDP (p<.01) compared with SR. No significant changes in all other 
measured variables, including intra-ventricular dyssynchrony measurements, 
were observed.  
RV pacing settings compared to AAI pacing showed within 10 s decreased SV 
(p<.01), EF (p<.05), and +dP/dtmax (p<.05) and increased EDP (p<.01). The 
diastolic relaxation indices -dP/dtmax (<.01) and Tau (p<.01) deteriorated. LV 
total dyssynchrony was only significantly increased during RVA, late systolic 
dyssynchrony was not changed, while early diastolic dyssynchrony was 
increased in all RV paced modes (p<.01). EDV was only slightly decreased 
(p<.05) during RVF pacing whereas ESV was not changed at any RV pacing 
site. 
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Fig. 25 and 26 show LV pressure and (segmental-) volume tracings and P-V 
loops of transitions from AAI to atrio-RV pacing within a 10s time-span. RVF 
pacing (Fig. 25) induced immediate decreases in LV basal segmental volume 
amplitudes and increases in apical amplitudes. Initially systolic dyssynchrony 
increases sharply followed by a decrease around the third RV paced beat, 
whereas diastolic dyssynchrony remains increased during the 10s episode. P-
V loops show initially distorted loops during iso-volemic contraction and 
relaxation (Fig. 25A), followed by improvement in cycle efficiency within the 
10s time-span (Fig. 25B). Fig. 26A shows the transition from AAI to RVA 
pacing affecting LV apical volume segments, decreasing EDV, and increasing 
dyssynchrony. Immediate ejection phase compensation can be observed in 
the basal segment. The P-V loops show signs of post-systolic contraction 
starting at the second RV paced beat (Fig. 26A), followed by some SV 
restoration and decrease in post-systolic contraction (Fig. 26B).  
 
Table 12. Baseline hemodynamic comparison at various pacing settings. 
 
 SR AAI RVA RVF RVS 
 a b c d e 
HR (bpm) 77±15 88±14a 88±14a 88±14a 88±14a 
CO (l/min) 5.4±1.5 5.84±1.5a 5.13±1.2b 4.25±1bb 4.85±1.2b 
SV (ml) 72±21 70±19 59±18b 48±15bb 57±22b 
EF (%) 58±14 57±14 52±12 43±13bb 50±16b 
EDV (ml) 133±51 127±49a 122±48 121±55b 124±50 
ESV (ml) 55±37 56±39 63±39 64±39 62±39 
EDP (mmHg) 9.8±2 7.6±3a 12.7±4b 11.6±4b 13.4±5bb 
ESP (mmHg) 123±15 125±15 115±17b 115±19 116±21 
+dP/dtmax (mmHg/s) 1538±257 1647±255a 1494±307b 1496±353b 1535±281b 
-dP/dtmax (mmHg/s) 1661±298 1712±297a 1414±370bb 1415±337bb 1409±29bb 
Tau (ms) 32±7 31±6 40±9bb 38±7bb 39±8bb 
DysT (%) 19.3±6 19.3±6 21.9±6b 21±7 21.5±7 
SysDysB (%) 13±8 13±8 14.4±8 16±10 13.7±9 
DiaDysA (%) 21±7 21±7 24±6bb 24±7bb 24±7bb 
CO, cardiac output; DiaDysA, early diastolic dyssynchrony; DysT, total dyssynchony; EDP, 
end-diastolic pressure; EDV, end-diastolic volume; ESP, end-systolic pressure; ESV, end-
systolic volume; EF, ejection fraction; HR, heart rate; SV, stroke volume; SysDysB, late 
systolic dyssynchrony. ap<0.05 vs SR;aap<0.01 vs SR; bp<0.05 vs AAI;bbp<0.01 vs AAI; Data 
is mean±sd, n=9.  
 
Beat-to-Beat Hemodynamic Responses at Worst RV Pacing Site 
The results of worst RV pacing sites for each patient (RVA 1pt, RVS 4pts, RVF 
4pts), as indicated by greatest initial SV decrease, were analyzed beat-to-beat 
from AAI to various periods, of 2s, 9s and 60 s of RV pacing and back to AAI 
(table 13). Values are mean of 12 consecutive heart cycles during atrial pacing 
and at 60s RV pacing, and mean of 3 beats at 2s and 9s after RV pacing 
onset. Marked significant decreases in SV and EF by 37% and 23% 
respectively were observed at 2s after RV pacing onset, followed by significant 
relative increases of 20% and 10% at 9s. No further changes in SV and EF 
were observed up to 60s. Acutely after transition to atrial pacing, SV and EF 
recovered to initial baseline values. ESP showed an acute significant 
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diminution at 2s and subsequent full recovery at 9s. Initially ESV and EDV did 
not change significantly, however at 60s after RV pacing onset EDV was 
significantly (p<.05) decreased. End-systolic elastance was significantly 
(p<.05) decreased at 2s after RV pacing onset, followed by recovery during 
the remaining RV stimulation episode. Ventricular-arterial coupling showed a 
marked decrease (p<.004) from 2s after RV pacing onset, followed by full 
recovery at AAI pacing. 
Peak +dP/dt was significantly (p<.05) decreased at 2s after onset of RV 
pacing, followed by a significant increase at 9s. The relaxation indices -
dP/dtmax and Tau showed significant (p<.01) impairment, at 2s after RV pacing 
onset with a mean decrease of 30% and mean prolongation of 32% 
respectively. At 9s and at 60s, both variables showed significant (p<.01) 
improvements compared to values at 2s, while both variables were remained 
decreased compared to baseline throughout RV pacing, followed by full 
recovery immediately during AAI.  
Mean total LV dyssynchrony, as calculated from the whole cardiac cycle, was 
increased significantly throughout the RV pacing episode. Late systolic 
dyssynchrony, measured during the ejection phase, was markedly increased 
relatively by 30% at 2s after RV pacing onset, followed by a fast recovery, with 
no significant differences from 9s and beyond with AAI pacing. Early diastolic 
dyssynchrony was significantly (p<.01) increased at 2s relatively by 25%, and 
remained significantly (p<.05) higher throughout the 60s RV pacing episode, 
followed by full recovery at control atrial pacing. 
 
Table 13. Beat-to-beat Hemodynamic responses at Worst right ventricular pacing site. 
 
DiaDysT, total diastolic dyssynchrony; DysT, total dyssynchony; EDP, end-diastolic pressure; 
EDV, end-diastolic volume;  Ees, end-systolic elastance; Ees/Ea; ventricular arterial coupling; 
EF, ejection fraction; ESP, end-systolic pressure; ESV, end-systolic volume; HR, heart rate; 
SV, stroke volume; EDP, end-diastolic pressure; EDV, end-diastolic volume; PFR, peak filling 
rate; SysDysB, late systolic dyssynchrony. ap<0.05 vs AAI;aap<0.01 vs AAI; bp<0.05 vs RV-
2;bbp<0.01 vs RV-2;etc. Data is mean±sd, n=9. 
 
 AAI RV-2s RV-9s RV-60s AAI-10s 
 a b c d e 
SV (ml) 62±19 39±9aa 47±14aabb 46±13aa 64±18dd 
EF (%) 52±13 40±12aa 44±14aab 44±14aa 53±12dd 
EDV (ml) 126±54 118±56 120±54 118±50a 125±49d 
ESV (ml) 61±40 65±43 63±41 61±38 62.6±38 
EDP (mmHg) 9±4 10±3 12±3 11±3 9±4 
ESP (mmHg) 124±13 111±20a 121±18bb 121±18 125±19 
Ees (ml/mmHg) 2.7±1.5 2.1±1.1a 2.4±1.1 2.5±1.2 2.6±1.4 
Ees/Ea 1.3±.7 .7±.4aa .9±.4a .9±.5aa 1.2±.7d 
+dP/dtmax (mmHg/s) 1662±321 1509±238a 1603±243bb 1564±278 1648±313 
-dP/dtmax (mmHg/s) 1738±300 1217±284aa 1411±307aabb 1516±344aabb 1690±333dd
Tau (ms) 31±6 41±8aa 38±7aabb 35.6±6.6aabb 33±6 
PFR (ml/s) 706±186 594±275a 626±25a 618±216a 732±180d 
DysT (%) 18.8±6.4 23.6±6aa 20.5±7abb 21±6.5ab 19±6 
SysDysB (%) 13±9 17±7aa 14±10b 14.4±9 14±8 
DiaDysT (%) 19±7 24.6±4aa 21.3±7b 21.8±6.3a 19.6±7.2 
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Figure 25. Left ventricular  pressure (P) and volume (V) tracings and P-V loops showing 
transition from atrial to right ventricular free wall (RVF) pacing within a 10s time-span. RVF 
pacing induces immediate decreases in basal segmental volume amplitudes (see arrow at S 
4) and increases in apical amplitudes (S1). The third beat after pacing onset shows a 
decrease of initially increased systolic dyssynchrony during the ejection phase. The P-V loops 
of the first paced beats show distorted loops during the iso-volemic contraction and relaxation 
phases. Figure 25B shows 5 recorded beats just before 10s after onset of RV pacing with less 
systolic dyssynchrony, but with marked early diastolic dyssynchrony. The P-V loops show 
improved iso-volemic contraction and less distortion during iso-volemic relaxation. EMG, intra-
cardiac derived electromyogram; Plv, left ventricular pressure; S, is ventricular volume 
segment, S1 apical, S5, basal; Vlv, left ventricular volume. Numbers in the P-V loops indicate 
sequential beat numbers. 
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Figure 26. Left ventricular (LV) Pressure (P) and volume (V) tracings and P-V loops showing 
transition from atrial to right ventricular apical (RVA) pacing within a 10s time-span. RVA 
pacing affects apical volume segments (see arrow, S1), decreases LV end-diastolic volume 
and increases dyssynchrony. Compensation during the ejection phase can be observed in the 
basal segment (S 5). The P-V loops show signs of post-systolic contraction starting at the 
second RV paced beat. The P-V loops of figure 26B show some SV restoration and decrease 
in post-systolic contraction. EMG, intra-cardiac derived electromyogram; Plv, left ventricular 
pressure; S, is ventricular volume segment, S1 apical, S5, basal; Vlv, left ventricular volume. 
Numbers in the P-V loops indicate sequential beat numbers.   
 
Regression Analysis  
Regression analysis comparing changes of different LV function variables 
during the first 10s after onset of the worst RV pacing sites is shown in figure 
27. SV changes inversely correlated with LV late systolic dyssynchrony 
changes and with changes in -dP/dtmax (Fig 27A,D). Total diastolic 
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dyssynchrony inversely correlated with changes in PFR (Fig 27B) and EDV 
(Fig 27C). Changes in Ees correlated with changes in diastolic dyssynchrony 
(r=-.730, p<.001), late systolic dyssynchrony (r=-.766, p<.0001), PFR (r=.777, 
p<.0001) and +dP/dtmax (r=.751, p<.001). Changes in ventricular-arterial 
coupling best correlated with changes in late systolic dyssynchrony (r=-.825, 
p<.0001) and diastolic dyssynchrony (r=-.803, p<.0001). 
Multiple variate regression analysis demonstrated that SV changes within 10s 
were best predicted (p<.012) by changes in systolic dyssynchrony with 
changes in +dP/dtmax, -dP/dtmax, Tau, PFR, EDV, EF, ESP, systolic 
dyssynchrony, and diastolic dyssynchrony as tested variables. 
 
Figure 27. Regression diagrams showing changes in performance and dyssynchrony as 
observed within a 10s time-span from atrial to right ventricular pacing at worst pacing sites. 
Diagram A shows percent change in stroke volume (%ΔSV) versus left ventricular (LV) 
systolic dyssynchrony as measured from the ejection phase (ΔSysDysB); diagram B shows 
percent changes in LV peak filling rate (%ΔPFR) versus in change in LV diastolic 
dyssynchrony (ΔDiaDys); diagram C depicts changes in LV end-diastolic volume (ΔEDV) 
versus ΔDiaDys; diagram D shows %ΔSV versus percent change in –dP/dtmax. Dotted lines 
represent 95% prediction limits. 
 
Discussion 
 
This study shows beat-to-beat effects of RV pacing induced LV mechanical 
dyssynchrony on LV performance in patients with normal EF. At worst RV 
pacing site, the change in conduction pattern acutely increased systolic 
dyssynchrony during the ejection phase effecting subsequent decreases in 
SV, Ees and -dP/dtmax, and increased diastolic dyssynchrony and Tau, and 
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decreased PFR. These changes were effective within 3s and were followed by 
recovery of late systolic dyssynchrony and Ees within a 10s time-span and 
partial recovery of SV, EF, ESP, -dP/dtmax, and diastolic dyssynchrony. From 
10s up to 60s no major changes in all measured variables occurred, except for 
improvement of the relaxation indices -dP/dtmax and Tau. These beat-to-beat 
results indicate dyssynchrony related cardiac dysfunction and suggest intrinsic 
dyssynchrony compensatory mechanisms, occurring within a 10s time-span. 
 
Hemodynamic Evaluation and Stabilization  
Acute hemodynamic effects of cardiac pacing are conventionally evaluated 
after stabilization episodes. The applied duration of stabilization periods in 
most cardiac pacing studies varied considerably, 30s by Hay et al, 1-2 min by 
Lieberman et al, 2 min by Kass et al (180,190,160). However, Aurricchio and 
colleagues observed that the LV paced-beat order had a significant effect on 
LV pressures and derivatives and pulse pressure responses, after an initial 
immediate increase in +dP/dtmax and pulse pressure both variables 
significantly decreased again after 2-3 paced beats (191). The present study 
shows similar reciprocal acute events for RV pacing in patients with normal EF 
and QRS duration. A profound decrease in cardiac performance and 
concomitant increase in mechanical dyssynchrony were observed immediately 
within 3s of RV pacing onset. Subsequently, compensatory mechanisms 
effected a total recovery of systolic dyssynchrony and Ees and partial recovery 
of SV, EF, ESP, -dP/dtmax, and diastolic dyssynchrony within 10s. Whereas 
no significant changes in systolic dyssynchrony could be detected from the 
averaged data of the first 10s (table 12), they were significantly present in the 
beat-to-beat analysis (table 13). Usage of any stabilization period prior to 
cardiovascular analysis may therefore mask acute positive or negative effects 
of cardiac pacing by compensatory mechanisms.  
 
LV Mechanical Dyssynchrony  
In this study we adopted indexes to quantify mechanical dyssynchrony derived 
by conductance catheter technique. In fact, it represents a unique tool to 
perform beat-to-beat evaluations, on the contrary techniques like 
echocardiography require beat averaging to derive indexes of dyssynchrony. 
For the same reason, among the indexes studied in this work we used DYS for 
this analysis. In fact, in addition to the good performances demonstrated in 
detecting dyssynchrony, it offers the highest temporal resolution. It quantifies 
the dyssynchrony beat-by-beat when estimated with the classical approach, 
and, within the beat, it allows the analysis of multiple phases of the cardiac 
cycle. 
These considerations seem to emphasize the value of those indexes 
estimated over single beats, when immediate and transient effects have to be 
observed, that can be masked by the adoption of averaging techniques for the 
extraction of cardiac cycle templates. 
RV pacing is known to induce LV mechanical dyssynchrony by altered 
activation sequence by temporal inhomogeneity inducing dyssynchrony based 
on impaired relaxation independent of preload and or afterload changes 
(28,192). Dyssynchrony of wall motion reduces mechanical efficiency of 
ventricular ejection by inducing premature onset and impaired relaxation (23). 
In patients with dilated cardiomyopathy (DCM), impairment of cardiac 
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performance is associated with impaired LV relaxation and diastolic and 
systolic ventricular mechanical dyssynchrony (82,140,145,189,190). LV 
mechanical dyssynchrony, as demonstrated in patients with DCM and left 
bundle branch block was shown to be a key predictor for multi-site pacing 
efficacy (104,40,82). 
Patients with DCM and marked LV dyssynchrony showed decreases in LV 
mechanical dyssynchrony by wall stress reduction following vasodilator 
administration, cardiomyoplasty, intra-aortic balloon pump (IABP) or LV 
reduction surgery, emphasizing the relationship between load, wall stress and 
mechanical dyssynchrony (23,140,142,143,193). In heart failure patients 
undergoing premature intra-aortic balloon inflation during IABP, it was shown 
that systolic dyssynchony increase, evoked by late systolic increase of load, 
induced a premature onset and impaired relaxation (193). The present study 
demonstrated a marked increase in LV systolic dyssynchrony after onset of 
RV pacing followed by normalization within 10s, whereas diastolic 
dyssynchrony partially decreased after 3s, and remained stable at an 
increased level after10s throughout the 60s RV pacing sequence.  
The markedly significant inverse correlation of systolic dyssynchrony versus 
SV (Fig 27A) from data measured during the first 10s of RV pacing indicates 
that systolic dyssynchrony, as measured from the ejection phase, is initially 
the most important determinant of SV as confirmed by multiple variate 
regression analysis. 
The present study in normal hearts and the IABP study for failing hearts 
indicate that late systolic dyssynchrony changes not only may modulate 
instantly changes in SV, but also may have the capability to recover on a beat-
to-beat basis (193). Moreover systolic dyssynchrony increase in a specific 
segment may be compensated by dyssynchrony decrease in another segment 
(Fig 25B, 26B). Changes in total diastolic dyssynchrony during the first 10s RV 
pacing inversely correlated with changes in PFR and EDV. This indicates that 
diastolic dyssynchrony is related to LV filling. Diastolic dyssynchrony also 
showed compensation as demonstrated by partial recovery at 10s after onset 
of RV pacing.  
Simantrikis et al demonstrated by LV pressure-volume analysis an increased 
contractile state as measured by Ees during LV or biventricular pacing 
compared to RV pacing in atrial fibrillation patients with normal EF (174). In a 
previous study we demonstrated that contractile state as measured by Ees 
inversely correlated with changes in diastolic dyssynchrony in patients 
undergoing LV restoration (143). Also in the non-heart failure patients of the 
current study an inverse correlation between changes in diastolic 
dyssynchrony and Ees due to RV pacing is demonstrated. Decreased 
contractile state as measured by Ees has also been demonstrated in an 
animal RV pacing study by Burkhoff et al (28). Prinzen et al demonstrated in a 
RV animal study loss of contractile function in early activated ventricular 
regions, but also demonstrated hyperfunctioning in late activated zones (31). 
The current results confirm this compensation; basal RV pacing inducing 
immediate increased apical segmental filling and ejection, and apical 
stimulation showing reciprocal results (Fig. 25,26). At longer term, 
asynchronous activation de to RV pacing induces asymmetric hypertrophy and 
LV dilatation (194). 
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Ventricular Mechanical Dyssynchrony-Pathophysiology 
According to Auricchio and Abraham, it is conceivable that ventricular 
mechanical dyssynchrony represents a newly appreciated pathophysiological 
process that directly depresses ventricular function and ultimately leads to 
ventricular dilation and heart failure (57). Brutsaert already demonstrated in 
normal animals that LV mechanical dyssynchrony may act as a physiologic 
modulator of cardiac performance together with heart rate, contractile state, 
preload and afterload (23). The present study, which shows this characteristic 
property of mechanical dyssynchrony in patients with normal EF, confirms 
results from previous studies in patients with heart failure (104,143,193). 
Mechanical ventricular dyssynchrony may therefore be regarded as an 
intrinsic cardiac property, with baseline dyssynchrony at increased level in 
heart failure patients.  
As can be derived from the fast changes in systolic dyssynchrony, from beat-
to-beat during the onset of RV pacing, the heart may control ejection duration 
by changes in systolic dyssynchrony. In direct relationship with changes in 
systolic dyssynchrony are changes in diastolic dyssynchrony, possibly with the 
ability to change cardiac function by adjusting filling rate and EDV.  
 
Limitations of the Study 
The current results should be interpreted within the constraints of certain 
potential limitations. We analyzed beat-to-beat hemodynamic effects occurring 
only within 60s after initiation of RV pacing in patients with normal EF and 
normal QRS duration and only at a single heart rate.  
 
Conclusions 
 
The usage of stabilization periods during evaluation of cardiac pacing may 
mask early changes in systolic and diastolic intra-ventricular dyssynchrony. 
The present study demonstrated a direct relationship between systolic and 
diastolic LV mechanical dyssynchrony and LV performance induced by RV 
pacing in patients with normal EF and normal ORS duration. The main LV 
dyssynchrony and performance related changes occurred within a 10s time 
span initiated by changes in ventricular mechanical dyssynchrony induced by 
aberrant conduction. Systolic ventricular dyssynchrony was best predictor of 
SV changes and showed total compensation between 3-10s after RV pacing 
onset. Diastolic dyssynchrony showed instant increases and compensation 
between 3-10s after RV pacing onset, and was markedly correlated with PFR 
and LVEDV. 
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7. Cardiac Output Derived From Left Ventricular Pressure During 
Conductance Catheter Evaluations: an Extended Modelflow Method 
 
This chapter is published in: 
S Valsecchi, GB Perego, F Censi, JJ Schreuder. Estimation of Cardiac Output from Left 
Ventricular Pressure by a Modified Modelflow Method. Computers in Cardiology 2006. Poster 
Session PA7 (Abs.199). 
and submitted to Am J Physiol. 
 
Introduction 
 
In 1981, Baan et al. introduced a multi-electrode conductance catheter (113) 
for real-time continuous ventricular volume measurements. The electrodes 
divide the ventricular volume into parallel segments perpendicular to the long 
heart axis and measure the electric conductance of each segment. The 
segmental volume is proportional to the segmental conductance and total 
ventricular volume can be computed by summing the segmental volumes. 
However, conductive tissues and fluids surrounding the ventricle affect the 
measure introducing an offset in the conductance signal, i.e. parallel 
conductance. When parallel conductance is not quantified, only changes in 
conductance as a measure of changes in volume can be presented 
(113,118,120). To extend the conductance method to absolute volume 
measurements, some calibration methods have been introduced (114,123). 
The conductance catheter technique was shown to accurately measure 
ventricular volume with high time resolution over single cardiac cycles 
(113,114,118,120,123,128). Nonetheless, as emphasized by Schreuder et al. 
(141), the concomitant use of an independent system for cardiac output (CO) 
estimation is advisable to confirm the results obtained with conductance 
volume method concerning the situations where the CO measure can be 
affected by the presence of artifacts. A possible approach is the simultaneous 
use of CO estimation from pressure signal analysis methods such as the 
Modelflow (195). According to Wesseling et al. (195), this method derives an 
aortic flow waveform from arterial pressure by simulation of a non-linear three-
element aortic input impedance model, estimates stroke volume (SV) by 
integrating the flow waveform and calculates CO by multiplying SV by the 
heart rate. This method was demonstrated to reliably monitor CO changes in 
a wide range of hemodynamic states and to precisely estimate absolute 
values of CO after calibration (196). 
The implementation of the Modelflow method requires the acquisition of the 
aortic pressure (Pao) signal that, during conductance measurements, can be 
obtained inserting a second micromanometer catheter in aorta or using a dual 
pressure sensor conductance catheter, which is not widely available. 
In this paper, we propose to derive aortic flow waveform from the left 
ventricular pressure (Plv) by using a modified version of the Modelflow 
method, to obtain a simplified independent estimation of CO in the setting of 
conductance measurements. 
 
Methods 
 
The model 
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The aortic Modelflow method (MFao) computes relative CO from Pao (CO-
MFao) using a nonlinear, time-varying three-element Windkessel model (195). 
The model includes aortic characteristic impedance (Z0), arterial compliance 
(Cw), and systemic vascular resistance (Rp) (Figure 28). Z0 and Cw depend 
on the aortic cross-sectional area, which can be estimated from mean arterial 
pressure, age, and sex by means of the arctangent model of Langewouters et 
al. (197). However, these estimations although precise are not highly accurate 
and the absolute value of the estimated CO remains uncertain, unless 
calibration against another method of measurement such as thermodilution is 
performed or a measurement of aortic diameter is introduced (198). 
For each beat, Rp is obtained as the ratio of mean Pao and the CO estimated 
from the previous beat, minus the current value of Z0. With this scheme, the 
model can follow changes in systemic peripheral resistance that occur with a 
time constant which is typically about 10s. 
 
 
Figure 28. The standard Modelflow method uses a nonlinear, time-varying three-element 
Windkessel model: aortic characteristic impedance (Z0), arterial compliance (Cw), systemic 
vascular resistance (Rp), aortic flow (Q(t)). To describe the aortic valve the model has been 
extended (dashed box). In ejection phase it includes an extra linear impedance (Rao), while in 
PLV(t) Pao(t) PLV(t) Pao(t) 
PLV(t) 
Q(t) 
Cw RP 
Z0 Rao 
Pao(t) 
PLV(t) 
Pao(t) 
PLV(t) 
Pao(t) 
Ejection phase Diastole 
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diastole Q(t) is zero: an estimated aortic pressure (Pao) is determined by the discharge of Cw 
over Rp, from the initial value recorded at the time of end-systole. 
 
Figure 29. Acquired signals and waveforms generated with the three methods. Aortic 
Modelflow: acquired aortic pressure (Pao(t)) and estimated aortic flow signal (Q(t)). The 
dicrotic notch is detected by identifying the first local minimum of Q(t) after peak flow. LV 
Modelflow: acquired LV pressure (Plv(t)) and its first derivative (dPlv(t)/dt), estimated aortic 
pressure (Pao(t)) and aortic flow signal (Q(t)). The end-systolic time is identified considering 
the negative dPlv/dt maximum, while the time when the Plv signal, during its systolic increase, 
crosses the simulated Pao signal identifies the start of systole. Conductance CO: acquired 
LV pressure (Plv(t)), its first derivative (dPlv(t)/dt) and LV volume by conductance 
measurement (Vol lv(t)). In order to eliminate contribution of possible regurgitant flows, 
effective conductance SV is defined as the difference between conductance volumes at the 
times of positive dPlv/dt max and negative dPlv/dt max. 
 100
 
To permit the computation of CO from Plv signal (CO-MFlv), we extended the 
described model simulating the aortic valve (Figure 28, dashed box). The first 
assumption of our model is the absence of systolic mitral regurgitation as the 
model computes forward flow into the aorta and ignores eventual backward 
flow. Moreover, we assumed a fixed value resistance (Rao) for the patent 
aortic valve placed in series to Z0 during the ejection phase (Figure 28, left 
panel). In diastole (Figure 28, right panel) we considered the absence of 
leakage (infinite resistance): the absence of aortic flow immediately after 
aortic valve closure and an estimated Pao determined by the discharge of Cw 
over Rp, from the initial value recorded at the time of end-systole. 
In our model the time of end-systole, which in MFao is detected at the first 
local minimum in the aortic flow signal after peak flow (199-201) in 
correspondence of the dicrotic notch, is selected as the time of negative 
dPlv/dt max. The time of the start of systole is determined by the crossing of 
simultaneously increasing Plv and the decreasing estimated Pao (Figure 29). 
In order to characterize the Rao, instead of using an arbitrary fixed value, the 
following procedure is proposed. The typical approach for conductance 
catheter placement is the retrograde insertion via the femoral artery. Before 
accessing the left ventricle (LV), the Pao can be recorded using the LV 
catheter micromanometer. A second acquisition is then performed with the 
catheter in the final location and the transducer placed in LV. Thus, the Rao 
value can be determined as the mean difference of Plv and Pao during the 
systolic phase divided by the CO-MFao estimated from the Pao recording. 
Once characterized Rao, its value is entered into the model and the aortic 
flow can be obtained simulating digitally the non-linear model. CO-MFlv is 
then computed by integrating the flow during systole and multiplying by heart 
rate. 
Usually, before conductance volume acquisitions, a thermodilution CO 
measurement (COtd) is carried out as part of the initial calibration procedure. 
This result can be also applied for CO-MFlv calibration, which was shown to 
improve the accuracy of the method by reducing the uncertainty in the 
patient’s aortic diameter (196) and is performed by multiplying CO-MFlv and 
CO-MFao by a calibration factor Klv = COtd / CO-MFlv and Kao=COtd/CO-
MFao.   
 
Patients and Materials 
21 patients with heart failure, undergoing biventricular pacing device 
implantation for cardiac resynchronization therapy, were studied at the time of 
the procedure. The Ethical Committee approved the protocol and all patients 
gave their informed consent to participate in the study (Table 14). 
Patients were mildly sedated with midazolam 5–10 mg. They all received right 
auricular, right ventricular and LV leads (Capsure Model 5334, Capsure Model 
5534 and Attain Model 2187, respectively, Medtronic Inc, Minneapolis, USA). 
The LV lead was placed in a lateral or posterolateral LV coronary vein. 
After permanent stimulation catheters were placed, through the femoral artery 
a 7-Fr combined pressure-conductance catheter with 1-cm interelectrode 
spacing (CD Leycom; Zoetermeer, The Netherlands) was positioned in the LV 
and a micromanometer catheter (Millar No. SPC-474A, Millar Instruments, 
Houston, TX) was advanced to the aorta. The catheters were connected to a 
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Cardiac Function Lab (CD Leycom) for online display and acquisition (sample 
frequency 250 Hz). LV volume was calibrated using thermodilution and 
hypertonic saline dilution, as previously described (114). Effective 
conductance SV was defined as the difference between conductance volumes 
at the times of positive dPlv/dt max and negative dPlv/dt max (Figure 29), 
which largely eliminates contribution of possible regurgitant flows. 
Conductance CO (COcond) has been then estimated by SV × heart rate. 
The simulation and the data analysis were performed with a custom-made 
software developed in LabVIEW 5.1 (National Instruments, Houston, TX, 
USA). 
 
Table 14. Demographics and baseline clinical parameters. 
Patient Age (years) Gender Etiology 
NYHA 
Class 
EF 
(%) 
LVEDD 
(mm) 
Conduction 
defect 
QRS 
width 
(ms) 
         
1 67 f ISC 3 16 80 LBBB 145 
2 68 f ISC 3 30 60 LBBB 150 
3 70 m ISC 3 33 57 LBBB 160 
4 64 m DCM 4 26 63 LBBB 180 
5 81 m DCM 2 34 60 LBBB 140 
6 58 m DCM 3 25 65 LBBB 170 
7 80 m ISC 3 30 69 RBBB 160 
8 68 m DCM 3 23 65 LBBB 160 
9 76 m DCM 3 22 67 LBBB 180 
10 63 f DCM 4 27 56 RV Pace 205 
11 64 m ISC 4 15 80 RBBB 200 
12 70 m ISC 3 25 56 RV Pace 200 
13 64 f ISC 3 25 51 LBBB 120 
14 70 m DCM 3 23 48 LBBB 170 
15 64 m DCM 3 33 78 LBBB 165 
16 78 m DCM 3 40 70 RBBB 160 
17 76 f ISC 3 28 59 LBBB 160 
18 68 m ISC 3 25 65 LBBB 180 
19 62 f DCM 2 38 57 LBBB 180 
20 70 m ISC 3 25 78 LBBB 180 
21 69 m DCM 3 28 63 LBBB 170 
         
mean 
(SD) 69 (6)   3.0 (0.5) 27 (6) 64 (9)  168 (21) 
 
NYHA = New York Heart Association; EF = Ejection fraction; LVEDD = Left ventricular end-
diastolic diameter; f = female; m = male; ISC = Ischemic; DCM = Dilated cardiomyopathy; 
LBBB = Left bundle branch block; RBBB = Right bundle branch block; RV Pace = LBBB 
induced by right ventricular pacing. 
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Measurement Protocol 
Hemodynamic tests were performed during temporary stimulation both in dual 
chamber pacing (DDD mode - 5 bpm over spontaneous sinus rate) and, when 
feasible, in atrial tracking ventricular pacing (VDD mode). The interval 
between right atrial pacing (or sensing) and right ventricular pacing (A-V 
interval) and the interval between right and left ventricular pacing (V-V 
interval) could be programmed independently: it was previously shown that 
significant hemodynamic changes are obtained with sequential biventricular 
pacing (202) and present test was performed to study the acute response to 
multisite pacing by pressure-volume plane analysis  
In each patient, we performed acquisitions at baseline and for each 
combination of different A-V (ranging from 80 ms to 160 ms, with steps of 20 
ms) and V-V (from -60 ms to 40 ms, with steps of 20 ms), in DDD and VDD 
mode. For each step, a 30 s recording period was preceded by a stabilization 
period of 30 s. All measures were averaged over 10-15 cardiac cycles after 
extrasystolic beats were removed from analysis. During offline analysis some 
recordings were discarded due to excessive arrhythmic beats. 
We compared CO-MFlv values with standard CO-MFao and COcond 
measures. In the first series, during unpaced sinus rhythm, Pao and Plv 
recordings were used to characterize Rao as described before. In this phase 
COtd, estimated during conductance calibration, was also used to calibrate 
CO-MFao and CO-MFlv through multiplication by a patient individual 
calibration factor (Kao = COtd / CO-MFao and Klv = COtd / CO-MFlv 
respectively). 
 
Statistical Analysis 
Data averages are given as mean and standard deviation (SD). Limits of 
agreement were computed plotting differences in data pairs against their 
average (Bland-Altman plots) (203). The agreement between the two models 
is computed as the bias (mean), with limits of agreement computed as bias ± 
2SD when differences followed normal distribution. Normality was tested with 
the Kolmogorov-Smirnov one-sample test. The coefficient of variation was 
computed as CV = (SD/mean)×100%. 
Moreover, to investigate the ability of MFlv to track changes in CO, a trend 
score was derived. If both CO-MFao and CO-MFlv simultaneously indicate a 
positive trend from baseline values, the changes compare positively and a 
positive score is counted. If both show a negative trend, they again compare 
positively. When the changes in CO are in opposite directions they compare 
negatively and a negative score is counted. Separate scores were made for 
all changes regardless of size, and also for changes where CO-MFao values 
differed by at least 0.5 l/min, which is considered clinically relevant. The 
Kappa statistic and its standard error (SE) were calculated to measure the 
agreement between MFao and MFlv measures of CO changes. 
All statistical analyses were performed using SPSS software (SPSS for 
Windows, version 12.0, SPSS Inc., Chicago, IL, USA). 
 
Results 
 
In 21 patients a total of 680 measures of acceptable quality were obtained 
during a median test time of 1 h 30 min. In 6 patients conductance volume 
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signal was not available and only pressure signals were acquired. 
Arrhythmias caused rejection of 143 acquisition series. Thus, excluding the 21 
acquisitions used to calibrate the methods, 516 series remained for 
comparisons between CO-MFlv and CO-MFao. For the comparisons between 
CO-MFlv and COcond, 267 series were available. 
In Figure 29 the acquired signals and the waveforms generated with the three 
methods are reported, in addition to the markers identifying the end-systolic 
and start systole timing points, as estimated by MFao, MFlv and conductance 
method. For standard MFao method, the Pao signal and the obtained aortic 
flow are shown. To describe MFlv method, the Plv is reported together with its 
first derivative that is used to identify the end-systolic point and to estimate the 
Pao signal. By applying the method described above, the aortic flow is then 
obtained. It can be noted that, the Pao waveform estimated through MFlv is 
similar to the real Pao also in the diastolic phase when the aortic valve is 
closed and the curve is completely determined by Cw and Rp. Consequently, 
also the aortic flow signals estimated with the two methods are similar. 
Finally, with conductance method, the LV volume and the Plv are acquired 
and the first derivative of this latter is used to identify the end-systolic and 
end-diastolic volumes for COcond measurement. 
Table 15 summarizes the results obtained in our patients: the ranges of CO 
during test, the estimated Rao, the differences between CO-MFlv and CO-
MFao estimations with the errors in end-diastolic and end-systolic timing 
points identification and the differences between CO-MFlv and COcond 
estimations. The data are presented in two fashions: averaged per patient and 
then pooled for the group, and with all the measurements pooled. 
The overall mean CO was 4.36 (1.38) l/min. Our multisite ventricular 
stimulation protocol produced large changes in the hemodynamic state of 
patients: within patients CO ranged up to 2:1 ratio during the tests, while 
pooling all series the range ratio for CO was 3:1. 
Comparing the two Modelflow methods, the absolute error ranged from -0.27 
l/min to 0.31 l/min, with a SD ranging from 0.17 l/min to 0.52 l/min. The mean 
absolute error for pooled data, i.e. bias (SD), was -0.04 (0.36) l/min, with limits 
of agreement of -0.77 and 0.70 l/min, and a coefficient of variation of 8.4%. 
For the comparisons between CO-MFlv and COcond, the mean absolute error 
ranged from -0.52 l/min and 0.29 l/min, with a SD ranging from 0.13 l/min to 
0.79 l/min. The bias was -0.10 (0.49), with limits of agreement of -1.12 and 
0.90 l/min, and a coefficient of variation of 12.5%. 
The Kolmogorov-Smirnov test for the difference between CO estimations 
(CO-MFlv Vs. CO-MFao and CO-MFlv Vs. COcond) did not indicate a 
significant deviation from normal distributions. 
Figure 30 (panels a and b) summarizes the results obtained with pooled 
measures. Panel a shows scatter plot of the 516 series. Panel b shows Bland-
Altman plot with the difference between CO-MFlv and CO-MFao versus their 
mean. The 19 largest differences, those outside the limits of agreement were 
recorded in 4 patients. 
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Table 15. Cardiac output estimation with MFlv versus standard MFao and conductance 
CO. 
 
 CO-MFlv Vs CO-MFao  CO-MFlv Vs COcond 
Patient N of Series 
min CO 
(l/min) 
max CO 
(l/min) 
Rao 
(mmHg*s/l) 
CO dif 
(l/min) 
SS-point 
error (ms) 
ES-point 
error (ms) 
 
 
CO dif 
(l/min) 
          
1 12 2.65 4.33 5.0 -0.27 (0.28) 24.9 (4.1) 28.4 (15.4)  -0.09 (0.60) 
2 20 2.77 3.43 6.6 -0.25 (0.20) 35.9 (2.9) 5.3 (3.9)  -0.07 (0.40) 
3 37 2.82 3.52 7.1 -0.03 (0.28) 28.2 (3.8) 23.8 (6.9)  -0.01 (0.32) 
4 16 2.85 3.39 4.8 0.02 (0.31) 19.2 (3.9) 25.4 (5.1)  -0.08 (0.79) 
5 41 3.25 5.78 4.6 0.00 (0.42) 34.3 (3.4) 33.9 (8.4)  -0.37 (0.31) 
6 20 4.12 4.85 4.5 -0.14 (0.33) 26.0 (2.6) 31.1 (4.4)  0.29 (0.46) 
7 3 3.31 3.39 6.4 0.09 (0.17) 11.8 (3.7) 28.8 (1.3)  0.21 (0.28) 
8 13 2.66 3.60 7.6 -0.20 (0.27) 36.1 (15.6) 19.0 (17.5)  -0.04 (0.35) 
9 22 2.87 5.01 7.7 0.31 (0.26) 12.8 (8.8) 22.5 (10.0)  0.03 (0.46) 
10 23 3.82 4.85 6.7 0.31 (0.22) 27.0 (3.1) 28.6 (2.6)  -0.04 (0.40) 
11 47 5.33 7.30 5.7 -0.19 (0.47) 17.4 (4.7) 21.1 (2.6)  -0.52 (0.59) 
12 33 2.42 2.81 7.2 0.05 (0.20) 5.0 (2.9) 26.5 (2.5)  -0.06 (0.33) 
13 27 3.38 4.52 4.9 0.18 (0.20) 24.8 (2.1) 26.0 (1.8)  0.04 (0.13) 
14 21 2.97 3.55 5.2 -0.16 (0.22) 29.3 (2.8) 29.0 (3.1)  -0.11 (0.41) 
15 38 2.73 3.59 7.4 -0.21 (0.23) 26.5 (7.4) 20.9 (7.7)  0.02 (0.40) 
16 12 3.87 4.50 6.3 -0.17 (0.24) 32.8 (4.5) 35.2 (8.6)   
17 36 3.83 7.33 8.1 -0.12 (0.43) 35.9 (2.6) 29.3 (10.3)   
18 35 5.09 7.59 7.8 0.00 (0.42) 33.3 (4.9) 30.6 (15.6)   
19 44 2.85 3.88 5.5 -0.09 (0.26) 28.5 (2.9) 32.3 (8.5)   
20 17 3.01 3.98 8.9 0.08 (0.25) 24.6 (10.5) 37.5 (10.6)   
21 20 3.35 7.51 8.3 0.16 (0.52) 38.9 (10.4) 26.4 (13.3)   
          
patient means 
(SD) 3.33 (0.78) 4.70 (1.52) 6.49 (1.35) -0.03 (0.17) 26.4 (8.9) 26.7 (6.8)  -0.05 (0.20) 
pooled means 
(SD)    -0.04 (0.36) 28.0 (12.6) 31.8 (24.5)  -0.10 (0.49) 
 
N of Series = Number of acquisition series, including the series used to calibrate the methods; 
min CO = Minimum cardiac output recorded; max CO = Maximum cardiac output recorded; 
Rao = Estimated value of aortic valve resistance in systolic phase; CO dif = Differences 
between CO estimations; SS-point error = Difference in start-systolic time estimations 
between Modelflow methods; ES-point error = Difference in end-systolic time estimations 
between Modelflow methods. 
 
In Figure 30 (panels c and d) the Bland-Altman plot analysis is reported for 
CO-MFlv Vs. COcond comparison, 10 differences lie outside the limits of 
agreement and were obtained in 3 patients. 
Of the 516 changes in CO from baseline values, 388 (75%) were scored in 
the same direction by both methods. Of 112 changes greater than 0.5 l/min, 
110 (98%) were indicated correctly in direction by MFlv. In both cases, the 
Kappa statistical analysis confirmed the presence of agreement between CO-
MFlv and CO-MFao: k=0.509 with SE=0.037 (p<0.001) and k=0.964 with 
SE=0.025 (p<0.001), respectively. 
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Figure 30. Diagrams showing the data pairs in all 21 patients (n=516) [Panel a] and in the 15 
patients with conductance measurements (n=267) [Panel c]. In the Bland-Altman plots: COdif 
= CO-MFlv – CO-MFao [Panel b] and CO-MFlv - COcond [Panel d], average CO is their 
mean. The dashed lines indicate the bias and limits of agreement between methods. 
 
 
In MFlv method, as well as in conductance estimation, the end-systolic point 
is identified by the time of negative dPlv/dt max and in our tests occurred at a 
mean of 31.8 (24.5) ms from the dicrotic notch, as predicted by MFao (Table 
15). 
With respect to the onset of the aortic flow obtained with MFao, the start 
systolic point occurred at 28.0 (12.6) ms in MFlv, and at 36.4 (8.3) ms in 
conductance estimation (time of positive dPlv/dt max) (p=0.045). The duration 
of the ejection phase as estimated by MFlv was 12.8 (27.7) ms shorter than 
with MFao. 
 
Discussion 
 
Modelflow method, with Pao signal analysis, demonstrated to provide 
continuous precise estimations of CO after calibration (196). The 
measurement of CO from the Plv signal can be extremely useful as an 
independent method during conductance catheter evaluations (141), or to 
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permit CO estimation whenever a single pressure transducer is positioned in 
LV for quantifying the contractile state by measuring the dPlv/dt. 
In this study we presented a method for Modelflow computation from the Plv 
signal. CO estimation is of clinical importance for patients with heart failure. In 
addition, recently, many studies described the effects of cardiac pacing for the 
treatment of heart failure patients using conductance volume catheter 
technique (63,188,189). For these reasons we performed the study in patients 
undergoing biventricular pacing device implant for cardiac resynchronization 
therapy. 
Thermodilution is the reference CO method in almost all studies. A single 
thermodilution estimate of CO has a coefficient of variation (error) of 15–20%, 
while a triplicate, phase-spreading injection technique has an error of 6% as 
the result of averaging. Thus, as stated by Critchley and Critchley (204), it is 
against these levels of inherent error that any new method of CO 
measurement has to be judged. 
Unfortunately in this study we were not able to assess directly the error 
between our method and COtd. Conversely, for all tested series we compared 
CO-MFlv estimation with the standard CO-MFao, that is the method to be 
replaced, and versus the COcond. CO-MFlv differed -0.04 (0.36) l/min on 
average from CO-MFao, with limits of agreements of -0.77 and 0.70 l/min, 
which are within the limits of acceptability for clinical use. 
The error of the comparison C of two estimations A and B can be computed 
as Variance (C) = Variance (A) + Variance (B) (204). 
The error that we measured comparing the two Modelflow methods is around 
8.4%, while the error of the standard MFao has been demonstrated to be 7% 
(196). However, considering the similarity of the two methods, we cannot 
assume their errors statistically independent, thus a covariant component 
needs to be added to the formula (i.e. Variance (C) = Variance (A) + Variance 
(B) - 2 Covariance (A,B)) (204). 
The equation can be solved considering that Covariance (A,B) ≤ √ Variance 
(A) × √ Variance (B) and from this relation we can just conclude that the error 
of CO-MFlv Vs. COtd is between 7% and 16%. 
On the contrary, due to the different mechanisms behind the two methods, 
when CO-MFlv and COcond are compared their measurement errors can be 
considered statistically independent. 
From the data available in (133), where the accuracy of the conductance 
method to determine SV was tested by comparison with thermodilution, we 
can assume an error of around 11% for COcond measurement. 
Approximately, the error we found between the CO-MFlv and COcond is 13%. 
Thus we can conclude that CO-MFlv presents an error of √169–121=7%, 
which is comparable to the probable error estimated for standard CO-MFao 
(196), and may therefore replace it. 
Moreover, apart from quantitative estimation of CO, we found a good 
agreement between MFao and MFlv measures of directional CO changes, 
demonstrating that the MFlv can reliably track trends in CO. 
A correct identification of beat-to-beat start and end systolic times is crucial for 
the accuracy of the proposed method. Many techniques were proposed in 
literature to identify the aortic valve closure by detecting the dicrotic notch 
from Pao signal (205). In particular, Modelflow method was used to detect and 
predict the dicrotic notch, by calculation of the aortic flow and identification of 
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its first local minimum after peak flow (Figure 29). This method demonstrated 
to be accurate in animal and man, during both regular rhythm and arrhythmic 
episodes (199-201), providing adequate results as system for real time intra 
aortic balloon pump inflation timing control. 
In MFlv the end-systolic time is identified considering the negative dPlv/dt 
maximum, i.e. the point generally used in conductance CO measurements in 
order to eliminate contribution of possible regurgitant flows (Figure 29). 
For the detection of start systolic time, we considered the time when the Plv 
signal, during its systolic increase, crosses the simulated Pao signal, that is 
determined by the discharge of the capacitor Cw (Figure 29). Other options 
could be the use of the ECG signal for R-waves identification or the use of the 
time of positive dPlv/dt max (as used in conductance CO) or the zero-crossing 
point of the dPlv/dt signal, as recently proposed (157). Our approach, with 
respect to the use of positive dPlv/dt max, resulted in significantly shorter 
delays, while other methods were not directly tested in this work. In our 
method both start and end systolic times were detected around 30 ms in 
advance with respect to the timing points identified by MFao, due to the phase 
shift of the two pressure curves. Whereas considering the ejection phase 
duration, the two estimations differed only 12.8 (27.7) ms. 
The proposed calibration procedure permits to determine the appropriate Rao 
value, instead of using an arbitrary fixed value. The conductance catheter is 
usually placed in LV with retrograde insertion via the femoral artery. Thus, the 
Pao acquisition, performed before accessing LV to estimate the Rao value, 
does not increase the complexity of the procedure. Nonetheless, in this work 
we did not study specifically the sensitivity of the results to the changes in 
Rao. 
 
Limitations 
In this study, measurements were only used whenever heart rhythm was 
regular. Because many heart failure patients show frequently arrhythmia, the 
new method should be tested also in this condition, by comparison with a 
method insensitive to irregularities in heart rhythm. 
A potential limitation of the method is the patient selection. Similarly to the 
standard aortic Modelflow method, it is required that patients have patent 
aortic valves and no aortic aneurysms. An aneurysm affects a patient’s aortic 
compliance. A patent aortic valve is required for proper model CO 
computation as the model computes forward flow into the aorta and in 
regurgitation ignores backward flow. For similar reasons, as mentioned 
above, a second assumption for the CO-MFlv analysis is the absence of 
systolic mitral regurgitation. 
The patients selected for our study were candidates to resynchronization 
therapy, these patients typically present intraventricular conduction delays 
that induce most frequently pre-systolic mitral regurgitation due to a 
lengthening of the pre-ejection time: this kind of regurgitation should not affect 
the precision of the method. 
 
Conclusions 
 
In patients without mitral valve and aortic abnormalities, undergoing 
conductance catheter evaluations, the continuous monitoring of CO using the 
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intra-ventricular pressure signal seems reliable. CO can be monitored 
quantitatively and continuously with a simple and low-cost method. 
After an initial calibration that can be executed simultaneously and 
automatically during conductance calibration, this method presents near zero 
bias and an acceptable precision sufficient to replace conventional aortic 
Modelflow estimations. 
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Conclusions and Future Works  
 
Dyssynchrony exacerbates heart failure in a variety of ways, generating 
cardiac inefficiency as well as pathobiologic changes at the tissue, cellular, 
and molecular levels. 
CRT reduces symptoms in heart failure patients, improves cardiac structure 
and function, and decreases all-cause as well as heart failure morbidity and 
mortality. However, the individual response to the therapy varies considerably 
among patients fulfilling current CRT indications, and numerous works 
suggested that the positive response to CRT may be predicted by the 
presence of extensive dyssynchrony. 
Dyssynchrony is commonly identified by a prolonged QRS duration with left 
bundle-branch block morphology on surface electrocardiogram. Moreover, 
various indexes based on magnetic resonance imaging or echocardiographic 
measurements are being used to quantify ventricular dyssynchrony. However, 
these methods are laborious and require substantial operator interaction and 
expertise. 
Recently, novel indexes were introduced to quantify dyssynchrony based on 
volume signals acquired with the conductance catheter during cardiac 
catheterization. This method is invasive but offers several advantages. The 
results are obtained immediately, and precise geometric assumptions 
regarding the ventricle or labor-intensive analyses are not required. 
Moreover, volumetry by conductance catheter permits to acquire real-time 
signals with high temporal resolution. It does not present the limitations of 
techniques like MRI or echocardiography that require beat averaging to derive 
indexes of dyssynchrony, masking all possible components associated with 
beat-to-beat hemodynamic variations. 
 
In this study, the extraction of the new indexes permitted to identify two 
components of ventricular dyssynchrony. The first component is represented 
by the inhomogeneities of cardiac contraction and relaxation that occur 
repetitively and that can be described and quantified by coherent averaging-
based indexes. 
The second component corresponds to the non-recurrent mechanical 
inhomogeneities that are in part quantified by the classical time-domain 
indexes estimated from each beat or, more specifically, by the indexes 
extracted by the residual signal and the parameters in the frequency domain. 
These non-recurrent mechanical ventricular non-uniformities are probably the 
expression of the substantial beat-to-beat hemodynamic variations, often 
associated with heart failure and due to cardiopulmonary interaction and 
conduction disturbances. 
 
In present work, the complete set of conductance catheter-based indexes of 
dyssynchrony was used to describe the acute effects of pacing therapies. The 
analysis of the changes of hemodynamic variables, in agreement with the 
literature, demonstrated a marked improvement of the cardiac function 
following CRT, in patients with ventricular dysfunction. 
The analysis of the indexes of dyssynchrony demonstrated that these indexes 
are able to detect the reduction of internal ineffective flows, the inhomogeneity 
during isovolumic contraction and relaxation as well as the decrease of the 
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beat-to-beat variations that seem associated to the spontaneous activation, in 
presence of ventricular dysfunction and left bundle branch block. 
Moreover, we observed a significant correlation between the acute changes in 
stroke volume induced by the pacing and the changes of dyssynchrony, as 
estimated by the indexes under study.  
This result may have practical implications for pacing therapy delivery. In fact, 
some authors advocated the need to perform a patient tailoring of pacing site, 
due to the considerable inter-patient variation in the hemodynamic response 
to pacing. The identification of parameters associated to the hemodynamic 
improvement may help in guiding the implant optimization. 
 
Moreover, using our new indexes of dyssynchrony we observed that right 
ventricular pacing worsens cardiac function unless the pacing site is 
optimized, and that pacing site may influence overall global ventricular 
function depending on its relative effects on regional function and synchrony. 
Similarly, we demonstrated that in CRT the right ventricular pacing site that 
produces the optimal acute hemodynamic response varies between patients. 
 
Using conductance catheter method we also showed that the stabilization 
periods that are usually applied to study the acute hemodynamic effects of 
cardiac pacing and that in most studies varied considerably, significantly 
affect the results of the analysis and thus have to be standardized to permit 
the comparison of results. 
 
The results obtained with this work should represent the background for the 
development of an automated system for optimal pacing lead delivery. 
In fact, recently systems have been designed to enable physicians to 
complete more complex interventional procedures by providing image guided 
delivery of catheters through the blood vessels and chambers of the heart to 
treatment sites. This is achieved using computer-controlled, externally applied 
magnetic fields that govern the motion of the working tip of the catheter, 
resulting in improved navigation, shorter procedure time and reduced x-ray 
exposure. 
This tool, together with a reliable and operator-independent system for 
hemodynamic evaluations, a set of indexes exhaustively describing the 
cardiac function and the effects of the intervention, and an efficient 
measurement protocol, constitute the required components of an automated 
closed-loop system for lead delivery. 
Obviously, it will become mandatory to verify the role of automated and 
optimized ventricular lead placement for cardiac pacing with a prospective, 
randomized outcomes-based clinical study. The study should compare this 
optimized lead implant with conventional lead implant techniques to determine 
the difference in chronic response to the therapy. 
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Appendix 
 
Ancillary Studies and Publications 
 
a. Physiologic Pacing: New Modalities and Pacing Sites. 
 
This chapter is published in: 
Padeletti L, Lieberman R, Valsecchi S, Hettrick DA. Physiologic pacing: new modalities and 
pacing sites. Pacing Clin Electrophysiol. 2006;29 Suppl 2:S73-7. 
 
Abstract 
 
Right ventricular (RV) apical pacing impairs left ventricular function by 
inducing dyssynchronous contraction and relaxation. Chronic RV apical 
pacing is associated with an increased risk of atrial fibrillation, morbidity, and 
even mortality. These observations have raised questions regarding the 
appropriate pacing mode and site, leading to the introduction of algorithms 
and new pacing modes to reduce the ventricular pacing burden in dual 
chamber devices, and a shift of the pacing site away from the RV apex. 
However, further investigations are required to assess the long-term results of 
pacing from alternative sites in the right ventricle, because long-term results 
so far are equivocal. The potential benefit of prophylactic biventricular, 
monochamber left ventricular, and bifocal RV pacing should be explored in 
selected patients with a narrow QRS complex, especially those with impaired 
left ventricular function. His bundle pacing is a promising and evolving 
technique that requires improvements in lead technology. 
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b. Long-Term Survival in Patients Treated With Cardiac 
Resynchronization Therapy: A 3-Year Follow-Up Study From the 
InSync/InSync ICD Italian Registry 
 
This chapter is published in: 
Gasparini M, Lunati M, Santini M, Tritto M, Curnis A, Bocchiardo M, Vincenti A, Pistis G, 
Valsecchi S, Denaro A. Long-Term Survival in Patients Treated with Cardiac 
Resynchronization Therapy: A 3-Year Follow-Up Study from the InSync/InSync ICD Italian 
Registry. Pacing Clin Electrophysiol. 2006;29 Suppl 2:S2-S10. 
 
Abstract 
 
Background 
Studies reporting the long-term survival of patients treated with cardiac 
resynchronization therapy (CRT) outside the realm of randomized controlled 
trials are still lacking. The aim of this study was to quantify the survival of 
patients treated with CRT in clinical practice and to investigate the long-term 
effects of CRT on clinical status and echocardiographic parameters. 
 
Methods 
The study population consisted of 317 consecutive patients with implanted 
CRT devices from eight Italian University/Teaching Hospitals. The patients 
were enrolled in a national observational registry and had a minimum follow-
up of 2 years. A visit was performed in surviving patients and mortality data 
were obtained by hospital file review or direct telephone contact. 
 
Results 
During the study period, 83 (26%) patients died. The rate of all-cause 
mortality was significantly higher in ischemic than nonischemic patients (14% 
vs 8%, P = 0.002). Multivariate analysis showed that ischemic etiology (HR 
1.72, CI 1.06–2.79; P = 0.028) and New York Heart Association (NYHA) class 
IV (HR 2.87, CI 1.24–6.64; P = 0.014) were the strongest predictors of all-
cause mortality. The effects of CRT persisted at long-term follow-up (for at 
least 2 years) in terms of NYHA class improvement, increase of left ventricular 
ejection fraction, decrease of QRS duration (all P = 0.0001), and reduction of 
left ventricular end-diastolic and end-systolic diameters (P = 0.024 and P = 
0.011, respectively). 
 
Conclusions 
During long-term (3 years) follow-up after CRT, total mortality rate was 
10%/year. The outcome of ischemic patients was worse mainly due to a 
higher rate of death from progressive heart failure. Ischemic etiology along 
with NYHA class IV was identified as predictors of death. Benefits of CRT in 
terms of clinical function and echocardiographic parameters persisted at the 
time of long-term follow-up. 
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c. Effects of Cardiac Resynchronization Therapy in Patients With Mild 
Symptoms of Heart Failure With Respect to Severely Symptomatic Heart 
Failure Patients: the InSync/InSync ICD Italian Registry. 
 
This chapter is submitted to: 
M Landolina, M Gasparini, M Lunati, M Santini, L Padeletti, A Puglisi, M Bocchiardo, S Orazi, 
GB Perego, S Valsecchi, A Denaro. Effects of Cardiac Resynchronization Therapy in Patients 
With Mild Symptoms of Heart Failure With Respect to Severely Symptomatic Heart Failure 
Patients: the InSync/InSync ICD Italian Registry. Am J Cardiol. Under Review. 
 
Abstract 
 
Background 
Cardiac resynchronization therapy (CRT) is recommended for patients with 
NYHA class III or IV heart failure (HF) and evidence of ventricular 
dyssynchrony. The effects of CRT in NYHA class II patients are still 
controversial. Aim of this study was to evaluate the effects of CRT in NYHA II 
with respect to NYHA III and IV patients. 
 
Methods 
The study population consisted of 952 patients (188 were in NYHA II) 
consecutively implanted with biventricular devices. They were enrolled in a 
national observational registry and underwent baseline evaluation and 
periodical follow-up visits. We estimated the clinical outcome after 12-month 
of CRT, and we assessed the long-term survival. 
 
Results 
At a median follow-up of 16 months, significantly less major cardiovascular 
events were reported in the NYHA II patients compared to the NYHA III/IV 
patients (rate 13.0 vs. 23.0 per 100 patient-years of follow-up, p< 0.001). 
The percentage of patients who improved the NYHA class after 12 months of 
CRT was lower in NYHA II than in NYHA III/IV patients (34% Vs. 69%, p< 
0.001), while the absolute increase of ejection fraction was similar in the two 
groups (8±9% Vs. 9±11%, p=NS), as well as the reduction of end-diastolic 
diameter (-3±8mm Vs. -3±8mm, p=NS) and end-systolic diameter (-4±10mm 
Vs. -6±10mm, p=NS). The NYHA II group experienced lower all-cause 
mortality (log-rank test p=0.018). In both groups, the patients with major 
cardiovascular events during follow-up exhibited less or no reverse 
remodeling compared to those with better long-term clinical outcome. 
 
Conclusions 
Our results indicate that CRT induced similar improvements of ventricular 
function in both groups, whereas the improvement in functional status was 
significantly lower for NYHA II than for III/IV patients. A positive effect of CRT 
on cardiac dimensions was associated with long-term beneficial effect on 
disease progression in NYHA II patients. 
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d. Efficacy of Cardiac Resynchronization Therapy in Very Old Patients. 
The InSync/InSync ICD Italian Registry 
 
This chapter is submitted to: 
A Achilli, M Gasparini, M Lunati, M Sassara, F Turreni, M Santini, M Landolina, L Padeletti, A 
Puglisi, M Bocchiardo, S Orazi, GB Perego, S Valsecchi, A Denaro. Efficacy of Cardiac 
Resynchronisation Therapy in Very Old Patients. The InSync/InSync ICD Italian Registry. Am 
Heart J. Under Review. 
 
Abstract 
 
Background 
This study aimed to assess the effects of cardiac resynchronization therapy 
(CRT) in ≥80years old patients versus patients <80years, in terms of clinical, 
functional and echocardiographic parameters, survival and incidence of 
arrhythmic events. 
 
Methods 
The study population consisted of 1181 patients (85 were ≥80years old) 
consecutively implanted with CRT devices, with and without ICD capabilities. 
They were enrolled in a national observational registry and underwent 
baseline evaluation and periodical follow-up visits. We estimated the clinical 
outcome after 12-month of CRT, and the mortality data. 
 
Results 
In the overall population, NYHA class and LV ejection fraction (EF) improved, 
and LV diameter decreased.  Similar changes were observed in the two 
groups after CRT. In the study population, 157 patients died, 144 (13%) in 
<80years group and 13 (15%) in ≥80years group. There was higher all-cause 
mortality (Log-rank test, p=0.015) among ≥80years patients and a trend 
toward higher sudden cardiac death (SCD) (p=0.057), with similar non-sudden 
cardiac death (p=0.293). However, using the combined end-point of SCD or 
appropriate shock from a defibrillator for ventricular fibrillation, and 
considering the higher proportion of combined CRT-defibrillator devices 
implanted in younger patients, no significant differences resulted between 
groups (p=0.455). In both groups, lower EF was associated with higher 
mortality. 
 
Conclusions 
Our results demonstrate similar efficacy of CRT in patients aged ≥80years 
and in those under 80, in terms of clinical and functional parameters and in 
terms of reverse remodeling. Similarly, CRT results in comparable effects on 
death for worsening heart failure and on sudden cardiac death. 
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e. Limited Thoracotomy as a Second Choice Alternative to Transvenous 
Implant for Cardiac Resynchronization Therapy Delivery 
 
This chapter is published in: 
Puglisi A, Lunati M, Marullo AG, Bianchi S, Feccia M, Sgreccia F, Vicini I, Valsecchi S, 
Musumeci F, Vitali E. Limited thoracotomy as a second choice alternative to transvenous 
implant for cardiac resynchronisation therapy delivery. Eur Heart J. 2004;25:1063-9. 
 
Abstract 
 
Aims 
Left ventricular (LV) pacing via transvenous implantation has an overall 
success rate ranging from 88% to 92%. The aim of this study was to assess 
whether LV pacing via limited thoracotomy would be feasible and safe when 
used on a routine basis for those cases in which standard transvenous 
procedures proved to be ineffective or unsatisfactory. 
 
Methods and results 
We enrolled 33 patients (8 females, 65±10 years) who experienced a 
transvenous implantation failure. All patients underwent a limited thoracotomy 
and an epicardial lead was implanted. The procedure time was 51±28 min. No 
surgical or post-operative complications occurred and optimal lateral position 
was achieved for all patients. In the 12 months follow-up period, 5 patients 
died from refractory heart failure, the remaining patients did not experience 
complications. At implant, the mean pacing threshold was 1.3±0.7 V, bi-
ventricular pacing impedance was 476±201 X and R-wave amplitude was 
15.0±6.1 mV. No significant differences were found in any of the electrical 
parameters between baseline and follow-up. Significant improvement was 
observed in functional and echocardiographic parameters. 
 
Conclusions 
Our results suggest that a combined approach to cardiac resynchronisation 
therapy delivery, including a transvenous attempt followed by a back up 
thoracotomic procedure, could potentially guarantee the success. 
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f. Evolution and Prognostic Significance of Diastolic Filling Pattern in 
Cardiac Resynchronization Therapy. 
 
This chapter is published in: 
Porciani MC, Valsecchi S, Demarchi G, Colella A, Michelucci A, Pieragnoli P, Musilli N, 
Gensini GF, Padeletti L. Evolution and prognostic significance of diastolic filling pattern in 
cardiac resynchronization therapy. Int J Cardiol. 2006;112:322-8. 
 
Abstract 
 
Background 
Cardiac resynchronization therapy (CRT) is an emerging treatment for heart 
failure patients with left bundle branch block; in these patients left ventricle 
filling pattern (LVFP) abnormalities are recognized as cause of symptoms and 
predictors of outcome. We investigated the effects of CRT on diastolic 
function and the prognostic value of LVFP in patients on CRT. 
 
Methods 
65 patients treated with CRT were studied over a 12 months period. At 
baseline, according to defined echocardiographic criteria, restrictive LVFP 
(RFP) was present in 25 patients, whereas 40 patients showed no-RFP. 
 
Results 
After CRT, opposite changes occurred in the two groups. In no-RFP patients, 
early-to-atrial filling velocity ratio (E/A) increased from 0.8±0.3 to 1.0±0.6 (p = 
0.006) and E wave deceleration time (DT) decreased from 234±83 ms to 
196±51 ms (p = 0.028). In 13 RFP patients, E/A decreased from 2.2±0.9 to 
0.8±0.5 and DT increased from 128±43 ms to 205±52 ms (both p < 0.001), 
leading to reversal of RFP. In both groups, clinical, functional and echographic 
benefits were evident, with mortality rates of 5% (2/40) and 15% (2/13) 
respectively. The remaining patients showed persistence of RFP (E/A and DT 
unchanged), no improvement and a mortality rate of 42% (5/12) (p = 0.005, 
versus no-RFP). 
 
Conclusions 
CRT improves diastolic function, inducing also reversal of LVFP in a 
consistent number of RFP patients. The persistence of RFP after CRT is 
associated to an extremely poor prognosis. 
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g. Results of the SCART Study: Selection of Candidates to Cardiac 
Resynchronization Therapy 
 
This chapter is published in: 
C Peraldo, A Achilli, S Orazi, M Sassara, F Laurenzi, A Cesario, G Fratianni, E Lombardo, S 
Valsecchi, A Denaro, A Puglisi. Results of the SCART Study: Selection of Candidates to 
Cardiac Resynchronization Therapy. J Cardiovasc Med. 2007; In Press. 
 
Abstract 
 
Aims 
To prospectively determine whether pre-specified selection criteria of ECG, 
echocardiography (ECHO) and tissue Doppler imaging (TDI) may predict the 
response to cardiac resynchronization therapy (CRT). 
 
Methods 
In this multicenter, prospective, non-randomized study, 96 heart failure 
patients with NYHA class III-IV symptoms, ejection fraction ≤35% and at least 
one marker of ventricular dyssynchrony according to pre-specified ECG, 
ECHO or TDI criteria were enrolled. The primary end-point was the 
improvement in clinical composite score at six months. 
 
Results 
At the enrollment, 70 patients fulfilled ECG criterion (QRS duration ≥ 150ms), 
77 subjects demonstrated ECHO signs of dyssynchrony, while TDI 
dyssynchrony criteria were present in 37 patients. 
The overall responder rate was 78/96 (81%). In particular, the primary end-
point was reached in 68 patients with ECHO criteria, compared to 10 patients 
not satisfying them (88% vs. 53%, p=0.001). 
Patients satisfying ECHO selection criteria showed a significant greater 
reduction of LVESD (p=0.029) and a larger improvement of QoL (p=0.017) 
with respect to patients not fulfilling them. Neither ECG nor TDI criteria 
seemed to predict the response to CRT. 
 
Conclusions 
In our patient population, mechanical indexes of dyssynchrony as detected by 
ECHO seemed to identify responders to CRT. Although TDI is useful to 
evaluate the reduction of ventricular dyssynchrony after CRT, the pre-selected 
TDI inclusion criteria used in this analysis did not increase the number of 
responder to CRT. 
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h. Prediction of Response to Cardiac Resynchronization Therapy: the 
Selection of Candidates for CRT (SCART) Study. 
 
This chapter is published in: 
Achilli A, Peraldo C, Sassara M, Orazi S, Bianchi S, Laurenzi F, Donati R, Perego GB, 
Spampinato A, Valsecchi S, Denaro A, Puglisi A. Prediction of Response to Cardiac 
Resynchronization Therapy: The Selection of Candidates for CRT (SCART) Study. Pacing 
Clin Electrophysiol. 2006;29 Suppl 2:S11-9. 
 
Abstract 
Background 
The aim of this study was to evaluate the ability of baseline clinical and 
echocardiographic parameters to predict a positive response to CRT. 
 
Methods 
We analyzed 6-month data from the first 133 consecutive patients enrolled in 
a multicenter prospective study. These patients had symptomatic heart failure 
(HF) refractory to pharmacological therapy (NYHA class II–IV), left ventricular 
ejection fraction (LVEF) ≤35%, and prespecified electrocardiographic, 
echocardiographic or tissue Doppler imaging markers of left ventricular (LV) 
dyssynchrony. 
 
Results 
After a follow-up period of 6 months, 1 patient died and 13 were hospitalized 
for worsening HF. There were significant (P < 0.01) clinical, functional, and 
echocardiographic improvements that included: New York heart Association 
Class, Quality-of-Life Score, QRS duration, LVEF, LV end-diastolic and 
endsystolic diameter (LVESD), and severity of mitral regurgitation A positive 
response was documented in 90/133 (68%) patients who presented an 
improved clinical composite score associated to an increase in LVEF ≥ 5 
units. A multivariate analysis identified that a smaller LVESD (OR = 0.957, 
95% CI 0.920–0.996; P = 0.030) and longer interventricular mechanical delay 
(IVMD) (OR = 1.017, 95% CI 1.005–1.029, P = 0.007) as independent 
predictors of a positive response. Receiver-operating curve analysis showed 
that a positive response to CRT may be predicted in patients with IVMD > 44 
ms (with a sensitivity of 66% and a specificity of 55%) or with LVESD < 60 
mm (with a sensitivity of 66% and a specificity of 61%). 
 
Conclusions 
Our results confirm the limited value of QRS duration in the selection of 
patients for CRT. A less-advanced stage of disease and echocardiographic 
evidence of interventricular dyssynchrony demonstrated to predict response 
to CRT, while intraventricular dyssynchrony did not predict response. 
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